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Abstract 
 
 
This research investigated two groups of patients diagnosed with dementia before the 
age of sixty-five. The patients were diagnosed with Alzheimer’s Disease (AD, n = 25) 
and Frontotemporal Dementia (FTD, n = 37). Patients were assessed for 
approximately 3 years. The study found that FTD is a valid and useful diagnostic 
category, and can be reliably differentiated from AD.  A combination of behavioural, 
neurological, and neuropsychological assessments were found to be complementary in 
the early and accurate diagnosis of early-onset dementia, and the differential diagnosis 
of FTD from AD. FTD patients were found to have relatively preserved visuo-spatial 
abilities compared to the AD patients. Problems associated with administering 
neuropsychological tests to early-onset dementia patients were highlighted. FTD 
patients were found to deteriorate more rapidly than AD patients, and to have 
significantly increased behavioural disturbances throughout the course of the illness in 
comparison with the AD patients.   Practical guidelines to assist with care and 
management of early-onset dementia patients were presented.  A strengths-based 
model of care was outlined. Individualised assessments and care plans were 
recommended for the development and provision of humane services to early-onset 
dementia patients.  Issues surrounding providing palliative care were discussed.  
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   1 
 
 
 
 “In striking contrast to Alzheimer’s Disease, the majority of 
dementia of the frontal type patients are brought along to the 
clinic blissfully unaware of the major changes of personality 
and behaviour observed by their relatives.”  
           Gregory & Hodges, 1996, p.111  
 
 
“The frontal lobes are both massive and neuroanatomically 
diverse. Their size predicates against generalisations; 
pathological involvement of different loci within the frontal 
lobes can be anticipated to produce quite different behavioural 
alterations. The uniqueness of the human prefrontal lobes 
removes the ability to use relatively clean animal studies for 
correlation: only human case material is valid. Thus the type 
of neuropathology and its relatively focal nature is of 
paramount importance to investigations of human frontal lobe 
functions”  
        Stuss and Benson 1986, p. 39    2 
 
CHAPTER 1 
INTRODUCTION 
 
“Caring for patients with Frontotemporal Dementia 
necessitates a whole new category of research”. 
        Passant & Elfgren et al. 2005, p. 17 
 
1.1 OUTLINE OF CURRENT STUDY 
1.1.1 Early Onset Dementia 
This research investigates conditions affecting people with early-onset dementia. A 
diagnosis of early-onset dementia is commonly given only if a person develops 
dementia before the age of sixty-five (Harvey, 1998; McMurtray, & Clark, 2006). In 
recent years, this group of younger early-onset dementia patients has become of 
increasing interest to researchers, specialists, and care providers (Harvey, 1998; 
McMurtray, & Clark, 2006).   
 
Early and accurate diagnosis of specific dementia sub-types has become increasingly 
important as new behavioural and pharmaceutical interventions become available to 
assist with the management and treatment of these high care-need patients   (Miller & 
Cummings, 1999; Pasquier, 1999;  Rosen & Hartikainen et al. 2002;  Pasquier & 
Richard et al.  2004; van Reekum & Binns et al. 2005; Chapman & Williams et al. 
2006). Knibb et al. (2006) make the point that revisions may be necessary to improve 
the validity and applicability of diagnoses of dementia, and suggest that  “Further   3 
research should aim to integrate detailed clinical, radiological, pathological and 
genetic information”.  This study has been designed to investigate the relatively new 
diagnostic category of Frontotemporal Dementia, evaluate current assessment 
protocols, and most importantly, to provide practical guidelines to assist with care and 
management of early-onset dementia patients.   There have been few systematic 
studies of the management and treatment of Frontotemporal Dementia (Diehl-Schmid 
& Pohl et al. 2006; Ishikawa & Shimomura et al. 2006).  
 
This research explores two groups of patients diagnosed with dementia before the age 
of sixty-five. The groups are patients diagnosed with Alzheimer’s Disease (n = 25) 
and Frontotemporal Dementia (n = 37). The study explores the syndromes associated 
with Frontotemporal Dementia (FTD), and the differential diagnosis of 
Frontotemporal Dementia from Alzheimer’s Disease (AD).  
 
The study assesses the two groups using clinical interviews with the patients, 
interviews with the patients’ primary carers, and behavioural observations over a 
period of between two years and nine months and three years and three months for 
each patient. Patients are assessed with a range of standardised neuropsychological 
measures. Neuropsychological test performance is evaluated qualitatively and 
quantitatively. Problems associated with administering neuropsychological measures 
to early-onset Alzheimer’s Disease and Frontotemporal Dementia populations are 
highlighted.    4 
1.1.2 Case Studies 
 In addition, behavioural and neurological syndromes associated with Frontotemporal 
Dementia and Alzheimer’s Disease are illustrated utilizing case studies. Case studies 
have been widely used in research into neurological conditions for several reasons. 
Firstly, researchers have experienced difficulties in obtaining sufficient sample sizes 
for valid statistical analysis (Stuss & Benson, 1986; Stuss, 1996; Marshall & 
Hutchinson, 2001). Secondly, many neurological researchers regard case studies as the 
most appropriate form of investigation due to the heterogeneous nature of many 
neurological conditions. The diversity of subjects even in established neurological 
diagnostic categories results in important clinical information being lost in group 
studies (Stuss & Benson 1986; Miller & Cummings et al. 1991; Marshall & 
Hutchinson, 2001).  Thirdly, case studies have been widely used in the study of 
patients with acute neurological conditions. Any group of patients with acute 
neurological conditions characteristically exhibit a wide range of impairments that 
make standardised neuropsychological assessment difficult or impossible (Johanson & 
Hagberg, 1989; Smeding & de Koning; 2000).  
 
1.1.3 Qualitative and Quantitative Aspects of this Research 
This research adds to the existing literature by providing detailed analysis of the 
behavioural changes associated with early-onset Frontotemporal Dementia and 
Alzheimer’s  Disease. Research in this area is difficult as early-onset dementia is 
significantly less common than late-onset dementia (i.e. beginning after the age of 
sixty-five; Snowden & Neary et al.  1996; Stuss, 1996;   5 
 Ritchie & Lovestone, 2002). This study provides detailed qualitative and quantitative 
evaluation of the test variables and behavioural changes in relatively large early-onset 
dementia subject groups (37 Frontotemporal Dementia and 25 Alzheimer’s Disease 
patients) over a three-year time interval (± 3 months) for each patient. This research 
also explores the difficulties involved in providing effective clinical services to early-
onset dementia   patients and their carers, and provides practical guidelines to carers 
and service-providers to assist with the effective management of this group of 
relatively young people with disabilities.  
 
1.1.4 Review of Literature 
An introductory literature review is presented to outline the diagnostic criteria for the 
various forms of early-onset dementia, and to show that early-onset dementia 
diagnostic criteria are still evolving. The introductory literature review sets the scene 
for the studies that follow.  
 
Several topics are addressed separately in separate chapters in this thesis. The topics 
include the value of formal psychometric assessment, neuropsychological tests, 
behavioural observations and neurological investigations in establishing a diagnosis of 
frontotemporal dementia or early-onset Alzheimer’s disease, and in predicting the rate 
of cognitive deterioration; and making use of this information to formulate care and 
treatment plans for patients with differing forms of early-onset dementia.    6 
 Each of these topics is reviewed in detail before the relevant findings are presented, to 
help the reader integrate the findings with existing knowledge.  
 
1.2 ORIGINS OF FRONTOTEMPORAL DEMENTIA AS A CATEGORY 
DISTINCT FROM ALZHEIMER’S DISEASE: DEFINING A NEW FORM OF 
DEMENTIA 
1.2.1 History of Frontotemporal Dementia 
A dementing illness with accompanying significant behavioural disturbance was first 
recorded by Arnold Pick, a professor of psychiatry in Prague (Pick, 1906). Pick 
described six patients with a dementing illness and behavioural disturbance that 
occurred in conjunction with bilateral frontal atrophy (Kertez, 1996; Snowden & 
Neary et al.  1996; Spatt, 2000 & 2003). Pick provided excellent behavioural 
descriptions of patients with the illness.  Pick did not, however, describe the 
accompanying changes in cells and tissue at the microscopic level, the underlying 
histological changes associated with Frontotemporal Dementia (Neary & Snowden, 
1996; Kertez, 1996; Spatt, 2000 & 2003).    
 
Alzheimer first documented the characteristic histological changes accompanying the 
behavioural disturbances in 1911 (Kertez, 1996; Neary & Snowden et al. 1996). 
Alzheimer found that a group of patients with specific behavioural disturbances had 
“ballooned cells, argentophilic globes, and spongicortical wasting in the frontal and 
anterior temporal lobes (Snowden & Neary et al. 1996).  This presentation of 
behavioural disturbance with circumscribed atrophy of the    7 
frontal and temporal lobes became known as “Pick’s Disease” (Onari & Spatz, 1926).   
 
1.2.2 Historical Diagnosis of Non-Alzheimer’s Dementia 
The groundbreaking early research by Pick, Alzheimer, and other researchers clearly 
indicated some dementias were not of the Alzheimer’s type (Kertez, 1996; Neary & 
Snowden, 1996; Spatt, 2000 & 2003). Despite this important early research, dementia, 
until recently, has been widely viewed as a generalized and undifferentiated 
impairment of mental functioning, with dementia being seen as synonymous with 
Alzheimer’s Disease (Miller & Darby et al. 1995; Snowden, Neary, Mann, 1996).   A 
major change in the understanding of the heterogeneity of dementia occurred in the 
late 1980’s when teams of Swedish and English researchers separately published 
journal articles that brought to attention the fact that dementing illnesses affecting 
primarily the frontal and anterior temporal lobes were significantly under diagnosed 
(Brun, 1987; Neary & Snowden, et al.1988).   
 
1.2.3 Problems with the Diagnosis of Non-Alzheimer’s Disease Dementias  
In recent years, researchers have highlighted major shortcomings in the diagnosis, 
research, and treatment of dementias that affect primarily the frontal and temporal 
lobes of the brain (Knopman & DeKosky et al. 2001; Derouesne, 2003).  Currently 
accepted diagnostic criteria (see Table 1 p.9) for dementia were put forward by the 
NINCDS-ADRDA: National Institute of Neurological and Communicative Disorders 
and Stroke / Alzheimer’s Disease and Related    8 
Disorders Association (McKhann & Drachman et al. 1984; Varma & Snowden et al. 
1999; Knopman & DeKosky et al. 2001).  
 
A growing body of research findings has indicated that the NINCDS-ADRDA criteria 
(see Table 1, p.9), although effective for detecting a wide range of neurological 
conditions, are overly inclusive (Varma & Snowden et al. 1999; Derouesne, 2003).  
The NINCDS-ADRDA criteria include all patients who exhibit disturbances of 
memory combined with deficits in one or more areas of functioning.  The overly 
inclusive nature of the NINCDS-ADRDA criteria has resulted in the diagnosis of 
Alzheimer’s Disease being given to patients who have later been shown to have 
unequivocal non-Alzheimer’s Disease pathology (Snowden & Neary et al. 1996; 
Lebert & Pasquier et al. 1998; Varma & Snowden et al. 1999; Graham & Davies et al. 
2005).   9 
Table 1: NINCDS-ADRDA diagnostic criteria for dementia.  
1) Essential clinical criteria for the diagnosis of possible dementia: 
a)  Dementia established by a clinical examination and documented by the 
Mini-Mental State Exam   (MMSE, Folstein, Folstein, &, McHugh, 1975), 
and confirmed by neuropsychological tests. 
b)  Deficits recorded in two or more areas of cognition.  
c)  Progressive deterioration of memory and other cognitive functions. 
d)  No disturbance of consciousness. 
e)  Absence of systemic disorders or other brain diseases that in and of 
themselves could account   for the progressive deficits in memory and 
cognition. 
2) A diagnosis of probable dementia is supported by: 
a)  Progressive deterioration of specific cognitive functions including 
language (aphasia), motor skills (apraxia), and perceptions (agnosia). 
b)  Impaired activities of daily living (ADL’s, e.g. Lehfeld, Reisberg, & 
Finkel, 1997) and altered patterns of behaviour. 
c)  Family history of dementia, particularly if confirmed neuropathologically. 
d)  Normal lumbar puncture as evaluated by standard techniques. 
e)  Normal pattern or non-specific changes in EEG, such as increased slow-
wave activity. 
f)  Evidence of cerebral atrophy on CT with progression documented by serial 
CT results. 
3) Other clinical features consistent with the diagnosis of probable dementia: 
a)  Plateaus in the course of the progression of the illness.  
b)  Associated symptoms of depression, insomnia, incontinence, delusions, 
illusions, hallucinations, catastrophic verbal, emotional, or physical 
outbursts, sexual disorders, and weight loss.  
c)  Other neurological abnormalities in some patients, especially with disease 
that is more advanced and including motor signs such as increased muscle 
tone, myoclonus, or gait disorder.  
d)  Seizures in advanced stages of the disease. 
4) Features that make the diagnosis of probable dementia uncertain or 
unlikely: 
a)  Sudden, apoplectic onset. 
b)  Focal neurological findings such as paralysis on one side of the body, 
sensory loss, visual field deficits, and incoordination early in the course of 
the illness. 
c)  Seizures or gait disturbances at the onset or very early in the course of the 
illness. 
d)  Pseudodementia 
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1.2.4 The Origins of “Frontotemporal Dementia” as a New Diagnostic Label: 
Challenges to the Homogeneity of Dementia 
Since the 1970s, a growing body of research has altered the understanding of 
dementias affecting the frontal and anterior temporal lobes of the brain (e.g. Tissot & 
Constantinidis et al. 1975; Snowden & Neary et al.  1996; Chow, 2003; Boccardi & 
Sabattoli et al. 2005; Mariani & Defendi et al. 2006).    This research has led to the 
new classification of Frontotemporal Dementia (FTD).  The classification of 
Frontotemporal Dementia is based on clinical, pathological, and genetic features 
associated with neuropathological conditions that researchers argue  are strikingly 
different to Alzheimer’s Disease   (Gustafson & Risberg, 1974; Brun & Gustafson et 
al. 1994; Filley & Kleinschmidt-De Masters et al. 1994; Gregory & Hodges, 1996; 
Snowden & Neary et al.  1996; Knopman & DeKosky et al. 2001; Curcio & Kawarai 
et al. 2002).     
 
Collaborative research between British and Swedish researchers (Lund and 
Manchester groups: Gustafson, 1987; Brun & Englund et al. 1994) has resulted in the 
classification of a dementia affecting primarily the frontal and temporal regions of the 
brain as “Frontotemporal Dementia” or “FTD” (Gustafson, 1987; Gustafson & Brun et 
al. 1994).   The researchers used the term “Frontotemporal Dementia” to clearly 
differentiate the disorder from Alzheimer’s Disease (Gustafson & Brun, 1999).  
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The Lund-Manchester collaboration produced initial clinical criteria for the 
differential diagnosis of Frontotemporal Dementia from other neurological  
conditions. The clinical criteria for Frontotemporal Dementia have been further 
refined by Neary and colleagues (Neary & Snowden & Neary et al.  1998; Faber, 
1999) The criteria (see  Table 2, p.12) developed by the above researchers have been 
found to significantly improve the differential diagnosis of Frontotemporal Dementia 
from other dementing conditions, especially Alzheimer’s disease (Duara & Barker et 
al. 2002; Mariani & Defendi et al. 2006). 
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Table 2: Diagnostic criteria for probable Frontotemporal Dementia (FTD).  
1) Essential diagnostic features 
 
a)  Insidious onset and gradual progression of the disease process. 
b) Decline in social interpersonal conduct early in the course of the illness. 
c)  Impairment in regulation of personal conduct early in the course of the illness. 
d) Early emotional blunting. 
e)  Early loss of insight.  
  
2) Supportive diagnostic features 
 
a) Behavioural disorder.  
i. Decline in personal hygiene and grooming. 
ii. Mental rigidity and inflexibility. 
iii. Distractibility and impersistence. 
iv. Hyperorality and dietary changes. 
v. Perseverative and stereotyped behaviour. 
vi. Utilization behaviour. 
  
  b) Speech and Language 
i. Altered speech output. 
ii. Aspontenaeity and economy of speech. 
iii. Stereotypy of speech.  
iv. Echolalia. 
v. Perseveration. 
vi. Mutism. 
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Table 2 continued: Diagnostic criteria for Frontotemporal Dementia (FTD).  
c) Physical signs 
i. Early primitive reflexes. 
ii. Early incontinence. 
iii. Akinesia, rigidity, and tremor. 
iv. Low and labile blood pressure. 
  
d) Investigations 
i. Neuropsychological examination.   
ii. Electroencephalography: normal on conventional EEG despite clinically evident dementia.  
iii. Brain imaging (structural and/or functional): predominant frontal and/or anterior temporal abnormality. 
  
e) Supportive Features 
i. Onset before 65: positive family history of similar disorder in first-degree relative. 
ii. Bulbar palsy, muscular weakness and wasting, fasciculations (associated motor neuron disease present in a 
minority of patients). 
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1.2.5 Labels for Frontotemporal Lobar Atrophy 
The understanding of disease processes involving primarily Frontotemporal 
lobar atrophy continues to improve with new research findings (Stuss, 1993; 
Brun & Passant, 1996; Gustafson & Brun, 1999; Neary & Snowden et al. 1998; 
Knoppman & DeKosky et al. 2001; Gee & Ding et al. 2003; Pasquier & Richard 
et al. 2004; Harciarek & Jozio, 2005; Roberson & Hesse et al. 2005).  A variety 
of terms have been used for this condition (See Appendix 2, p.235,  Hodges, 
2001; Tanabe¸ 2000; Rossor, 2001; Wahlund, Andersen, & Östberg, 2002; 
Pasquier & Richard et al. 2004; Pasquier, 2005).  For the purposes of this 
research, in line with recent consensus criteria “Frontotemporal Dementia” or 
“FTD” refers specifically to neurological disorders that cause damage primarily 
to the frontal and anterior temporal lobes of the brain (Levy & Miller et al. 
1996; Neary & Snowden, 1996; Neary & Snowden et al. 1998; Tanabe, 2000).  
The term “Frontotemporal Dementia” is now used in preference to “Pick’s 
Disease” (Hodges, 2001).   
 
1.2.6 Heterogeneity of Frontotemporal Dementia 
It is important to note that the term “Frontotemporal Dementia” is a 
heterogeneous term.  Frontotemporal Dementia refers to a clinical and 
pathological cluster of disorders. The pathalogical cluster includes Motor 
Neurone Disease with associated dementia (MND/FTD), Pick’s Disease, frontal 
lobar degeneration (FLD). Progressive aphasia is a clinical cluster for anterior-
type dementia (Snowden & Neary et al. 1996; Boone & Miller et al. 1999; 
Gustafson & Brun, 1999; Kertesz, Martinez-Lage et al. 2000).  In line with the    15 
heterogeneity of Frontotemporal Dementia, research indicates that there is no  
single specific cause, as the frontal and temporal regions of the brain can be 
damaged by a wide range of disease processes (Bird, 1998; Gustafson & Brun, 
1998; Snowden & Neary et al.  2004).  
 
1.2.7 Heterogeneity of Alzheimer’s Disease 
Galton and colleagues (Galton & Patterson et al. 2000) described the widely 
differing clinical presentations of patients diagnosed with Alzheimer’s Disease.  
The researchers found that in a group of thirteen Alzheimer’s Disease patients 
four presented with a typical Alzheimer’s Disease amnesic syndrome, one 
exhibited progressive visual dysfunction, two progressive biparietal syndrome, 
and six progressive aphasia.  Imaging studies of the patients indicated 
significantly different patterns of neurodegeneration.     
 
The heterogeneity of both Alzheimer’s Disease and Frontotemporal Dementia 
groups provides challenges for researchers attempting to accurately diagnose 
each group, and to accurately diagnose the variations in the disease taking place 
in each patient.  
 
1.2.8 The Underdiagnosis of Frontotemporal Dementia 
Despite the significant recent advances in the understanding and diagnosis of 
different forms of dementia, it is believed that Frontotemporal Dementia is 
frequently misdiagnosed as Alzheimer’s Disease, or under-diagnosed (Gregory  
& Hodges, 1996; Neary & Snowden et al. 1998; Pasquier & Lebert et al. 1998; 
Ratnavalli & Brayne et al. 2002; Pasquier & Richard et al. 2004; Passant &   16 
Elfgren et al. 2005).   A U.K. study  has indicated that Alzheimer’s Disease may 
account for only fifty per cent of dementia cases if patients are diagnosed in line 
with the latest clinical diagnostic criteria (Harvey, 1998).   
 
One study found that approximately 85 percent of patients eventually diagnosed 
with   Frontotemporal Dementia had previously been given a diagnosis of 
Alzheimer’s Disease (Miller & Ikonte et al. 1997).  Passant and colleagues 
(2005) in a study of 19 Frontotemporal Dementia patients found that only 1 had 
been initially diagnosed correctly. Patients were diagnosed initially with 
psychiatric disorders and other neurological conditions. Dementias affecting 
primarily the frontal and temporal lobes are believed to affect between eight and 
twenty percent of dementia patients (Gustafson, 1987, 1993; Neary & Snowden 
et al. 1987; Harvey, 1998; Lebert & Pasquier et al. 1998; Ikeda & Ishikawa et al. 
2004).  Recent studies have found Frontoemporal Dementia to be more common 
in men, and to be a significant cause of ealry onset dementia Ratnavalli & 
Brayne et al. 2002).  
 
1.2.9 Current Criteria for the Diagnosis of Frontotemporal Dementia 
The clinical diagnosis of Frontotemporal Dementia is based on the occurrence 
of profound personality change and alterations in social conduct accompanying 
frontal and anterior temporal lobe deterioration (Snowden & Neary et al. 1996;    17 
Kertesz & Davidson et al. 1997; Snowden & Neary et al.  2002).  The diagnosis 
of Frontotemporal Dementia always requires a complex assessment, as the 
diagnostic criteria do not fit precisely with known neuropathological 
phenotypes.  In contrast to Frontotemporal Dementia, a condition such as 
Creutzfeldt–Jakob disease (CJD) has a precise match between diagnostic criteria 
and neuropathology (Knoppman & DeKosky et al. 2001).   Diagnosis of  
Frontotemporal Dementia consists of a complete family and medical history, 
behavioural assessment, neuropsychological assessment, neurological 
examination, MRI, SPECT, and CT imaging studies of the brain (Snowden & 
Neary et al. 1996; Neary & Snowden et al. 1998; Duara & Barker et al.  1999; 
Charpentier &  Lavenu et al.  2000; Sjogren & Gustafson et al. 2000).  
 
Obtaining a correct diagnosis is important for patients, their families, and carers, 
as the diagnosis has major implications for prognosis, possible treatments, and 
the provision of appropriate supports.  Due to the genetic link in many families, 
diagnosis can have serious long-term implications for other family members.  
Patients diagnosed with early onset dementia often require costly and 
specialized institutional care (Harvey, 1998; Cucio & Kawarai et al. 2002; 
Chapman & Williams et al. 2006).    Understanding the specific care needs of 
relatively young dementia patients is important if health services are to provide 
appropriate ongoing care (Harvey, 1998).    18 
 
 
1.2.10 Age of Onset & Length of Illness 
The age of onset for Frontotemporal Dementia is generally between the 45 and 
60 years (Snowden & Neary et al. 1996; Diehl & Kurz, 2002).  Equal incidences 
for men and women have been reported.   The length of the illness varies from 2 
to 20 years, with a median duration of illness of approximately 8 years before 
the patient dies (Pasquier & Lebert et al. 1999; Pasquier & Richard et al. 2004; 
Kertesz & McMonagle et al. 2005).  
 
1.3 SUMMARY  
This research explores and evaluates two groups of patients (Alzheimer’s 
Disease and Frontotemporal Dementia) diagnosed with early-onset dementia.  
The evaluation uses behavioural, neurological, and neuropsychological 
assessment. Case studies are also utilised to illustrate differing neurological 
conditions.  A major objective of the research is to provide practical information 
to those involved in the care and treatment of patients with early-onset 
dementia.     
 
A review of the literature supporting Frontotemporal Dementia as a distinct 
category from Alzheimer’s Disease was provided.  Current diagnostic criteria 
for Frontotemporal Dementia and Alzheimer’s Disease were given. Problems 
associated with the overly inclusive Alzheimer’s Disease diagnostic criteria 
were explored.  Methodology is presented in Chapter 2.    19 
 
 
1.4 MAJOR OBJECTIVES OF CURRENT STUDY  
The major objectives of this study are to: 
•  Further evaluate the validity and utility of the relatively new diagnostic          
category of Frontotemporal Dementia. 
•   Evaluate the importance of behavioural, neurological, and neuropsychological 
assessment in the early and accurate diagnosis of dementia. 
•  Provide practical information to care providers regarding the needs of people 
who receive a diagnosis of early onset dementia.  
 
1.5 HYPOTHESES  
1.  The clinical criteria developed by Neary & Snowden et al. (1998) will be 
able to differentially diagnose early-onset Frontotemporal Dementia 
patients from early-onset Alzheimer’s Disease patients.  
 
2.  The analysis of this group of patients will provide information that may 
assist in the formulation of care and treatment plans for patients with 
differing forms of early-onset dementia. 
 
3.  The Frontotemporal Dementia patient group will have significantly 
increased behavioural disturbances throughout the course of the illness in 
comparison with Alzheimer’s Disease patient group. Evaluation of    20 
4.  behavioural profiles will assist with the differential diagnosis of 
Frontotemporal Dementia patients from Alzheimer’s Disease patients. 
Previous research has indicated that the evaluation of behavioural profiles 
can assist in differentially diagnosing Frontotemporal Dementia from 
Alzheimer’s Disease (Levy & Miller et al. 1996; Duara & Barker et al.  
1999; Pasquier 1999; Tanabe & Ikeda et al. 1999; Bozeat & Gregory et 
al. 2000; Cummings & McPherson, 2001; Ikeda & Brown et al. 2002; 
Shingenobu & Ikeda, 2002; Kertesz & Davidson et al. 2003; Mourik & 
Rosso et al. 2004; Srikanth & Nagaraja et al. 2005; Engelborghs & 
Maertens et al. 2005; Thompson & Stopford et al. 2005).    
 
5.  Frontotemporal Dementia and Alzheimer’s Disease patients will show 
significant differences on neuropsychological tests, with Frontotemporal 
Dementia patients having relatively preserved visuo-spatial functioning.  
This pattern of impaired visuo-spatial abilities in Alzheimer’s Disease 
and relatively preserved visuo-spatial abilities in Frontotemporal 
Dementia has been a consistent result of neuropsychological 
investigations of these two groups (Elfgren & Passant et al. 1993; Stuss, 
1993; Gregory & Orrell et al. 1997; Duara & Barker et al.  1999; 
Pasquier, 1999; Ikeda & Tanabe, 2000; Storey & Slavin et al. 2002; 
Kramer & Jurik et al. 2003; Harciarek Jodzio, 2005).    21 
 
6.  The course of the illnesses will differ significantly between the early-
onset Frontotemporal Dementia and Alzheimer’s Disease groups. 
Frontotemporal Dementia patients are expected to have rapid progression 
of disease symptoms, with Alzheimer’s Disease patients showing a more 
gradual deterioration.   Early-onset Frontotemporal Dementia patients 
have consistently been found to deteriorate more rapidly than early-onset 
Alzheimer’s Disease patients (Barber, Snowden & Caufurd, 1995; 
Pasquier & Richard et al. 2004; Kertesz & McMonagle et al. 2005; 
Roberson & Hesse et al. 2005; Pasquier & Lebert et al. 2005).  
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CHAPTER 2 
METHOD 
2.1 SUBJECTS AND PROCEDURE 
Subjects in the study were sixty-two Health Department of Western Australia 
outpatients diagnosed with dementia. The author was involved in the assessment 
and management of the patients over a five-year period. He provided 
behavioural management training and support to families and staff in the home 
and in hospitals or nursing homes.  
 
Patients in the study were referred to a unit specialising in early-onset (onset 
before 65 years of age) neurodegenerative disorders. Referrers were families, 
self-referrals, general practitioners, psychiatrists, and neurologists.  Data were 
collected from the sixty-two patients aged between 35 and 65 (mean age = 58.8 
years, Table 3 below).     The average number of years of education for the 
subjects was 10.9 years.  Thirty-four of the subjects were female, and twenty-
eight of the subjects were male.  There was no significant difference between 
the two groups for age, sex, or education (Tables 3 & 4 below).   
 
Family members were asked to estimate the age when changes in behaviour 
and/or memory were first noticed (Table 3 below).  Average estimated age of 
onset was 54.1 years for the Frontotemporal Dementia group and 55.9 years for 
the Alzheimer’s Disease group. There was no significant difference between the 
two groups.   23 
Table 3: Age first assessed for current study, estimated age of onset, and 
years of education of Frontotemporal Dementia and Alzheimer’s Disease 
patients at first assessment.  
 
  FTD      AD     
Levene’s 
Test For    
  N  Mean 
Std. 
Dev  N  Mean 
Std. 
Dev 
Equality 
of 
Variance  t(df)*  
Age  37  58.8  7.1  25  60.1  4.8  0.96  .81(60) 
Est. Age of 
Onset  27  54.1  7.5  18  55.9  5.4  0.55  .87(43) 
Education  37  10.9  2.4  24  10  1.8  3.80  1.74(59)  
* = none of the differences between groups were statistically significant 
 
Table 4: Sex of Frontotemporal Dementia and Alzheimer’s Disease patients. 
 
SEX  FTD  AD  Total 
Chi 
Square 
Male  17  11  28  0.02 * 
Female  20  14  34   
Total  37  25  62   
* = not significant 
 
Written consent was obtained from all subjects or their legal guardians 
(Appendix 1, p. 233).  All patients in the study underwent an extensive clinical 
evaluation by a multi-disciplinary team.  The team consisted of a neurologist 
specialising in the diagnosis and treatment of patients with early-onset dementia, 
a clinical psychologist registrar (the author), psychiatrist, speech pathologist, 
and social worker.   All initial assessments for each patient occurred within a 
three-month time frame.  Not all subjects were assessed by each member of the 
team.  Assessments were conducted to assist with the clinical care of the 
patients and were not conducted primarily for research purposes.  No additional 
assessments were performed beyond those routinely    24 
administered by the hospital to enhance patient care. This was a requirement of 
the Murdoch University Ethics Committee to avoid placing families and carers 
under additional stress.  
 
The team neurologist made referrals to members of the team for assessment and 
treatment.   Full family and personal histories were taken from family members 
or primary carers.  Semi-structured interviews were used to obtain the following 
information:  
• Activities of daily living — self-care, orientation, communication, managing 
finances, using domestic appliances, using transport, concentration, coping with 
unfamiliar situations, participation in social activities,  and planning ability.   
• Age of onset. 
• Education and vocational history. 
• Family history of dementia or other neurological conditions. 
• Psychiatric symptoms — paranoid and delusional ideation, hallucinations, 
activity disturbances, aggressiveness, diurnal rhythm disturbances, inappropriate 
activity, ritualistic behaviours, affective disturbance, fears, phobias and 
anxieties.      
• Substance and alcohol usage history. 
•  Loss of insight. Patients were asked  “Do you have
 an illness or a problem that 
requires medical attention?” “
 Is your behaviour significantly different now, 
compared to a
 few years ago?” and “Do family/friends think that you have an 
illness
 or that something is wrong with you?".   
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Carers were used as a primary source of information about the patients.  This 
was done as many of the patients, especially the Frontotemporal Dementia 
patients, had severe memory disturbance and/or behavioural disturbance  
combined with marked verbal and non-verbal communication deficits at the 
time of their initial presentation at the hospital. The Health Department of 
Western Australia provided long-term clinical services to all the patients, their 
families, and carers who took part in the study.  
 
Patients were clinically assessed repeatedly during the study.   Average length of 
time for neurological review was six months.   Assessments were specifically 
designed for the provision of clinical services to the patients and their families.    
 
Patients with long-term major psychiatric illnesses were excluded from the 
study (n = 3); one patient had a long-term diagnosis of bipolar disorder, and two 
patients had received long-term electroconvulsive therapy for depression.    
Detailed case notes were kept for all patients.   All patients underwent 
neurological examinations, electroencephalogram (EEG), computed tomography 
(CT) and/or magnetic resonance imaging (MRI).  Forty-seven of the sixty two 
subjects underwent single photon emission computed tomography (SPECT).  
All patients were administered routine screening blood tests.  
 
All patients were assessed with a neuropsychological test battery (Table 5 p.27).  
The neuropsychological tests were administered in a non-standardised manner 
due to the severe behavioural and/or memory disturbances exhibited by many of 
the patients and to minimize their discomfort.  Neuropsychological assessment    26 
was conducted primarily to assist with patient treatment and care, and not for 
research purposes.  Due to the lack of adherence to standardised testing 
protocols, any statistical analysis of data must be treated with caution (Lezak, 
1995; Stuss, 1996; Pasquier & Lebert et al. 1999).    27 
Table 5:  Neuropsychological tests used in study, number of subjects tested, and brief description of test.  
 
Test  Brief Description of Test 
FAS verbal fluency test and Animal naming test 
(Lezak, 1995).  FAS —FTD n = 28, AD n = 17; 
Animal Naming FTD n=20, AD n=10.  
A test of ability to generate as many words as possible in four 60 second intervals starting 
with the letters “F”, “A”, & “S”, followed by animal names.  
Tactile Finger Recognition Test (Reitan & 
Davison, 1974). FTD n = 20, AD n = 13  
 
Part of Halsted-Reitan test battery.  The examiner assigns a number to each finger. When 
subjects’ eyes are closed and hands extended, the examiner touches fingers in a 
predetermined order, and asks the subject to identify the touched finger by naming the 
finger by its assigned number.  Subjects with verbal deficits can be asked to identify the 
finger by moving it or tapping it on the test table.  
Purdue Pegboard Test (Purdue Research 
Foundation, 1968) FTD n = 24, AD n = 14 
Test of manual dexterity requiring placing pegs in holes with left, right, and both hands in 
30 second intervals.  
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Table 5 continued:  Neuropsychological tests used in study, number of subjects tested, and brief description of test.  
 
Test  Brief Description of Test 
Freehand clock drawing test (Borod, Goodglass 
& Kaplan, 1980). FTD n = 23 AD n = 15 
A test of ability to draw a clock freehand, and set the hands at “10 past 11”.   
Mini Mental State Exam (MMSE, Folstein, 
Folstein & McHugh, 1975) FTD n = 25 AD n = 
14 
A brief screening test for dementia that measures orientation, registration, attention and 
calculation, recall, and language.  
Paired Associates Learning Task (PALT, 
Wechsler, 1944). FTD n = 26 AD n = 12 
A paired-word learning test consisting of ten word-pairs, with six “easy” pairs, and four 
“hard” pairs.  
Rey-Osterrieth Complex Figure Test (Bennett-
Levy, 1984).   
FTD n = 27; AD n = 15.  
A test of perceptual organisation and immediate and delayed visual memory.  Subjects are 
asked to copy a complex figure using six coloured pens, and the examiner changes pens 
after each section is completed. An immediate recall trial is given after 60 seconds, and 
delayed recall after approximately 30 minutes.   
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Table 5 continued:  Neuropsychological tests used in study, number of subjects tested, and brief description of test.  
 
Test  Brief Description of Test 
Symbol Digit Modalities Test 
(SDMT, Smith, 1968) 
FTD n = 27; AD n = 12. 
 
This test measures the ability to connect numbers to a series of different symbols. There are a maximum 
of 120 matches in a 90 second period. There is a written and oral component to the test.  In one, the 
matching number must be written in the blank box directly below each symbol and in the other, the 
subject must say aloud which number matches each symbol.  This is a measure of visual search and 
memory, fine motor control and concentration (Turner 1999).  
The Wechsler Adult Intelligence 
Scale-111 (WAIS-111, Wechsler, 
1997) FTD n = 26; AD n = 15 
Intelligence test battery containing 13 subtests: Information, Comprehension, Arithmetic, Similarities, 
Digit Span, Vocabulary (measures of verbal skills), Digit Symbol-Coding, Picture Completion, Picture 
Arrangement, Block Design, Matrix Reasoning, Object Assembly, Symbol Search (measures of non-
verbal skills).   
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Table 5 continued:  Neuropsychological tests used in study, number of subjects tested, and brief description of test.  
 
 
Test  Brief Description of Test 
Wechsler Memory Scale Logical 
Memory and Visual Reproduction 
subtests (WMS, Wechsler, 1974) 
FTD n = 25; AD n = 15. 
Visual Reproduction: a test of immediate and delayed visual recall. Three designs are shown for 5 
seconds each, and subjects are asked to draw the design immediately then again after 20 minutes.  
Logical Memory: a test of immediate and delayed verbal recall. Two stories are read, and the subject is 
asked to recall as many details as possible.  A delayed recall trial is given after 20 minutes.  
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2.1.1 Diagnostic Criteria Employed in the Study 
The patients in the study were given a diagnosis of Frontotemporal Dementia or 
Probable Alzheimer’s Disease by the hospital neurologist. The diagnosis was 
made in line with the currently accepted international diagnostic criteria (see 
below).    
 
Diagnostic Criteria for Probable Alzheimer’s Disease 
The diagnosis of probable Alzheimer’s disease was made in accordance with the 
criteria published by the National Institute of Neurological and Communicative 
Disorders and Stroke/ Alzheimer’s Disease and Related Disorders Association 
(NINCDS-ADRDA, McKhann et al. 1984).  The NINCD-ADRDA diagnostic 
criteria are the most widely accepted criteria for Alzheimer’s Disease (Varma & 
Snowden et al. 1999; Storey, Slavin & Kinsella, 2002, see Table 1, p.9 for full 
NINCDS-ADRDA diagnostic criteria).   
    
Diagnostic Criteria for Frontotemporal Dementia 
The diagnosis of Frontotemporal Dementia was made in accordance with the 
criteria proposed by Neary and colleagues (1998).  These criteria are the most 
commonly used by neurologists in the diagnosis of Frontotemporal Dementia 
(Chayer & Freedman, 2001).   Subjects were diagnosed with Frontotemporal 
Dementia if all core diagnostic criteria listed were present (see Table 2, p.13 for 
full Frontotemporal Dementia diagnostic criteria).  
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Diagnostic Exclusion Features for Frontotemporal Dementia and 
Alzheimer’s Disease 
Patients were not included in the study if the following features were present.   
1. Historical and Clinical 
•  Abrupt onset with ictal events. 
•  Head trauma related to onset. 
•  Logoclonic, festinant speech with loss of train of thought. 
•  Corticospinal weakness. 
•  Cerebellar ataxia. 
•  Choreoathetosis. 
  
2. Neurological Investigations 
•  Brain imaging (CT, MRI, and SPECT) indicates predominantly postcentral 
structural or functional   deficit, and/or multifocal lesions. 
•  Laboratory tests indicating brain involvement or inflammatory disorder such as 
Multiple Sclerosis, syphilis, AIDS or herpes simplex encephalitis. 
  
3. Exclusion features 
•  Typical history of chronic alcoholism or drug use. 
•  Sustained hypertension. 
•  History of vascular disease (such as angina, claudication).   33 
CHAPTER 3 
NEUROLOGICAL AND 
NEUROPATHOLOGICAL CHANGES IN 
FRONTOTEMPORAL DEMENTIA AND 
ALZHEIMER’S DISEASE 
 “The frontal lobes are relatively large. However, it is rare to find well-
localised pathology in the frontal lobes.  Due to the fact that the right and 
left frontal lobes are immediately next to one another, pathology that 
affects one frontal lobe tends to affect the other lobe”.  
 Stuss & Benson, 1986, p. 63 
“In the past dementia was conceived as a non-specific decline in cognition 
associated with generalised atrophy. This is an outmoded notion and it is 
now clear that dementia is a generic term encompassing a number of 
specific neuropsychological syndromes, which are dictated by the regional 
distribution of pathology within the brain associated with particular 
disorders. Alzheimer’s Disease has an affinity with the limbic system and 
parieto-temporal association cortex…..Frontotemporal Dementia is 
associated with circumscribed atrophy of the frontal and temporal lobes”.   
Snowden, Neary & Mann 1996, p. 176-177   34 
3.1 NEUROPATHOLOGICAL CHANGES IN FRONTOTEMPORAL 
DEMENTIA & ALZHEIMER’S DISEASE 
3.1.1 Introduction 
Probable Frontotemporal Dementia is diagnosed when the neuropathological 
changes and atrophy accompanying the onset of the dementia occur primarily in 
the frontal and anterior temporal lobes, and the changes are not of the 
Alzheimer’s Disease type (Neary & Snowden, 1996; Snowden & Neary et al.  
2004). Although both Frontotemporal Dementia and Alzheimer’s Disease are 
often diagnosed without autopsy-confirmation, autopsy remains the gold 
standard (Storey, Slavin, & Kinsella, 2002).  Frontotemporal Dementia 
deterioration is often asymmetric, affecting differing regions of the right or left 
frontal and temporal lobes (Snowden & Neary et al. 1996; Miller et al. 1997; 
Varma, Adams, & Lloyd, 2002; Jeong & Song et al. 2005). 
 
Atrophy of the basal ganglia and substantia nigra can also be characteristic 
features as the illness progresses.  Neuropathological changes often include a 
combination of mild status spongiosus (irregular cavities in gliotic neuropil 
following extensive neuronal loss), gliosis of the cortical layers (gliosis is the 
production of a dense fibrous network and a proliferation of astrocytes 
associated with neurodegeneration), cell loss in the hypoglossal nucleus (this 
nucleus lies just off the midline beneath the floor of the fourth ventricle) and cell 
loss in the anterior horns of the spinal cord.  The hippocampus is often relatively 
preserved, and where hippocampal atrophy is found it is generally focal. In 
Alzheimer’s Disease hippocampal atrophy is generally    35 
diffuse (Filley & Kleinschmidt-DeMasters, 1994; Laakso & Frisoni et al. 2000).  
There is often atrophy of the anterior cerebral cortex in Frontotemporal 
Dementia  (Brun et al. 1994; Foster & Sima & Defendini et al. 1996; Neary et 
al. 1988; Neary & Snowden et al. 1990; Frisoni & Laakso et al. 1999).  
 
Alzheimer’s Disease is diagnosed when there is clear evidence from imaging of 
parietal and parieto-temporal atrophy (Duara & Barker et al. 1999).  
Hippocampal and medial temporal lobe deterioration occurs early in the course 
of the illness, resulting in characteristic deterioration in verbal and visuo-spatial 
memory (Frisoni & Laakso et al. 1999).   Significant loss of entorhinal cortex 
volume occurs early in the course of both Alzheimer’s Disease and 
Frontotemporal Dementia (Frisoni & Laakso et al. 1999).  
 
3.1.2 Evidence from Electroencephalogram (See Table 6 p.39 below for 
summary of neuropathological findings) 
Electroencephalogram (EEG) Findings  
In Frontotemporal Dementia, EEG findings generally have been found to change 
slowly during the course of the disease, with slowing of waveforms occurring in 
the late stages of the illness (Snowden & Neary et al. 1996; Pasquier & Petit, 
1997).  There is evidence that the accuracy of diagnosis of Frontotemporal 
Dementia can be enhanced utilizing quantitative EEG (Yener & Leuchter et al. 
1996). Yenner and colleagues (1996) found that 85 per cent of Frontotemporal 
Dementia patients could    36 
be distinguished from Alzheimer’s Disease patients with quantitative evaluation 
of EEG recordings from the temporal region and parietal region.  
 
Structural Imaging (Computed Tomography and Magnetic Resonance 
Imaging) 
 
Structural imaging by Computed Tomography (CT) and magnetic resonance 
imaging (MRI) indicates frontotemporal atrophy is universally found in 
Frontotemporal Dementia patients (Snowden & Neary et al.  1996; Duara & 
Barker et al. 1999).  CT scans also indicate that in conjunction with 
frontotemporal atrophy there can be cases of non-specific cerebral atrophy in 
Frontotemporal Dementia patients.  It is not uncommon to find a pronounced 
widening of the interhemispheric and sylvian fissures (Snowden & Neary et al.  
1996; Duara & Barker et al. 1999; Kaga & Nakamuru et al.  2004).   
 
Computed Tomography (CT) has also been found effective in differentially 
diagnosing Frontotemporal Dementia from subcortical white matter dementia 
(Sjogren, et al. 2000; Passant & Ostojic et al. 2004).  CT and MRI scans are 
useful in differentially diagnosing Alzheimer’s Disease from Frontotemporal 
atrophy.  In contrast to the Frontotemporal Dementia changes noted above, CT 
and MRI imaging of Alzheimer’s Disease patients has indicated primarily 
hippocampal, medial temporal, and tempoparietal lobe atrophy (Duara & Barker 
et al. 1999; Lavenu & Pasquier et al. 1997).  
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Single Photon Emission Computed Tomography (SPECT) 
 
SPECT is not regarded as a highly sensitive indicator of Frontotemporal 
Dementia if used alone (Pasquier & Lebert et al. 1999).  However, SPECT 
studies of Frontotemporal Dementia patients have become increasingly 
sophisticated, and provide significant assistance in the differential diagnosis of 
Frontotemporal Dementia from Alzheimer’s Disease and other 
neurodegenerative conditions (Charpentier et al. 2000).  Functional imaging by 
SPECT reveals a selective anterior hemisphere reduction in cerebral blood flow 
and reduced fronto-temporal tracer activity in patients with Frontotemporal 
Dementia (Read & Miller et al. 1995).    SPECT studies have also found 
reduced regional cerebral blood flow measurements in the mesial superior 
frontal gyrus, near the polus frontalis in Frontotemporal Dementia patients 
(Sjogren & Gustafson et al. 2000). Mendez & Shapira (2005) reported that 
SPECT studies of Frontotemporal Dementia patients with marked loss of insight 
and lack of concern typically showed frontal lobe hypoperfusion and 
hypometabolism. SPECT studies of patients with Alzheimer’s Disease show 
clear parietotemporal abnormalities. This result clearly contrasts with the 
Alzheimer’s Disease  SPECT profile outlined above (Duara & Barker et al. 
1999).   If SPECT indicates posterior cerebral uptake decrease, a diagnosis of 
Frontotemporal Dementia is excluded (Lebert & Pasquier et al. 1998).   
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Charpentier and colleagues (2000) found SPECT imaging used in conjunction 
with the Mini Mental State Exam (MMSE) to be effective in differentially 
diagnosing Frontotemporal Dementia and Alzheimer’s Disease.  Charpentier 
and colleagues were able to correctly classify 100 per cent of Frontotemporal 
Dementia patients (20/20), and 90 per cent of   Alzheimer’s Disease patients 
(18/20) with SPECT imaging and the MMSE.   39 
Table 6: Summary of EEG and Imaging findings in Frontotemporal Dementia and Alzheimer’s Disease. 
  Frontotemporal Dementia  Alzheimer’s Disease 
Localisation  Deterioration in the frontal and anterior temporal lobes of the 
brain (Snowden & Neary et al. 1996). 
Parietotemporal deterioration (Duara 
& Barker et al. 1999). 
EEG   Changes in frontotemporal readings. Decrease in fast wave 
activity, with minimal increase in slow wave activity (Yenner & 
Leuchter et al. 1996; Lindau & Jelic et al. 2003).  
Generalized slowing. Marked increase 
in slow wave activity (Yenner & 
Leuchter et al. 1996; Lindau & Jelic et 
al. 2003). 
MRI & CT  Frontal and anterior temporal atrophy, non-specific atrophy, 
pronounced widening of the interhemispheric and sylvian 
fissures.  Early entorhinal cortex atrophy (Frisoni & Laakso et 
al. 1999; Duara & Barker et al. 1999; Snowden,  
Neary & Mann, 1996) 
Primarily parietal, hippocampal and 
medial temporal lobe atrophy (Duara 
& Barker et al: 1999; Frisoni & 
Laasko et al. 1999). 
SPECT  Selective anterior hemisphere reduction in cerebral blood flow, 
reduced fronto-temporal tracer activity. Reduced regional 
cerebral blood flow measurements in the mesial superior frontal 
gyrus, near the polus frontalis 
(Duara & Barker et al. 1999; Read & Miller et al. 1995; Sjogren 
& Gustafson et al. 2000).   
 
Clear Parietotemporal deficits (Curran 
& Murray et al. 1993; Duara & Barker 
et al. 1999).  
 
Cerebrospinal 
Fluid (CSF) 
Stable Neuropeptide Y CSF level.  Increased Delta Sleep 
Inducing Peptide CSF level (Minthon & Edvinsson et al. 1990).  
 
Reduced Neuropeptide Y and Delta 
Sleep Inducing Peptide CSF levels 
(Minthon & Edvinsson et al. 1990).  
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3.2 NEUROLOGICAL SIGNS IN FRONTOTEMPORAL DEMENTIA 
AND ALZHEIMER’S DISEASE 
3.2.1 Neurological Signs in Alzheimer’s Disease 
In Alzheimer’s Disease, neurological examination commonly indicates 
significant impairment of memory functioning on simple verbal recall tasks 
accompanied by impaired functioning on simple visuo-spatial tasks.  
Disturbances of gait, tremor, akinesia, rigidity, or myoclonus  typically increase 
as the disease progresses (Cummings & Benson, 1986; Tariot, 2003).  
 
3.2.2 Neurological Signs in Frontotemporal Dementia 
Neurological signs accompanying Frontotemporal Dementia are generally the 
primitive reflexes (involuntary muscular responses to sensory stimuli). These 
muscular responses include: 
•  Grasping. 
•  Pouting. 
•  Involuntary sucking.  
•  The extensor plantar response.  
These primitive reflexes are also known as “infantile reflexes” as they occur in 
early childhood.  The primitive reflexes gradually disappear during the course of 
a healthy childhood.  If there is any re-emergence of these primitive reflexes it is 
typically a sign of significant neurological damage (Miller & Darby et al. 1997).  
The extensor plantar response/reflex, or Babinski reflex, is an indicator of upper    41 
motor neurone degeneration.  If motor neurone functioning is healthy in an adult 
the extensor plantar response is automatically suppressed (Barraquer-Bordas, 
1998).    
 
In a small minority of Frontotemporal Dementia patients neurological signs may 
be absent even when gross behavioural and cognitive changes are evident 
(Miller & Ikonte et al. 1997).  The opposite pattern has sometimes been found, 
with Frontotemporal Dementia patients remaining free from behavioural 
disturbances until there is evidence of significant neurological deterioration 
(Snowden & Neary et al. 1996).  
 
In some cases of Frontotemporal Dementia clinical signs of striatal disorder 
become evident late in the course of the illness. The clinical signs associated 
with striatal disorder are akinesia (absence of movements), rigidity, and tremors 
(Miller & Ikonte et al. 1997).   
 
3.3 NEUROLOGICAL IMAGING: RESULTS OF CURRENT STUDY 
3.3.1 Collection of Neurological Imaging Data 
Neurological imaging results were collected within an 18 month period of the 
initial assessment. Imaging studies were conducted in several different hospitals 
in Western Australia.    42 
Table 7: Neurological Imaging and EEG results for Frontotemporal Dementia 
Patients (n=37) 
Patient 
No.  CT  MRI  SPECT  EEG 
1.  frontal lobe 
atrophy 
frontal lobe 
atrophy 
Frontal 
hypoperfusion 
fronto-temporal 
slowing 
2.  frontotemporal 
atrophy 
fronto-
temporal 
atrophy 
fronto-temporal 
hypoperfusion 
fronto-temporal 
slowing 
3.  abnormal, clin. 
Signif 
fronto-
temporal 
atrophy 
fronto-temporal 
hypoperfusion 
temporal lobe 
slowing 
4.  reduced 
attenuation in 
frontal lobes 
frontal lobe 
atrophy 
frontal 
hypoperfusion 
generalised slow 
wave activity 
5.  frontal lobe 
atrophy 
frontal lobe 
atrophy 
reduced activity  generalised slow 
wave activity 
6.  reduced 
attenuation in 
frontal lobes 
fronto-
temporal 
atrophy 
frontal 
hypoperfusion 
generalised slow 
wave activity 
7.  frontotemporal 
atrophy 
fronto-
temporal 
atrophy 
no results  generalised slow 
wave activity 
8.  frontal lobe 
atrophy 
frontal lobe 
atrophy 
generalized 
cerebral 
hypoperfusion 
fronto-temporal 
slowing 
9.  frontal lobe 
atrophy 
frontal lobe 
atrophy 
no results  fronto-temporal 
slowing 
10. frontotemporal 
atrophy 
fronto-
temporal 
atrophy 
fronto-temporal 
hypoperfusion 
diffuse slow wave 
activity 
11. frontotemporal 
atrophy 
fronto-
temporal 
atrophy 
frontal 
hypoperfusion 
short dysrhythmic 
bursts 
12. frontotemporal 
atrophy 
frontal lobe 
atrophy 
no results  nonspecific 
13. frontal lobe 
atrophy 
frontal lobe 
atrophy 
fronto-temporal 
hypoperfusion 
temporal lobe 
slowing 
14. frontotemporal 
atrophy 
frontal lobe 
atrophy 
frontal 
hypoperfusion 
generalised slow 
wave activity 
15. abnormal, 
clinically 
significant 
fronto-
temporal 
atrophy 
fronto-temporal 
hypoperfusion 
generalised slow 
wave activity 
16. frontal lobe 
atrophy 
fronto-
temporal 
atrophy 
no results  generalised slow 
wave activity   43 
Table 7 Continued: Neurological Imaging and EEG results for Frontotemporal 
Dementia Patients (n=37) 
 
Patient 
No.  CT  MRI  SPECT  EEG 
17. abnormal, 
clinically 
significant 
fronto-
temporal 
atrophy 
frontal 
hypoperfusion 
fronto-temporal 
slowing 
18. frontal lobe 
atrophy 
fronto-
temporal 
atrophy 
fronto-temporal 
hypoperfusion 
short dysrhythmic 
bursts 
19. frontotemporal 
atrophy 
frontal lobe 
atrophy 
fronto-temporal 
hypoperfusion 
fronto-temporal 
slowing 
20. frontotemporal 
atrophy 
fronto-
temporal 
atrophy 
no results  fronto-temporal 
slowing 
21. frontotemporal 
atrophy 
frontal lobe 
atrophy 
frontal 
hypoperfusion 
diffuse slow wave 
activity 
22. frontotemporal 
atrophy 
frontal lobe 
atrophy 
fronto-temporal 
hypoperfusion 
generalised slow 
wave activity 
23. frontotemporal 
atrophy 
frontal lobe 
atrophy 
fronto-temporal 
hypoperfusion 
fronto-temporal 
slowing 
24. frontal lobe 
atrophy 
fronto-
temporal 
atrophy 
fronto-temporal 
hypoperfusion 
fast wave activity 
25. frontal lobe 
atrophy 
frontal lobe 
atrophy 
no results  generalised slow 
wave activity 
26. frontotemporal 
atrophy 
fronto-
temporal 
atrophy 
fronto-temporal 
hypoperfusion 
fronto-temporal 
slowing 
27. frontotemporal 
atrophy 
fronto-
temporal 
atrophy 
generalized 
cerebral 
hypoperfusion 
generalised slow 
wave activity 
28. reduced 
attenuation in 
frontal lobes 
frontal lobe 
atrophy 
fronto-temporal 
hypoperfusion 
fronto-temporal 
slowing 
29. frontal lobe 
atrophy 
frontal lobe 
atrophy 
frontal 
hypoperfusion 
diffuse slow wave 
activity 
30. frontal lobe 
atrophy 
fronto-
temporal 
atrophy 
frontal 
hypoperfusion 
fronto-temporal 
slowing 
31. frontotemporal 
atrophy 
fronto-
temporal 
atrophy 
no results  short dysrhythmic 
bursts 
32. abnormal, 
clinically 
significant 
frontal lobe 
atrophy 
generalized 
cerebral 
hypoperfusion 
diffuse slow wave 
activity 
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Table 7 Continued: Neurological Imaging and EEG results for Frontotemporal 
Dementia Patients (n=37) 
 
 
Patient 
No.  CT  MRI  SPECT  EEG 
33. frontotemporal 
atrophy 
frontal lobe 
atrophy 
fronto-temporal 
hypoperfusion 
generalised slow 
wave activity 
34. frontal lobe 
atrophy 
frontal lobe 
atrophy 
frontal 
hypoperfusion 
abnormal, clinically 
significant 
35. frontotemporal 
atrophy 
fronto-
temporal 
atrophy 
frontal 
hypoperfusion 
generalised slow 
wave activity 
36. abnormal, 
clinically 
significant 
fronto-
temporal 
atrophy 
no results  generalised slow 
wave activity 
37. frontotemporal 
atrophy 
fronto-
temporal 
atrophy 
fronto-temporal 
hypoperfusion 
diffuse slow wave 
activity 
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Table 8: Neurological Imaging and EEG results for Alzheimer’s Disease Patients 
(n=25) 
 
Patient 
No. 
CT  MRI  SPECT  EEG 
1.    parieto-
temporal 
atrophy 
cerebral 
atrophy  
parietal 
hypoperfusion 
temporal lobe 
slowing 
2.    temporal 
lobe atrophy 
cerebral 
atrophy  
parietal 
hypoperfusion 
generalised slow 
wave activity 
3.    white matter 
changes 
temporal lobe 
atrophy 
temporal 
hypoperfusion 
temporal lobe 
slowing 
4.    parietal lobe 
atrophy 
parieto-
temporal 
atrophy 
no results  generalised slow 
wave activity 
5.    temporal 
lobe atrophy 
temporal lobe 
atrophy 
parietal 
hypoperfusion 
diffuse slow wave 
activity 
6.    ventrical 
dilation 
ventricular 
dilation 
no results  generalised slow 
wave activity 
7.    cerebral 
atrophy 
parieto-
temporal 
atrophy 
tempro-parietal 
hypoperfusion 
tempoparietal 
slowing 
8.    parieto-
temporal 
atrophy 
temporal lobe 
atrophy 
generalized cerebral 
hypoperfusion 
generalised slow 
wave activity 
9.    temporal 
lobe atrophy 
parieto-
temporal 
atrophy 
reduced activity  temporal lobe 
slowing 
10.   parietal lobe 
atrophy 
parietal lobe 
atrophy 
tempro-parietal 
hypoperfusion 
generalised slow 
wave activity 
11.   parietal lobe 
atrophy 
cerebral 
atrophy  
generalized cerebral 
hypoperfusion 
tempoparietal 
slowing 
12.   parieto-
temporal 
atrophy 
parieto-
temporal 
atrophy 
no results  nonspecific 
13.   parietal lobe 
atrophy 
cerebral 
atrophy  
no results  temporal lobe 
slowing 
14.   temporal 
lobe atrophy 
parieto-
temporal 
atrophy 
generalized cerebral 
hypoperfusion 
diffuse slow wave 
activity 
15.   parieto-
temporal 
atrophy 
parieto-
temporal 
atrophy 
no results  nonspecific 
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Table 8 Continued: Neurological Imaging and EEG results for Alzheimer’s 
Disease Patients (n=25) 
 
Patient 
No. 
CT  MRI  SPECT  EEG 
16.   temporal lobe 
atrophy 
cerebral 
atrophy  
generalized cerebral 
hypoperfusion 
generalised slow 
wave activity 
17.   abnormal, 
clin. Signif 
cerebral 
atrophy  
generalized cerebral 
hypoperfusion 
nonspecific 
18.   temporal lobe 
atrophy 
cerebral 
atrophy  
parietal 
hypoperfusion 
tempoparietal 
slowing 
19.   parieto-
temporal 
atrophy 
parieto-
temporal 
atrophy 
no results  diffuse slow wave 
activity 
20.   parietal lobe 
atrophy 
parieto-
temporal 
atrophy 
no results  generalised slow 
wave activity 
21.   parietal lobe 
atrophy 
cerebral 
atrophy  
temporo-parietal 
hypoperfusion 
generalised slow 
wave activity 
22.   cerebral 
atrophy 
temporal lobe 
atrophy 
generalized cerebral 
hypoperfusion 
nonspecific 
23.   parietal lobe 
atrophy 
temporal lobe 
atrophy 
parietal 
hypoperfusion 
temporal lobe 
slowing 
24.   parieto-
temporal 
atrophy 
cerebral 
atrophy  
temporo-parietal 
hypoperfusion 
generalised slow 
wave activity 
25.   temporal lobe 
atrophy 
parieto-
temporal 
atrophy 
generalized cerebral 
hypoperfusion 
generalised slow 
wave activity   47 
Table 9: Summary of Frontotemporal Dementia and Alzheimer’s Disease 
Patients Neurological Imaging and EEG Results 
 
CT & MRI 
IMAGING 
CATEGORIES 
CT   MRI  SPECT 
IMAGING 
CATEGORIE
S 
SPECT  EEG IMAGING 
CATEGORIES 
FRONTOTEMPORAL DEMENTIA 
frontal lobe 
atrophy 
12 
(32.4%) 
18 
(48.6%) 
frontal 
hypoperfusion 
11 (29.7%)  Fronto-temporal 
slowing 
frontotemporal 
atrophy 
17 
(45.9%) 
19 
(51.3%) 
fronto-
temporal 
hypoperfusion 
14 (37.8%)  temporal lobe 
slowing 
reduced 
attenuation in 
frontal lobes 
3 (8.1%)  0  reduced 
activity 
3 (8.1%)  generalised slow 
wave activity 
abnormal, 
clinically 
significant 
5 
(13.5%) 
0  generalized 
cerebral 
hypoperfusion 
1 (2.7%)  Short dysrhythmic 
bursts 
      no results  8 (21.6%)  diffuse slow wave 
activity 
          fast wave activity 
          abnormal, 
clinically 
significant 
          nonspecific 
TOTAL  37  37    37   
ALZHEMER’S DISEASE 
temporal lobe 
atrophy 
7 (28%)  5 (20%)  parietal 
hypoperfusion 
5 (20%)  temporal lobe 
slowing 
parietal lobe 
atrophy 
7 (28%)  1 (4%)  temporal 
hypoperfusion 
1 (4%)  tempoparietal 
slowing 
parieto-temporal 
atrophy 
6 (24%)  9 (36%)  temporo-
parietal 
hypoperfusion 
4 (16%)  generalised slow 
wave activity 
cerebral atrophy  2 (8%)  9 (36%)  generalized 
cerebral 
hypoperfusion 
7 (28%)  diffuse slow wave 
activity 
ventrical 
dilation 
1 (4%)  1 (4%)  Reduced 
activity 
1 (4%)  nonspecific 
white matter 
changes 
1 (4%)    no results  7 (28%)   
abnormal, clin. 
Signif 
1 (4%)         
TOTAL  25  25    25   
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3.4 NEUROLOGICAL IMAGING and EEG RESULTS DISCUSSION 
3.4.1 Comparison of Imaging Techniques 
Tables 7 and 8 (above) show the neurological imaging results for each 
Frontotemporal Dementia and Alzheimer’s Disease patient. Table 9 (above) 
provides a summary of the neurological imaging results.   
 
Although there were some differences in results between the various imaging 
modalities, direct comparison between the different imaging modalities was not 
possible, as neurological imaging assessments were not conducted at the same 
time for each patient.  Generally patients were first assessed with CT scans. 
Other imaging assessments occurred up to 18 months after the initial CT scans.   
During this interval it is probable that further deterioration occurred, especially 
in this group of patients with the generally more aggressive forms of early-onset 
dementia.  
 
3.4.2 Pattern of Imaging Results for Frontotemporal Dementia Patients 
All Frontotemporal Dementia patients showed evidence of clear frontal or 
frontotemporal lobe neuropathological changes on at least two of the 
neuroimaging studies (see Table 7 above).  Approximately 80 % of the 
Frontotemporal Dementia patients showed frontal or frontotemporal lobe 
atrophy with CT scans (see Table 9 above).  All Frontotemporal Dementia 
patients showed frontal or frontotemporal lobe atrophy on MRI scans.   
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SPECT results showed approximately 80% of Frontotemporal Dementia patients 
had frontal or frontotemporal hypoperfusion. EEG imaging produced more 
varied findings. Approximately 30% of Frontotemporal Dementia patients 
showed frontotemporal lobe slowing. Approximately on0ne third of patients 
were found to have generalised slow wave activity, and approximately 13% 
showed diffuse slow wave activity.  Approximately 8% of patients exhibited 
short dysrhythmic bursts.  Small numbers of patients were recorded with either 
temporal lobe slowing, fast wave activity, or classified as “abnormal, clinically 
significant”.   
 
3.4.3 Pattern of Imaging results for Alzheimer’s Disease Patients 
As shown in Tables 8 & 9 (see above), CT scans showed approximately 30% of 
Alzheimer’s Disease patients had temporal lobe atrophy, approximately 30% 
showed parietal lobe atrophy, and approximately 25% showed parieto-temporal 
atrophy.  8% of patients showed cerebral atrophy. Small numbers of 
Alzheimer’s Disease patients showed either ventricular dilation, white matter 
changes, or were classified as “abnormal, clinically significant”.   
 
MRI results showed 20% of patients had temporal lobe atrophy, 36% showed 
parieto-temporal atrophy, and 36% showed cerebral atrophy.  One patient 
showed ventricular dilation, and one patient showed parietal lobe atrophy.  
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EEG results showed approximately one third of Alzheimer’s Disease patients 
had either temporal lobe slowing or tempo-parietal lobe slowing.  40% of 
Alzheimer’s Disease patients showed generalised slow wave activity, and 12% 
diffuse slow wave activity.  
 
SPECT results showed 40% of Alzheimer’s Disease patients had parietal 
hypoperfusion, tempo-parietal hypoperfusion, or temporal hypoperfusion. 
Approximately 30% showed generalised cerebral hypoperfusion.  
 
3.5 NEUROLOGICAL IMAGING CONCLUSIONS 
The neurological imaging results (Tables 7, 8 & 9: CT, MRI, EEG, & SPECT) 
show that the Frontotemporal Dementia group and Alzheimer’s Disease group 
exhibited clearly differentiated and clinically significant patterns of 
neuroradiological changes. The pattern of neurodegeneration detected in the 
Alzheimer’s Disease patients involved primarily the temporal and parietal lobes. 
In marked contrast, the Frontotemporal Dementia patients imaging results 
showed primarily frontal and frontotemporal lobe degeneration. These findings 
are consistent with the findings of other researchers (e.g. Chan & Fox et al. 
2001; Neary & Snowden et al. 1998; Pasquier & Delacourte, 1998) which have 
shown that neurological imaging studies are an essential component to assist 
with the differential diagnosis of Frontotemporal Dementia from Alzheimer’s 
Disease.   51 
The results indicate that the Frontotemporal Dementia and Alzheimer’s Disease 
groups were clearly differentiated on neuropathological criteria, thus justifying 
further investigation in terms of neuropsychological function and behaviour.  
 
3.6 AUTOPSY FINDINGS IN FRONTOTEMPORAL DEMENTIA AND 
ALZHEIMERS DISEASE 
Autopsy studies of dementia patients revealed that a significant number of 
patients had definite non-Alzheimer’s Disease pathology (Brun, 1987).   More 
recent autopsy findings of patients with dementia have indicated that 
Frontotemporal Dementia may account for up to 20% of dementia cases 
(Gustafson, 1993; Lebert & Pasquier et al. 1998).  Neuropathological changes in 
Frontotemporal Dementia patients noted at autopsy included non-specific frontal 
and temporal atrophy without the characteristic clumps and deposits of 
degenerating cells (amyloidal plaques and neurofibrillary tangles) associated 
with Alzheimer’s Disease changes (Lebert & Pasquier et al. 1998).   
 
Autopsy studies have found that the majority of Frontotemporal Dementia 
patients have marked degeneration of the amygdala and hippocampus. These 
brain structures play a crucial role in memory functioning (Johanson & Hagberg, 
1989).  Frontotemporal patients who exhibited relatively well-preserved 
memories throughout the course of their illness were found to also have 
comparatively well-preserved hippocampal and amygdalar areas   (Johanson & 
Hagberg, 1989; Neary & Snowden, 1996).   52 
3.7  AUTOPSY RESULTS 
Autopsy results were available for 4 of the 7 Frontotemporal Dementia patients 
who died after the 3-year follow-up.  No autopsy results were available for the 
one Alzheimer’s Disease patient who died during the course of this research.  
Nearly 20% of the Frontotemporal patients died during the course of this study 
compared with only 4% of the Alzheimer’s Disease patients.   This result is 
consistent with previous findings that have shown that Frontotemporal Disease 
patients have significantly shorter life spans after diagnosis than that of early-
onset Alzheimer’s Disease patients (Pasquier & Richard et al. 2004; Roberson & 
Hesse, 2005).   
 
This finding has significant implications for caregivers as this result indicates 
that patients move through stages of  their disease rapidly, and require flexible 
and rapid treatment if their care needs are to be met.  This research indicates that 
a significant number of Frontotemporal Disease patients will require palliative 
care within 2 years of diagnosis.  Traditional dementia services are designed for 
the slower progression of Alzheimer’s Disease, and may not cope with the 
rapidly changing requirements of this group of Frontotemporal Dementia 
patients with early-onset dementia (i.e. Harvey, 1998; Tanabe & Ikeda et al. 
1999). 
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Autopsy Results for “Ingrid”  
Ingrid was diagnosed with Frontotemporal Dementia at age 60.  She died 3 years 
later. The autopsy report showed narrowing of the gyri and widening of the sulci 
over the frontal lobes.  The leptomeninges were thin and translucent.  The 
brainstem and cerebellum were normal. The cranial nerves were normal.  
Conclusion:  Frontal lobe atrophy, pallor of the substantia nigra.   
 
Autopsy Results for “Les” 
Les was diagnosed with Frontotemporal Dementia at age 53.  He died two years 
later. The autopsy finding showed unequivocal frontal lobe atrophy.   
Conclusion: Frontotemporal Atrophy.   
 
Autopsy Results for “Julie” (see Section 7.3.4, p. 208 for case study) 
Julie was diagnosed with Frontotemporal Dementia with parkinsonism at age 
46. She died 3 years later. The autopsy findings showed atrophy of frontal and 
temporal regions and pallor of the substantia nigra.   
Conclusion not available.  
 
Autopsy Results for “Ray” 
Ray was diagnosed with Frontotemporal Dementia at age 57. He died 4 years 
later.  The autopsy findings showed narrowing of the gyri and widening of the 
sulci over the frontal lobes.  The leptomeninges were thin and translucent.  The 
brainstem and cerebellum were normal. The cranial nerves were normal.  
Conclusion:  Frontal lobe atrophy, pallor of the substantia nigra.     54 
Summary of Frontotemporal Dementia Patient Results   
The autopsy results outlined above confirmed clear frontal and/or temporal lobe 
degeneration in all of the 4 patients diagnosed with Frontotemporal Dementia.  
Two of the 4 patients had pallor of the substantia nigra. This finding is 
consistent with previous research linking changes to the substantia nigra to 
Frontotemporal Dementia (Filley & Kleinschmidt-DeMasters, 1994; Laakso & 
Frisoni et al. 2000).  None of the characteristic neuropathological changes 
associated with Alzheimer’s Disease, the amyloidal plaques and neurofibrillary 
tangles, were noted in the autopsy reports. These findings add support to the 
validity of Frontotemporal Dementia as a valid diagnostic category, and are 
consistent with a growing body of research (i.e. Rascovsky & Salmon, 2002). 
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CHAPTER 4 
NEUROPSYCHOLOGICAL ASSESSMENT OF 
FRONTOTEMPORAL DEMENTIA AND 
ALZHEIMERS DISEASE 
 
4.1 INTRODUCTION TO NEUROPSYCHOLOGICAL ASSESSMENT 
OF FRONTOTEMPORAL DEMENTIA AND ALZHEIMER’S DISEASE  
Neuropsychological tests have been widely utilised to assist with the clinical 
diagnosis of Frontotemporal Dementia (Snowden & Neary et al. 1996; Gregory 
& Hodges, 1996; Neary & Snowden et al. 1998; Miller & Diehl et al. 2003; 
Pasquier, 1999).  Neuropsychological tests have been found to be a useful 
clinical tool in assisting with the differential diagnosis of Frontotemporal 
Dementia from Alzheimer’s Disease, other forms of dementia, normal aging, 
and non-organic psychological problems (Pasquier, 1999; Gustafson & Brun, 
1999; Neary & Snowden et al. 1998).   Cognitive impairments identified by 
neuropsychological assessment in both Alzheimer’s Disease and Frontotemporal 
Dementia have been found to have a high correlation with SPECT, MRI, and 
CT findings (Duara & Barker et al.  1999; Elfgren, Ryding & Passant, 1996).  
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Typically, neuropsychological assessment of Frontotemporal Dementia patients 
has produced a distinctive profile indicating relatively preserved visuospatial 
abilities combined with impaired verbal fluency, executive functions, and 
vocabulary (Johansen & Hagberg, 1989; Miller & Cummings et al. 1991; 
Elfgren & Ryding et al. 1996; Lindau & Almkivist et al. 2000; Rascovsky & 
Salmon et al. 2002).   
 
Several researchers have questioned the capacity of neuropsychological test 
batteries to discriminate Frontotemporal Dementia patients from Alzheimer’s 
Disease patients ( Kertez & Davidson et al. 2003; Harciarek & Jodzio, 2005).   
Kertez and colleagues (2003) assessed 52 Alzheimer’s Disease patients and 52 
Frontotemporal Dementia patients with a comprehensive battery of 
neuropsychological tests.  They found that the majority of the 
neuropsychological tests were unable to discriminate between the two groups. 
Tests of memory were shown to be the most useful. Alzheimer’s Disease 
patients produced lower scores on memory tasks than Frontotemporal Dementia 
patients, and Frontotemporal Dementia patients produced lower scores on verbal 
language tasks than Alzheimer’s Disease patients. Kertesz and colleagues 
(2003) also found that analysis of the behaviour of the patients was significantly 
more effective in discriminating between the two groups. The majority of the 
subjects in this study subsequently had their diagnosis confirmed by autopsy.   
 
A comprehensive review of the literature on the differential diagnosis of 
Frontotemporal Dementia from Alzheimer’s Disease (Harciarek & Jodzio,    57 
2005)   indicated that most neuropsychological tests did not discriminate 
between the two groups. However, the researchers found that Alzheimer’s 
Disease patients performed better on tests of executive functioning than 
Frontotemporal Dementia patients.  Alzheimer’s Disease patients were found to 
perform more poorly on tests of memory than Frontotemporal Dementia patients 
early in the course of the illness.  
 
4.2 ROUTINE METHODOLOGICAL PROBLEMS ENCOUNTERED IN 
THE ASSESSMENT OF FRONTOTEMPORAL DEMENTIA PATIENTS 
There are significant methodological problems when neuropsychological 
assessments are conducted with Frontotemporal Dementia patients and dementia 
patients generally (Pasquier & Lebert et al. 1995; Smeding & de Koning, 2000): 
 
4.2.1 Multiple Task Demands 
Most, if not all, neuropsychological tasks make multiple demands on cognition, 
often assessing a variety of cognitive functions including attention, receptive 
and expressive language, visuo-spatial abilities, organisation, planning, 
cognitive endurance, motor speed, speed of information processing, and 
abstraction (Lezak, 1995; Pasquier & Lebert et al. 1999).   Therefore, it is 
possible that patients with differing forms of dementing illnesses will produce 
scores within the same range on the same test, but will have impairment in 
vastly differing areas of cognitive functioning (Lezak, 1995; Pasquier & Lebert 
et al. 1999).      58 
4.2.2 Small Sample Sizes 
An ongoing problem associated with the neuropsychological assessment studies 
of Frontotemporal Dementia patients has been small sample size (Stuss, 1993; 
Snowden & Neary et al. 1996; Marshall & Hutchinson, 2001). Stuss (1993), in a 
study of neuropsychological assessment of the frontal and anterior temporal 
lobes pointed to the fact that the majority of neuropsychological studies in this 
area relied on small sample sizes.  Stuss (1993) cautioned that, due to the small 
sample sizes employed, most neuropsychological studies of frontal and anterior 
temporal lobe functioning had produced results of limited reliability and 
validity.    
 
4.2.3 Behavioural Disturbance & Impoverished Communication Skills 
Patients with Frontotemporal Dementia are typically difficult, if not impossible, 
to assess soon after the onset of the disease due to behavioural disturbance, 
wandering and pacing, lack of cooperation, loss of motivation, and mutism 
(Miller & Cummings et al. 1991; Pasquier, 1999; Smeding & de Koning; 2000; 
Snowden & Neary et al. 1996).   The lack of capacity for concerted effort, 
combined with impoverished communication skills, are characteristic features of 
Frontotemporal Dementia. These characteristic deficits, and lack of concern 
about accurate test performance, invariably depress test scores on all 
neuropsychological measures (Snowden & Neary et al. 1996; Pasquier, 1999).   
 
Some of the problems and dangers associated with the neuropsychological 
assessment of Frontotemporal Dementia patients were documented by Miller    59 
and colleagues (1991) in a series of case studies.  For example, one of the 
patients involved in their study left the assessment, and could not be stopped 
from leaving the hospital. He was found 18 hours later, having wandered twenty 
kilometres from the hospital.  
 
Frontotemporal Dementia patients often become distracted by irrelevant visual 
stimuli in the test rooms, and commonly get out of their seats to investigate 
objects of interest to them (Snowden & Neary et al. 1996).  Frontotemporal 
Dementia patients show marked perseverations (perseveration is the 
uncontrollable repetition of a particular response, such as a word, phrase, or 
gesture, despite the absence or cessation of a stimulus).  Perseveration is an 
indicator that the patient has lost the ability to shift “mental set” (Lezak, 1995).   
Interference effects from previous tasks are common, and such interference 
effects are a form of perseveration (Snowden & Neary et al. 1996).  
 
4.3 THE IMPORTANCE OF QUALITATIVE ASSESSMENT AND 
MISSING VALUES  
Researchers (e.g. Elfgren, Passant, & Risberg, 1993; Gainotti, 1991; Johanson & 
Gustafson et al. 1986; Smeding & de Koning; 2000) have also highlighted the 
importance of qualitative as well as quantitative assessment of Frontotemporal 
Dementia patients.  
 
Qualitative variables of particular note are degree of cooperation, loss of insight, 
speech abnormality, apathy, distractibility, flight reactions, and test strategies    60 
(Gustafson & Brun, 1999; Diehl & Kurz, 2002; Gainotti, 1991; Johanson & 
Hagberg, 1989; Engelborghs & Martens, 2002; Rankin & Baldwin et al. 2005; 
Thompson & Stopford et al. 2005).  
 
The difficulties invariably encountered in the assessment of Frontotemporal 
Dementia lead to many missing values in neuropsychological test results 
(Johanson & Hagberg, 1989; Smeding & de Koning; 2000).   These researchers 
argue that it is important to evaluate the test behaviour responsible for the 
missing values, as this evaluation provides rich diagnostic information. 
Evaluation of such test behaviour highlights the cognitive and behavioural 
deficits that prevent the patients from successfully undertaking standard 
neuropsychological test batteries.   
 
 
4.4 ASSESSMENT OF SPECIFIC NEUROPSYCHOLOGICAL SKILLS 
IN FRONTOTEMPORAL DEMENTIA AND ALZHEIMER’S DISEASE 
4.4.1 Speech, Reading and Writing Skills   
Although speech output is characteristically reduced, primary linguistic 
competence is usually preserved in the early stages of Frontotemporal Dementia 
(Diehl & Kurz, 2002; Snowden & Neary et al. 1996; Kertez & Davidson et al. 
2003).  Frontal lobe dysfunction leads to economy of speech, perseverative 
speech, and marked reduction in speech output (dynamic aphasia), with mutism 
frequently occurring in the latter stages of the illness (Neary & Snowden et al. 
1998; Snowden & Neary et al. 1996; Pasquier & Leber et al. 1999).     61 
 Impaired verbal fluency alone has been found to be a good indicator of frontal 
lobe dysfunction (Gregory & Hodges, 1993).   In rare cases Frontotemporal 
Dementia is accompanied by a period of increased talking in the early stages of 
the illness (Gustafson & Brun, 1999).  Patients with frontotemporal atrophy 
characteristically suffer a deterioration of both quality and quantity of language 
output early in the course of the illness (Miller & Darby et al. 1997; Johanson & 
Hagberg, 1989).   
 
A characteristic feature of Frontotemporal Dementia patients is that they rarely 
initiate conversations.  Responses to questions tend to be extremely brief and 
unelaborated. The speech patterns characteristic of Frontotemporal Dementia 
patients indicates minimal application of mental effort (Rosen &  Gorno-
Tempini et al. 2002).  Health professionals assessing the Frontotemporal 
Dementia patient, caregivers and relatives are more likely to receive answers to 
questions that require only a single-word answer than to open ended questions 
that require generation and organisation of a complete sentence (Miller & Darby 
et al. 1995; Snowden & Neary et al. 1996). 
 
Frontotemporal Dementia patients tend to overuse irrelevant and stereotypical 
remarks instead of meaningful conversation, and speech is often perseverative 
(Bathgate & Snowden et al. 2001).  Over-learned repertoires are often repeated 
verbatim.  Echolalia and verbal perseverations become more common in the 
middle stages of the disease (Bathgate & Snowden et al. 2001).     62 
The increasing occurrence of echolalia and verbal perseverations reflects an 
increasing impoverishment in the patient’s constructive and generative 
language. Patients are unable to generate, plan, and organise novel responses to 
questions.  Utterances are usually grammatically correct, and word-finding 
performance is generally well preserved until the advanced stages of the illness.   
Over learnt, automatic language may persist long after spontaneous speech has 
disappeared (Gustafson & Brun, 1999; Bathgate & Snowden et al. 2001). 
 
Loss of language output is more pronounced in patients with primarily left 
frontal deterioration (Miller & Darby et al. 1995).   Patients with Frontotemporal 
Dementia often are unable to read silently, and make uncontrolled vocalisations 
when watching television or engaging in daily activates (Klinger, 2001).  
Changes in writing include spelling errors, and speed of handwriting.  
Alzheimer’s Disease patients often have dysgraphic, error-filled handwriting, 
whereas Frontotemporal Dementia patients handwriting is often impoverished 
(Gustafson & Brun, 1999).  
 
The cluster of language deficits occurring with Frontotemporal Dementia is 
known as the PEMA Syndrome:  Palilalia, Echolalia, Mutism, and Amimia (see 
Table 27  p. 103, Guiraud, 1936). This syndrome is extremely rare in 
Alzheimer’s Disease  (Gustafson & Brun, 1999).   
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In comparison to Frontotemporal Dementia, speech in Alzheimer’s Disease 
tends to be significantly less economical and concrete (Neary, 1988).   
Speech in Alzheimer’s Disease, particularly in the early course of the illness 
tends to feature a lack of meaningfulness and poor concept formation 
(Cummings & Benson, 1986).  
 
4.4.2 Visual Perception and Spatial Skills 
 
There is no convincing evidence of the common “parietal” type deficits 
associated with Alzheimer’s Disease in Frontotemporal Dementia. 
Frontotemporal Dementia patients, in the early stages of their illness, typically 
have little difficulty in the perceptual recognition of objects; do not make major 
perceptual errors on naming tests of line drawings, and generally use objects 
appropriately (Snowden & Neary et al. 1996; Rascovsky & Salmon et al. 2002).   
In most cases Frontotemporal Dementia patients can accurately copy simple 
geometric designs when they are first assessed (Johanson & Hagberg, 1989; 
Snowden & Neary et al. 1996; Rascovsky & Salmon, 2002).  This stands in 
marked contrast to Alzheimer’s Disease patients, who generally exhibit 
impaired copying abilities at first assessment (Johanson & Hagberg, 1989; 
Fisher & Rourke et al. 1999).  
 
Frontotemporal Disease patients generally experience little difficulty locating 
objects in their immediate environment, and can usually negotiate their way 
around their environment without becoming lost (Neary & Snowden et al. 1988;    64 
Mathuranath & Nestor et al. 2000).   However, due to loss of motivation, 
distractibility, and the tendency to perseverate on test instructions, patients may 
perform poorly on constructional tasks such as drawing and block constructions.   
Perseverations are common on drawing tasks, and on block design tasks blocks 
are often moved randomly (Snowden & Neary et al.  1996).  
 
4.4.3 Memory 
 
Reports of memory disturbance accompanying Frontotemporal Dementia are 
common.  Memory of important episodes in a patient’s life (episodic memory) is 
commonly relatively well-preserved in the early stages of the illness (Lindau & 
Almkvist et al. 2000).  However, recent research has indicated that a significant 
number of  Frontotemporal Dementia  patients exhibit severe new learning 
deficits and impaired memory for recent events (anterograde amnesia) early in 
the course of Frontotemporal Dementia  (Caine & Patterson et al. 2001; Graham 
& Davies et al. 2005).  Frontotemporal Dementia patients perform poorly on 
standardised tests of memory for both recall and recognition (Johanson & 
Hagberg, 1989; Gustafson, 1993).  Frontotemporal Dementia patients are often 
not clinically amnesic, and can be oriented for time and place, and can provide 
accurate information about current autobiographical events if given sufficient 
prompts (Snowden & Neary et al. 1996).  Performance on tasks during a 
neurological examination can also generally be improved if specific, directive 
questions are used.  Patients’ memory performance also typically improves with 
frequent cues and with the provision of multiple-choice alternative responses 
(Snowden & Neary et al. 1996).   65 
These findings suggest that Frontotemporal Dementia patients may have 
information available to them that they do not, or are unable to, access 
spontaneously.  Patients appear to have difficulties with spontaneous 
information generation and organised searching.    
 
There is no evidence of attempts to integrate information, or abstract the general 
thematic content.   Delayed recall of a fable 1 hour later mirrored impaired 
immediate recall performance, with sporadic elements of the story given 
(Snowden & Neary et al. 1996).  
Table 10: Major neuropsychological studies comparing Frontotemporal    
Dementia, Semantic Dementia  & Alzheimer’s Disease patients. 
No. of  FTD, 
AD, & SD 
subjects in 
study. 
 
 
Authors & Findings Summary 
FTD  AD  SD   
16  6  Ikeda & Tanabe, 2000; neuro-psychological tests did not 
discriminate between FTD & AD* 
12  12  Gregory & Orrell et al. 1997; neuro - psychological tests 
were poor discriminators between FTD & AD.* 
52  52  Kertez & Davidson et al. 2003; most neuropsychological 
tests did not discriminate FTD from AD. Memory scores 
lower in AD and language scores lower in  FTD*  
14  28  Rascovsky & Salmon et al. 2002;  AD verbal fluency scores 
higher than FTD.  FTD visuospatial scores higher than AD. 
51  69  13  Diehl & Monsch et al. 2005 A A combination of Animal 
Fluency and Boston Naming Test discriminated 90% of FTD 
patients from AD patients  
14  14    Siri & Benaglio et al. 2001; most neuropsychological tests 
did not discriminate FTD from AD.  AD verbal fluency 
scores higher than FTD.  FTD visuospatial scores higher than 
AD. 
  * = behaviours good discriminators between FTD and AD   66 
Neuropsychological studies of patients with Alzheimer’s Disease and 
Frontotemporal Dementia (Table 10) have shown consistently that the majority 
of neuropsychological tests do not accurately discriminate between the two 
groups.   Some visuospatial and verbal fluency tests have been found to 
discriminate between Frontotemporal Dementia and Alzheimer’s Disease (Table 
10). 
 
4.5 PERFORMANCE ON STANDARD TESTS OF COGNITIVE 
FUNCTIONING: MINI MENTAL STATE EXAM (MMSE, Folstein, 
Folstein, & McHugh, 1975) 
The Mini Mental State Exam (MMSE) is a widely used dementia assessment 
and monitoring tool (Husain, 2003).  Husain (2003) cautions that interpreting 
individual MMSE scores without clinical information about the patient can be 
misleading. 
 
The MMSE has been found to have very limited capacity to to detect executive 
functioning, abstract reasoning, and visuo-spatial construction deficits (Nys & 
Zandvoort et al. 2005).   As noted above, executive functioning and abstract 
reasoning deteriorate in the early stages of Frontotemporal Dementia, and 
visuospatial constructional deficits occur in the early stages of Alzheimer’s 
Disease.  The MMSE’s lack of sensitivity to these deficits may account for the 
fact that both Frontotemporal Dementia and Alzheimer’s Disease patients have 
been found to produce scores within normal limits in the early stages of their    67 
illnesses (Schmitt & Ranseen et al. 1989; Miller & Cummings et al. 1991).    
Schmitt and colleagues (1989) found that dementia patients sometimes produced 
scores of 29 and 30.  
 
Given the above, the MMSE  has been found to have limited capacity to 
differentiate Frontotemporal Dementia from Alzheimer’s Disease when used 
alone (Miller et al. 1991; Kertez & Davidson et al. 2003; Diehl & Monsch et al. 
2005).    However, several researchers have incorporated the MMSE into brief  
and effective test batteries that accurately differentially diagnose Frontotemporal 
Dementia from Alzheimer’s Disease (Mathuranath & Nestor et al. 2000; Diehl 
& Monsch et al. 2005).   The MMSE scores have been found to deteriorate 
significantly faster in Frontotemporal Dementia patients than Alzheimer’s 
Disease patients (Miller & Cummings et al. 1991; Pasquier & Lebert et al. 1999: 
Chow & Hynan et al. 2006).  
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4.6 MINI MENTAL STATE EXAM MMSE RESULTS 
Table 11: Mini Mental State Exam Frequency table for Frontotemporal    
Dementia & Alzheimer’s Disease MMSE scores 
MMSE 
Score 
FTD  %  AD  % 
6  2  5.4%     
10  3  8.1%  1  7.1% 
11      1  7.1% 
13  1  2.7%  1  7.1% 
14  1  2.7%     
15      1  7.1% 
16      2  14.3% 
17  2  5.4%     
18      2  14.3% 
19      1  7.1% 
20  4  10.8
% 
   
22  1  2.7%  1  7.1% 
23  2  5.4%  1  7.1% 
24  1  2.7%  1  7.1% 
25  1  2.7%     
26  1  2.7%     
27  3  8.1%  1  7.1% 
28  1  2.7%  1  7.1% 
29  2  5.4%     
Total  25      14 
 
Table 11 indicates a very broad range of scores on the MMSE for both 
Frontotemporal Dementia and Alzheimer’s Disease patients, with 
Frontotemporal Dementia MMSE scores falling between 6 and 29, and 
Alzheimer’s Disease MMSE scores falling between 10 and 28.   
 
This finding is consistent with previous research (eg. Schmitt & Ranseen et al. 
1989) that found dementia patients commonly produced a broad range of scores, 
with scores sometimes falling within normal limits.    69 
Table 12: Mini Mental State Examination (MMSE) Results: Number of 
Frontotemporal Dementia & Alzheimer’s Disease subjects below and above 
the dementia cutoff score (23) and Chi Square result 
 
MMSE 
Score  FTD  AD 
Chi 
Square 
≤ 23 
16 
(64%)  11 (78.6%)  .34ª 
> 23 
9 
(36%)  3 (21.4%)   
Total  25  14   
 
ª not statistically significant 
4.7 MMSE DISCUSSION 
There was no significant difference between the number of Frontotemporal 
Dementia and Alzheimer’s Disease subjects falling below the dementia cutoff 
score of 23 (Table 12).  A clinically significant number of patients in both 
groups (36% of Frontotemporal Dementia patients and 21% of Alzheimer’s 
Disease patients) produced scores above the dementia cutoff score of 23.  This 
result indicates that patients with clear neuropathological deterioration 
consistent with either Frontotemporal Dementia or Alzheimer’s Disease can 
produce MMSE scores not necessarily indicative of dementia.  This result 
supports previous research findings (Miller & Cummings et al. 1991; Snowden 
& Neary et al.  1996; Schmitt & Ranseen et al. 1989) that some Frontotemporal 
Dementia and Alzheimer’s Disease patients produced MMSE scores that were 
not markedly impaired in the early stages of their illness.      70 
This result is consistent with previous research findings that have indicated the 
MMSE does not discriminate between Frontotemporal Dementia and 
Alzheimer’s Disease patients (Miller & Cummings et al. 1991; Roberson & 
Hesse et al. 2005).   
 
4.8 PERFORMANCE ON STANDARD TESTS OF COGNITIVE 
FUNCTIONING:THE WECHSLER ADULT INTELLIGENCE SCALE-
111 (WAIS-111, WECHSLER, 1997) 
Some Frontotemporal Dementia patients perform within normal limits on the 
Wechsler Adult Intelligence Scales (Neary & Snowden, 1996).   However, 
performance is more commonly impaired, and becomes increasingly impaired as 
the disease progresses.  There are typically depressed scores on the Wechsler 
Adult Intelligence Scales’ Comprehension, Similarities, and Picture 
Arrangement subtests (Neary & Snowden, 1996; Zakzanis, Kielar, Young, & 
Boulos, 2001).  Comprehension scores tend to be depressed because 
Frontotemporal Dementia patients lose the ability to understand the underlying 
rules of sentence structure (Snowden & Neary et al. 1996, see Table 13 below 
for summary of Frontotemporal Dementia patients’ performance on 
neuropsychological tests).     71 
Table 13: Neuropsychological profile summary (Snowden & Neary et al. 
1996) 
Neuropsychological Profile Summary  
Performance.  Cursory responses, minimal effort, slowing of response 
initiation, perseveration 
Language.  Economy of speech, perseveration, echolalia, stereotypy, 
concreteness, late mutism. 
Calculation.  Impaired for mentally demanding tasks.  
Perception.  Preserved. 
Spatial functioning.  Preserved throughout disease.  Errors of 
construction secondary to organisational deficits.   
Memory.  Variable, idiosyncratic day-to-day memory, preserved 
orientation in time and place, poor information retrieval, recall enhanced 
by cues and directional probes.  
Planning and abstraction.  Concrete responses, poor set shifting, 
organisational and sequencing failure, perseveration.   
 
 
4.9 WAIS-111 RESULTS 
Table 14: WAIS-111 IQ: Full Scale IQ, Verbal IQ, and Performance IQ scores 
and T-test scores for Alzheimer’s Disease and Frontotemporal Dementia patients 
at initial assessment 
FTD  AD 
  N  Mean 
Std. 
Dev  N  Mean 
Std. 
Dev 
Levene’s 
Test For  
Equality of 
Variance  t(df) sig 
Verbal IQ  26  87.4  14.6  15  90.8  14.7  0.00  0.72(39) 
Performance 
IQ  26  87  10.7  15  76.1  12.5  0.21 
2.95(39) 
* 
Full Scale IQ  26  86.3  12.1  15  83.5  12.9  0.01  0.71(39) 
* = p < .01 
 
Frontotemporal Dementia and Alzheimer’s Disease patients produced full scale 
IQ scores in the low-average range (see Table 14 above).    72 
Both Frontotemporal Dementia and Alzheimer’s Disease Verbal IQ scores fell 
in the average to low-average range.  Performance IQ scores for the 
Frontotemporal Dementia patients were significantly higher than the scores for 
Alzheimer’s Disease patients, with Frontotemporal Dementia Performance IQ 
scores falling in the low-average range and Alzheimer’s Disease Performance 
IQ scores falling in the borderline range. There was a large scatter of scores 
around the mean for both Frontotemporal Dementia and Alzheimer’s Disease 
subjects. 
 
Table 15: WAIS-111 Verbal IQ (VIQ) subtest scores and T-test scores for 
Alzheimer’s Disease and Frontotemporal Dementia patients at initial assessment 
FTD  AD 
Verbal IQ scores  N  Mean 
Std. 
Dev  N  Mean 
Std. 
Dev 
 
Levene’s 
Test For 
Equality 
of 
Variance  t(df) ª 
Information  30  8.3  3.6  17  7.8  3.8  0.19  0.52(45) 
Comprehension  26  6.6  3.5  17  8  3.7  0.02  1.3(41) 
Similarities  31  6.3  3.1  17  6.9  2.5  0.13  0.78(46) 
Arithmetic  26  7.7  3.1  16  6.8  2.6  0.69  0.97(40) 
Digit Span  31  7.8  2.2  18  7.2  3.1  0.90   .74(26.9) 
Vocabulary  27  7.3  3.2  16  9.1  3.3  0.29  1.76(41) 
ª = none of the t-tests were statistically significant 
All the Frontotemporal Dementia and Alzheimer’s Disease WAIS-111 Verbal 
IQ scores fell in either the low-average or borderline range (see Table 15 above).  
This result indicates that WAIS-111 Verbal IQ scores do not discriminate 
between Frontotemporal Dementia and Alzheimer’s Disease patients.  This 
finding is consistent with previous research findings (Kertez & Davidson et al. 
2000).   73 
Table 16: WAIS-111 Performance IQ (PIQ) scores and T-test scores for 
Alzheimer’s Disease and Frontotemporal Dementia patients at initial 
assessment 
FTD  AD 
Performance 
IQ scores  N  Mean 
Std. 
Dev  N  Mean 
Std. 
Dev 
Levene’s 
Test For 
Equality of 
Variance  t(df) sig 
Object 
Assembly  26  6.8  2.9  15  5.1  2.9  0.00  1.75(39) 
Block Design  30  7  3.3  17  4.4  2.9  0.21 
2.74(45) 
* 
Picture 
Arrangement  28  6.4  2.3  15  5.3  2.1  0.02  1.41(41) 
Picture 
Completion  31  7.2  2.8  17  4.6  2.2  1.00 
3.37(46) 
* 
* = p < .01 
 
All the Performance IQ subtest scores for Frontotemporal Dementia subjects fell 
in the borderline or low average ranges.  Performance IQ scores for Alzheimer’s 
Disease subjects fell in the impaired/borderline range.  Frontotemporal 
Dementia subjects mean scores for the Block Design and Picture Completion 
subtests were significantly higher than scores for Alzheimer’s Disease subjects.  
 
4.9.1 WAIS-111 Results Summary 
The above findings indicate that the WAIS-111 is an effective dementia 
assessment tool, with both the Alzheimer’s Disease and Frontotemporal 
Dementia groups producing results consistent with significantly compromised 
intellectual functioning. However, the results indicate that no WAIS-111 Verbal 
IQ subtests effectively discriminated between the Frontotemporal Dementia and    74 
Alzheimer’s Disease patient groups.  Only two of the Performance IQ subtests, 
Block Design and Picture Completion, discriminated between the 
Frontotemporal Dementia and Alzheimer’s Disease groups.  
 
The pattern of WAIS-111 results, with Frontotemporal Dementia patients 
showing relatively preserved visuospatial skills in comparison to Alzheimer’s 
Disease patients, is consistent with previous research (Johansen & Hagberg, 
1989; Miller & Cummings et al. 1991; Elfgren, Ryding & Passant, 1996; Lindau 
& Almkivist et al. 2000; Rascovsky & Salmon et al. 2002).  
 
4.9.2 Subjective Assessment 
Subjective assessment of the groups provided valuable clinical information. 
Only 26 of the 37 (84%) Frontotemporal Dementia patients and 15 of the 25 
(72%) Alzheimer’s Disease patients (Table 14) were able to complete all the 
WAIS-111 subtests.  There were a number of reasons why patients were unable 
to complete the WAIS-111 including inability to understand test instructions, 
agitation, and patient distress.  The large numbers of Alzheimer’s Disease and 
Frontotemporal Dementia patients unable to complete the full WAIS-111 
indicates that both groups of patients were significantly impaired.  
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4.10  PAIRED ASSOCIATES LEARNING TASK (PALT) RESULTS 
Table 17: Paired Associates Learning Task (PALT) scores and T-test scores for 
Alzheimer’s Disease and Frontotemporal Dementia patients at initial assessment. 
FTD  AD 
Learning 
Task  N  Mean 
Std. 
Dev  N  Mean 
Std. 
Dev 
Levene’s 
Test For  
Equality of 
Variance  t(df) ª 
PALT Easy 
words trial 1  26  3.2  1.5  12  3.7  1.5  0.17  .27(36)  
PALT  Easy 
words trial 2  26  5  1.1  12  4.4  1.6  0.98  1.4(36)  
PALT Easy 
words trial 3  26  5  1.2  11  5.3  0.8  1.90  0.6(35)  
PALT Hard 
words trial 1  26  0.5  0.9  12  0.1  0.3  0.92   1.5(34) 
PALT Hard 
words trial 2  26  1.1  1.3  12  0.4  0.8  2.60  1.7(36)  
PALT Hard 
words trial 3  26  1.6  1.4  11  0.6  0.9  3.90  1.9(35)  
ª = none of the t-tests were statistically significant 
Scores for both Frontotemporal Dementia and Alzheimer’s Disease subjects fell 
in the impaired range for all Easy and Hard trials (see Table 17 above).   There 
was no significant difference between the two groups of patients on any of the 
trials.  Previous research has shown that Frontotemporal Dementia patients 
perform significantly better than Alzheimer’s Disease patients on the PALT 
(Lee & Rahman et al. 2003).   The research by Lee and colleagues (2003) did 
not use early-onset dementia patients exclusively; therefore direct comparisons 
between their research findings and the current study are not possible.   
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4.11 PURDUE PEGBOARD TEST RESULTS 
Table 18: Purdue Pegboard Test scores and T-test scores for Alzheimer’s Disease 
and Frontotemporal Dementia patients at initial assessment 
FTD  AD 
  N  Mean 
Std. 
Dev  N  Mean 
Std. 
Dev 
Levene’s 
Test For  
Equality 
of 
Variance  t(df) sig 
Right 
hand   24  13.1  2.3  14  10.7  3.9  6.1 *  2.1(17.9)  
Left 
hand   23  12.3  2.3  14  10.5  2.7  0.20  2.1(35) * 
Both 
hands  17  9.6  2.5  11  7  .6  1.60 
2.3 (26) 
* 
* = p < .05 
Scores for both Frontotemporal Dementia and Alzheimer’s Disease subjects 
indicated impaired performance with the exception of “Right Hand” for the 
Frontotemporal Dementia patient group.  Frontotemporal Dementia patient 
scores were significantly higher than the Alzheimer’s Disease patient scores for 
the “Left Hand” and “Both Hands” components of the test.   This finding 
indicates relatively preserved hand-eye coordination and manual dexterity in 
Frontotemporal Dementia patients. This test has not been used previously to 
assess Frontotemporal Dementia patients. The use of the Purdue Pegboard test 
with early-onset dementia patients warrants further research. 
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4.12 DIGIT SPAN TEST RESULTS (WAIS-111, WECHSLER, 1997) 
Table 19: Digits Forward and Backward recalled. Scores and T-test scores for 
Alzheimer’s Disease and Frontotemporal Dementia patients at initial assessment 
FTD  AD 
  N  Mean 
Std. 
Dev  N  Mean 
Std. 
Dev 
Levene’s 
Test For  
Equality 
of 
Variance  t(df) ª 
Digits 
Forward  29  5.5  1.2  18  5.7  1.3  0.60  .4(45)  
Digits 
Backward  29  3.6  1  18  2.9  1.4  0.60  1.9(45)  
ª = none of the t-tests were statistically significant 
 
The number of digits repeated verbatim and repeated in reverse order was 
impaired for both Frontotemporal Dementia and Alzheimer’s Disease groups, 
with no significant difference between the two groups.  
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4.13 WECHSLER MEMORY SCALE (WMS, WECHSLER, 1974)  TEST 
RESULTS 
Table 20: Wechsler Memory Scale (WMS) Logical Memory and Visual recall 
scores and T-test scores for Alzheimer’s Disease and Frontotemporal Dementia 
patients at initial assessment 
FTD  AD 
Logical 
Memory  N  Mean 
Std. 
Dev  N  Mean 
Std. 
Dev 
Levene’s 
Test For  
Equality 
of 
Variance  t(df) sig 
Immediate 
recall Story 
1  29  6.3  3.4  18  4.5  3.2  0.10  1.7(45)  
Immediate 
recall Story 
2  29  6.1  3.8  18  3.9  3  0.60 
2.1(45) 
* 
Immediate 
recall Total  29  12.4  6.7  18  8.4  5.9  0.40 
2.1(45) 
* 
Delayed 
Recall Story 
1  25  5.4  4.1  14  3.4  3.4  0.10  1.8(37)  
Delayed 
Recall Story 
2  25  4.5  3.6  14  3.7  3.7  0.10  1.5(37)  
Delayed 
Recall Total  25  9.9  7.4  14  5.6  6.5  0.10  1.7(37)  
* = p < .05 
The Wechsler Memory Scale (WMS) scores were impaired for both 
Frontotemporal Dementia and Alzheimer’s Disease groups, and for both the 
immediate and delayed recall condition of the tests (see Table 20 above).  The 
Frontotemporal Dementia group was able to recall significantly more of “Story 
2” than the Alzheimer’s Disease group. Total Immediate Recall score was 
significantly higher for the Frontotemporal Dementia group than the 
Alzheimer’s Disease group.  This finding is consistent with the findings of 
Kertez and colleagues (2003).  79 
 Table 21: Wechsler Memory Scale (WMS) scores and T-test scores for 
Alzheimer’s Disease and Frontotemporal Dementia patients at initial 
assessment on the Visual Recall subtest 
FTD  AD 
Visual 
Recall  N  Mean 
Std. 
Dev  N  Mean 
Std. 
Dev 
Levene’s 
Test For  
Equality 
of 
Variance   t(df) sig 
Immediate 
Recall 
Design 1  28  2.1  0.9  15  1  0.9  0.10  3.8(41) * 
Immediate 
Recall 
Design 2  28  2.1  1.5  15  1.1  0.8  6.7 * 
2.7(40.9) 
* 
Immediate 
Recall 
Design 3  27  2.2  1.8  15  0.6  0.8  12.3 ** 
3.9(38.8) 
** 
Immediate 
Recall 
Total  27  6.6  2.9  15  2.7  2.2  1.40 
4.6(41) 
** 
Delayed 
Recall 
Design 1  25  1.4  1.2  11  0.5  0.9  6.9 * 
2.8(28.1)
* 
Delayed 
Recall 
Design 2  25  1.8  1.5  11  0.6  1.1  3.60 
3.0(28) 
** 
Delayed 
Recall 
Design 3  25  1.7  1.9  11  0.5  0.8  11.0 ** 
2.7(33.9) 
* 
Delayed 
Recall 
Total  25  4.9  3.2  11  1.5  2.1  0.50 
3.3(34) 
** 
* = p < .05; ** = p < .01 
 
Both Immediate Recall and Delayed Recall scores fell in the impaired range for 
all visual designs for both Frontotemporal Dementia and Alzheimer’s Disease 
groups. Mean recall scores were significantly higher for the Frontotemporal 
Dementia group on all sections of the test.   80 
This result indicates the Frontotemporal Dementia group has relatively 
preserved immediate and delayed visual memory for designs in comparison to 
the Alzheimer’s Disease group, and is consistent with previous research findings 
(Kertez & Davidson, 2003).  
 
4.14 REY-OSTERRIETH COMPLEX FIGURE TEST RESULTS 
Table 22: Rey-Osterrieth Complex Figure Test scores and T-test scores for 
Alzheimer’s Disease and Frontotemporal Dementia patients at initial assessment 
FTD  AD 
  N  Mean 
Std. 
Dev  N  Mean 
Std. 
Dev 
Levene’s 
Test For  
Equality 
of 
Variance  t(df) sig 
Copy  27  32.7  6.2  15  24.3  10.1  7.3 * 
2.8(19.5) 
* 
Immediate 
Recall  20  12.6  6.9  10  6.2  6.1  0.40  2.4(28) * 
* = p < .05 
 
Both the Alzheimer’s Disease and Frontotemporal Dementia mean scores fell in 
the impaired range for both the “Copy” and “Immediate Recall” conditions of 
the test (see Table 22 above).  The Frontotemporal Dementia group was able to 
recall significantly more details of the design at both conditions of the test.  This 
result indicates that the Frontotemporal Dementia group had relatively preserved 
ability to copy and recall complex visuospatial designs compared to the 
Alzheimer’s Disease group.  This finding is consistent with previous research 
(Edwards-Lee & Miller et al. 1997; Perri & Koch et al. 2005).    81 
4.15 SYMBOL DIGIT MODALITIES TEST RESULTS 
Table 23: Symbol Digit Modalities Test Scores (written component) and T-test 
scores for Alzheimer’s Disease and Frontotemporal Dementia patients at initial 
assessment 
FTD  AD 
  N  Mean 
Std. 
Dev  N  Mean 
Std. 
Dev 
Levene’s 
Test For  
Equality 
of 
Variance  t(df) sig 
Written  27  27.6  11.9  12  21.5  9.7  2.20 
2.1(23) 
* 
 * = p < .05 
There were insufficient scores for the verbal component of the test for statistical 
analysis. 
 
Both Frontotemporal Dementia and Alzheimer’s Disease groups produced 
scores in the impaired range on the Symbol Digit Modalities Test (SDMT, see 
Table 23 above).  The Frontotemporal Dementia group score was significantly 
higher than the Alzheimer’s Disease group score.  This result indicates relatively 
preserved capacity in the Frontotemporal Dementia group for completing a 
coding task with a significant complex scanning and visual tracking component 
in comparison to the Alzheimer’s Disease group.  This finding is consistent with 
previous research (Ringholz & Appel et al. 2005).    82 
4.16 TACTILE FINGER RECOGNITION TEST  RESULTS 
Table 24:  Tactile Finger Recognition Test error-scores and T-test scores for 
Alzheimer’s Disease and Frontotemporal Dementia patients at initial assessment 
FTD  AD 
  N  Mean 
Std. 
Dev  N  Mean 
Std. 
Dev 
Levene’s 
Test For  
Equality 
of 
Variance  t(df) sig 
Right 
Hand  20  1.1  1.7  13  4.8  3.8  9.3* 
3.3(15.1)*
* 
Left 
Hand  20  1.3  1.5  13  4.2  5.4  25.1**  1.9(13.1) 
* = p < .05; ** = p < .01 
 
The Frontotemporal Dementia group produced scores within normal limits for 
both right and left hands (see Table 24 above). The Alzheimer’s Disease group 
produced results in the impaired range for both hands.  The result for the left 
hand did not reach statistical significance due to the large variance in the 
Alzheimer’s Disease group.  Many of the Alzheimer’s Disease subjects became 
disoriented during the test, and expressed discomfort at having to close their 
eyes and concentrate on their fingers. This result indicates that the Tactile Finger 
Recognition Test may be a simple, easy to administer test to assist with the 
differential diagnosis of Frontotemporal Dementia from Alzheimer’s Disease.  
There are no published studies that have used finger recognition tasks with 
Frontotemporal Dementia.  The above results indicate that Frontotemporal 
Dementia patients are capable of maintaining orientation in the present with 
their eyes closed, whereas Alzheimer’s Disease patients appear more reliant of 
visual cues to remain oriented. The use of the Tactile Finger Recognition Test 
with early-onset dementia patients warrants further research.  83 
4.17 FAS VERBAL FLUENCY AND ANIMAL NAMING TEST 
RESULTS 
Table 25:  FAS Test of Verbal Fluency & Animal Naming Test scores and T-test 
scores for Alzheimer’s Disease and Frontotemporal Dementia patients at initial 
assessment 
FTD  AD 
  N  Mean 
Std. 
Dev  N  Mean 
Std. 
Dev 
Levene’s 
Test For  
Equality 
of 
Variance  t(df)ª 
F  28  8.7  4.6  17  9.7  4.1  .2  .7(43) 
A  28  6.5  4.2  17  7.8  5.1  1.3  .9(43) 
S  28  8.7  5.6  17  9.7  5.1  .2  .7(43) 
Animals  20  11.9  5.1  10  10.8  5.1  .7  .5(28) 
ª = none of the t-tests were statistically significant 
 
 
Scores for both the Frontotemporal Dementia and Alzheimer’s Disease groups 
fell in the impaired range for the letters “F”, “A”, and “S”, and also for the 
animal-naming task (see Table 25 above).  There was no statistical difference 
between the two groups.  The animal naming result is inconsistent with the 
findings of Perri and Koch et al (2005) who found significantly lower animal 
naming scores in Frontotemporal Dementia patients than Alzheimer’s Disease 
patients.   Perri and colleagues study (2005) included subjects over the age of 
65, therefore direct comparison between the two groups is not possible.  
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4.18 FREEHAND CLOCK DRAWING TEST RESULTS 
Table 26: Freehand clock drawing test scores and T-test scores for 
Alzheimer’s Disease and Frontotemporal Dementia patients at initial 
assessment 
FTD  AD  Chi Square 
  N = 23  N = 15   
Impaired  9 (39%)  13 (87%)  8.42 * 
* = p < .05 
 
Both Frontotemporal Dementia and Alzheimer’s Disease groups showed 
significant impairment on the clock-drawing task (see Table 26 above). The 
Alzheimer’s Disease group was significantly more impaired, with all but 13% of 
the group unable to successfully complete the task. In contrast, 61% of the 
Frontotemporal Dementia group were able to successfully complete the task.  
This result provides further evidence that the Freehand Clock Drawing Test is a 
useful dementia screening tool.   This result is consistent with previous research 
(Libon & Swenson et al. 1993; Juby & Tench et al. 2002; Tench, & Barker, 
2003; Blair & Kertesz et al. 2006). The Freehand Clock Drawing Test is simple 
to administer and may assist with the differential diagnosis of Frontotemporal 
Dementia from Alzheimer’s Disease. Its use with early-onset dementia patients 
warrants further research. 
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4.19 NEUROPSYCHOLOGICAL RESULTS SUMMARY AND 
CONCLUSION 
4.19.1 Non Standardised Assessment 
Due to the advanced state of cognitive deterioration displayed by many of the 
patients, testing was not conducted in a standardised manner.  
Neuropsychological assessment was conducted to assist with patient 
management, and not for research purposes.  The assessments produced 
clinically useful information and outlined the relative strenghths of each patient.  
Due to the non-standardised use of neuropsychological tests the statistical 
analysis of the results in this study must be treated with some caution.     
 
4.19.2 Summary 
The neuropsychological assessment of the two groups of early-onset dementia 
patients produced variable results that generally support previous research in the 
area of early-onset dementia, with both the Frontotemporal Dementia and 
Alzheimer’s   patient groups producing below average to impaired results on all 
assessment measures. The Frontotemporal Dementia group had relatively 
preserved visuo-spatial skills compared to the Alzheimer’s Disease group.  
 
4.19.3 Task Failure 
Significant numbers of both the Frontotemporal Dementia and Alzheimer’s 
Disease group were unable to successfully complete many of the 
neuropsychological tests.  For example, 16 % of the Frontotemporal Dementia    86 
patients, and 28% of the Alzheimer’s Disease patients were unable to complete 
the WAIS-111.  The number of subjects who were unable to undertake 
standardised assessment tasks is an important result. The high percentage of 
task-failure indicates that the neuropsychological test results may be 
overestimates of the level of functioning for these two groups.  The usual 
reasons for task failure were agitation, distress, distractibility, and inability to 
understand test instructions.   
 
As a general rule distractibility and inability to understand test instructions 
appeared to be more common in the Frontotemporal Dementia patients, whereas 
distress and agitation appeared to be more common in the Alzheimer’s Disease 
group.  It was my impression that many of the Alzheimer’s Disease group were 
aware of task failure, whereas the Frontotemporal Dementia patients generally 
appeared to be unaware of their deficits.  
 
4.19.4 Effective Dementia Screening and Differential Diagnosis Instruments 
All of the assessment measures were found to be effective tools that may assist 
with the assessment of dementia, but few of the verbal tests proved useful in the 
differential diagnosis of Frontotemporal Dementia from Alzheimer’s Disease.   
The majority of measures that were found to have differential diagnostic 
potential with these groups did not require a verbal response. The measures    87 
found to be effective were the WAIS-111 Block Design and Picture completion 
subtests, the Purdue Pegboard Test, the Tactile Finger Recognition Test, the 
Rey-Osterrieth Complex Figure Test, the Freehand Clock Drawing test, the 
written component of the Symbol Digit Modalities Test, and the Wechsler 
Memory Scale Visual Recall Test. The immediate recall condition of the 
Wechsler Memory Scale Logical Memory test was found to be the only subtest 
requiring a verbal response to discriminate between the two groups.  
 
4.19.5 Ineffective Differential Diagnosis Instruments 
The following tests did not discriminate between Frontotemporal Dementia and 
Alzheimer’s Disease: the WAIS-111 Verbal IQ subtests, the Mini Mental State 
Exam, the Paired Associates Learning Task, Digit Span, the FAS and Animal 
Naming test.   All of these tests, with the exception of some items on the Mini 
Mental State Exam, require verbal responses.   
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CHAPTER 5 
CHARACTERISTIC BEHAVIOURAL AND 
PSYCHIATRIC CHANGES 
DIFFERENTIATING FRONTOTEMPORAL 
DEMENTIA FROM ALZHEIMER’S DISEASE 
 
 
 
“Personality changes in Alzheimer’s Disease are in keeping with, and 
perhaps to some extent the product of, preserved social awareness; 
personality changes in Frontotemporal Dementia reflect breakdown in 
social capacity. Frontotemporal Dementia patients are alienated early 
from relatives, because of loss of emotional rapport, resulting in relatively 
early admission of patients to permanent residential care.”  
                Snowden & Neary et al. 1996, p. 47 
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5.1 INTRODUCTION TO CHARACTERISTIC BEHAVIOURAL AND 
PSYCHIATRIC CHANGES DIFFERENTIATING FRONTOTEMPORAL 
DEMENTIA FROM ALZHEIMER’S DISEASE 
Commonly, Frontotemporal Dementia is first noticed due to significant 
behavioural changes such as rapidly deteriorating social skills, loss of 
spontaneity, rudeness, and disregard for others (Brun & Englund et al. 1994; 
Walsh & Darby, 1999).  The behavioural changes associated with 
Frontotemporal Dementia result in a rapid deterioration in occupational 
performance early in the course of the illness (Elfgren & Passant et al. 1993).   
 
The rapid onset of behavioural and personality changes accompanying 
Frontotemporal Dementia stand in marked contrast to the comparatively mild 
personality and behavioural changes commonly accompanying the early stages 
of Alzheimer’s Disease (Miller & Cummings  et al. 1995; Trimble, 1991; 
Engelborghs & Martens, 2005).  There is evidence that accurate differentiation 
between Frontotemporal Dementia and Alzheimer’s Disease can be made solely 
on the retrospective analysis provided by primary carers of patient behaviours 
during the course of the illness (Barber, Snowden & Crausfurd, 1995).    90 
 Behavioural and psychiatric changes commonly associated with Frontotemporal 
Dementia and Alzheimer’s Disease are described in detail below.  A summary 
of the differential changes associated with each condition is summarised in 
Table 27 (p. 103).  
 
5.1.1 Loss of Motivation/Apathy, and Clinical Depression in 
Frontotemporal Dementia and Alzheimer’s Disease  
Loss of motivation and depression commonly occur with both Frontotemporal 
Dementia and Alzheimer’s Disease (Engelborghs & Martens, 2002; Van 
Reekumk, Stuss, & Ostrander, 2003; Mourik & Rosso et al. 2004; Diehl-Schmid 
&  Pohl et al. 2006).  There is a strong relationship between loss of motivation 
and depression, and the diagnostic criteria for these two syndromes have 
extensive similarities (Van Reekumk, Stuss, & Ostrander, 2003).   
 
Although loss of motivation and depression commonly coexist, many patients 
with neurological conditions lose motivation and become apathetic, but do not 
develop other characteristics of depression (Levy & Cummings et al. 1998).   
There are no longitudinal data on loss of motivation in Frontotemporal 
Dementia, and only one longitudinal study of Alzheimer’s Disease patients. This 
study found that loss of motivation and apathy progressed steadily over a three 
year period (Petry & Cummings et al. 1989).  
 
Loss of motivation has been found to occur more commonly early in the course 
of Frontotemporal Dementia than in early Alzheimer’s Disease (Snowden &    91 
Neary et al. 1996; Pasquier & Lebert et al. 1999). Frontotemporal Dementia 
patients commonly do not instigate activities unaided, and show lack of 
motivation in most situations (Pasquier & Lebert et al. 1999; van Reekum, 
Stuss, & Ostrander, 2003).  In contrast, Alzheimer’s Disease patients are more 
likely to become frustrated when they are unable to complete tasks, and engage 
in “covering up behaviour”. That is, patients attempt to mask their underlying 
deficits, often by making excuses, or by minimising the behaviours (Barber, 
Snowden, & Craufurd, 1995; Binetti & Locascio et al. 2000).   
 
The characteristic lack of motivation accompanying Frontotemporal Dementia 
has been mistaken for several other clinical conditions including menopause, 
depression and chronic fatigue syndrome (Pasquier & Delacourte, 1998).  The 
loss of motivation commonly occurring in early Frontotemporal Dementia has 
been found by several researchers to make formal assessment difficult (Miller & 
Cummings et al. 1991; Smeding & de Koning; 2000; Snowden, Neary & Mann; 
1996).   In contrast, patients in the early stages of Alzheimer’s Disease generally 
try to perform well on assessment tasks, and are aware of test-failure (Snowden 
& Neary et al. 1996). 
 
5.1.2 Behavioural Changes Associated with Executive Function 
Deterioration in Alzheimer’s Disease and Frontotemporal Dementia 
Executive functions are the cognitive abilities to successfully and independently 
engage in purposeful activities such as initiating activities, planning, self-
regulation, and volition (Lezak, 1995).  Frontotemporal Dementia patients 
rapidly lose these executive functions, which are controlled by the frontal lobes:   92 
they become unconcerned, lack initiative, judgment and foresight (Mendez & 
Anderson et al. 2005). Personal responsibilities and self-care are generally 
neglected (Walsh & Darby, 1999; Diehl & Kurz, 2002).  The loss of abstract 
thinking ability (or the manifestation of “concrete thinking”) is a universal 
feature of Frontotemporal Dementia.  Patients with Frontotemporal Dementia 
tend to take objects at their face value, and lose the ability to dissociate 
themselves from their immediate environment.  Ability to foresee consequences, 
effective planning and goal-directed behaviours therefore become increasingly 
rare (Walton, 1993; Gustafson & Brun, 1999). 
 
5.1.3 Social Skills in Frontotemporal Dementia and AD 
The early loss of executive functioning in Frontotemporal Dementia leads to 
rapid loss of social skills. Spatial skills, visual and auditory perception, motor 
skills, and memory, tend to be reasonably well preserved in the early stages of 
the illness. In marked contrast, Alzheimer’s Disease patients often experience 
deterioration of spatial skills, visual motor skills and memory, with relatively 
preserved social skills (Gustafson & Brun, 1999; Walsh & Darby, 1999).    In 
Alzheimer’s Disease, social graces, manners, and courtesy often remain well 
preserved throughout the course of the illness (Bozeat & Gregory et al. 2000; 
Snowden & Neary et al. 1996).    
5.1.4 Facade of Normality in Alzheimer’s Disease 
Alzheimer’s Disease patients, through their preserved social skills, often attempt  
to maintain social relationships until the late stages of the illness, and are able to  
present and maintain a facade of normality in environments and familiar 
situations.  This facade of normality, or “covering-up behaviour” masks the   93 
patient’s underlying deficits, and can often lead others who have not seen the 
Alzheimer’s Disease patient in a variety of situations, to assume that there is no, 
or minimal deterioration  (Rubin & Morris et al. 1987).   This “facade of 
normality” generally becomes apparent when the Alzheimer’s Disease patient is 
required to deal with novel situations, or tasks that they are unable to complete.  
In these situations the Alzheimer’s Disease patient often becomes anxious, 
perplexed, and agitated as the “covering-up” behaviours are unable to meet the 
environmental demands (Cummings & McPherson, 2001; Mendez & Shapira, 
2005).     
 
5.1.5 Lack of Concern in Frontotemporal Dementia 
In sharp contrast to the relatively preserved social skills and attempts to cover-
up deficits that characterise many Alzheimer’s Disease patients, Frontotemporal 
Dementia patients rarely show any evidence that they are aware of often 
profound social skills deficits.  Frontotemporal Dementia patients typically 
appear unconcerned about breaches of social protocol and task failure 
(Cummings & McPherson, 2001; Mendez & Shapira, 2005).   It is common for 
Frontotemporal Dementia  patients to deny experiencing any difficulty or    94 
decline in their level of social functioning, even when presented with clear 
evidence that there has been a dramatic change in functioning (Gustafson & 
Brun, 1999).    Frontotemporal Dementia patients typically do not attempt to 
maintain social relationships. They show little or no distress or anxiety when  
unable to complete tasks that they had previously completed routinely,  
and do not attempt to mask social deficits (Snowden & Neary et al. 1996; 
Gustafson & Brun, 1999).    
 
5.1.6 Neuropathology of Aggression in Frontotemporal Dementia 
Some Frontotemporal Dementia patients exhibit aggressive behaviours that pose 
significant challenges to those involved in providing care for the patients 
(Tanabe & Ikeda et al. 1999). A significant association has been found between 
aggression and hypoperfusion in the left anterior temporal cortex and bilateral 
dorsofrontal cortex (Hirono & Mega et al. 2000; Miller & Darby et al. 1997).  
Increased levels of aggression have been linked to mutations in chromosome 
17q21-22 (Heutkin & Stevens et al. 1997).  Other researchers have highlighted 
the role of degeneration of frontotemporal regions in aggressive behaviour, in 
particular degeneration of the right frontotemporal region (Mychack & Kramer 
et al. 2001).   
 
Several researchers have argued that it is probable that factors beyond pure 
neuropathology are involved in the manifestation of behaviours classified as 
“aggressive”.  For example, quality of nursing care, behavioural management, 
support from primary carers, and medication, are all likely to reduce aggressive    95 
behaviours (LaVigna, Willis, Shaull, Adebi & Sweitzer, 1994; Tanabe, Ikeda & 
Komori, 1999).  
 
Overactivity 
Hyperorality, Smoking and Alcohol Consumption  
Dramatic excesses of eating and drinking are common early in the course of 
Frontotemporal Dementia (Miller & Darby et al. 1995; Ikeda & Brown et al. 
2002).  These changes are linked to hyperorality. Hyperorality is defined as 
excessive and indiscriminant eating, gluttony, preference for sweet food, and 
carbohydrate craving. Hyperorality is relatively common in Frontotemporal 
Dementia, but is rare in Alzheimer’s Disease. Hyperorality is generally 
accompanied by rapid weight gain (Bathgate & Snowden et al. 2001; Miller & 
Darby et al. 1995).   
 
The presence of hyperorality and associated gluttony and preference for sweet 
foods in dementia patients has been found to accurately discriminate 
Frontotemporal Dementia from Alzheimer’s Disease (Miller & Darby et al. 
1997; Bathgate & Snowden et al. 2001).    In a study of 14 patients diagnosed 
with Frontotemporal Dementia and 14 patients diagnosed with Alzheimer’s 
Disease, Miller and colleagues (1995) found that weight gain occurred in 64% 
of the Frontotemporal group, compared with only 7% in the Alzheimer’s 
Disease group.  Carbohydrate craving was found in 79% of the Frontotemporal 
group, but in none of the Alzheimer’s group. 
 
Smoking and alcohol consumption typically increases in the early stages of    96 
Frontotemporal Dementia (Bathgate & Snowden et al. 2001).   Alcohol abuse 
has, in some cases, resulted in patients being misdiagnosed with an alcohol-
induced dementia (Gustafson, 1987).  
 
Hypersexuality   
Hypersexuality rarely occurs in Alzheimer’s Disease (Dell & Halford, 2002).  It 
is more common in Frontotemporal Dementia, and its occurrence can be 
extremely challenging for primary caregivers (Dell & Halford, 2002; Tang-Wai 
& Lewis et al. 2002; Higgins & Barker et al. 2004).    
 
Restlessness & pacing   
Restlessness, pacing, and apparently directionless wandering are commonly 
associated with Frontotemporal Dementia (Snowden & Neary et al. 1996; 
Snowden & Bathgate, 2001).  
 
Stereotypical & Ritualistic Behaviours 
Ritualistic and stereotypical behaviours are common in the early stages of 
Frontotemporal Dementia, and generally persist throughout the course of the 
illness.  These behaviours generally occur only in the late stages of Alzheimer’s 
Disease, and commonly do not occur throughout the course of the illness (Neary    97 
& Snowden, 1996; Shigenobu & Ikeda et al. 2002; Nyatsanza & Shetty et al. 
2003).   Common stereotypical and ritualistic behaviours include behaviours 
such as collecting coupons or papers, spending many hours in the bathroom, or 
repetitive pacing (Gregory & Hodges, 1993; Pasquier & Delacourte, 1998; 
Bathgate & Snowden et al. 2001; Miller & Cummings et al. 1995). The 
behaviours associated with the reptilian brain are primarily ritualistic and 
stereotypical. These behaviours have commonly been associated with frontal 
lobar atrophy, and their presence assists in the differential diagnosis of 
Frontotemporal Dementia from Alzheimer’s Disease (Miller & Darby et al. 
1997; Tanabe & Ikeda  et al. 1999).  
 
Utilisation behaviour 
Utilisation behaviour is the tendency to pick up and manipulate any object in the 
environment, and its appearance is an indicator of frontotemporal 
neurodegeneration. Utilisation behaviour is extremely rare in Alzheimer’s 
Disease (Ikeda & Tanabe, 2000; Nyastanza & Shetty et al. 2003). 
 
5.1.7 Psychiatric Symptoms Associated with Frontotemporal Dementia and 
Alzheimer’s Disease.  
The pattern of rapidly emerging “psychiatric” symptoms commonly 
accompanying the onset of Frontotemporal Dementia is markedly different from 
the relatively subtle, slow changes that generally occur with the onset of 
Alzheimer’s Disease (Bozeat & Gregory et al. 2000).  Due to the marked 
behavioural and personality changes associated with the early stages of   98 
Frontotemporal Dementia, many Frontotemporal Dementia patients have been 
misdiagnosed with a psychiatric illness before they are diagnosed with 
Frontotemporal Dementia  (Merriam & Aronson, 1988). In contrast, psychiatric 
symptoms rarely occur before cognitive and behavioural decline in Alzheimer’s 
Disease (Merriam & Aronson, 1988). 
 
Frontotemporal Dementia patients commonly experience affective disorders, 
radically altered emotional and social conduct, and transient psychiatric 
symptoms, including hallucinations, before or during the early stages of 
cognitive and behavioural decline (Elfgren & Passant et al. 1993; Lopez &  
Gonzalez et al. 1996; Neary & Snowden, 1996; Gallant & Muggier et al. 1998).    
 
Acquired obsessive-compulsive disorder is common in Frontotemporal 
Dementia.  Many patients develop compulsions as the disease progresses such 
as collecting meaningless objects and repetitive pacing (Pasquier & Delacourte, 
1998).   
 
5.1.8 Changes in Sleep Pattern 
 
Sleeping patterns often change dramatically with the onset of Frontotemporal 
Dementia.   Some patients become more lethargic, and spend up to 18 hours 
each day sleeping, while in others sleeping patterns become erratic (Harper & 
Stopa et al. 2001).  In marked contrast, levels of nocturnal activity increase 
significantly in Alzheimer’s Disease patients (Harper & Stopa et al. 2001).  
Differential nocturnal activity levels between Alzheimer’s Disease and 
Frontotemporal Dementia patients are accompanied by significant   99 
neurochemical cerebrospinal fluid (CSF) differences (Minthon & Edvinson et al. 
1990).  Alzheimer’s Disease patients showed significantly reduced 
Neuropeptide Y and Delta Sleep Inducing Peptide levels.  In contrast, 
Frontotemporal Dementia patients showed no reduction in Neuropeptide Y 
levels, and increased Delta Sleep Inducing Peptide levels.  Neuropeptide Y has a 
role in eating behaviour, circadian rhythms, and anxiety responses (Minthon & 
Edvinson et al. 1990).   Delta Sleep Inducing Peptide is believed to assist with 
maintaining natural healthy sleep rhythms (Schneider-Helmert  & 
Schoenenberger, 1983).   
5.1.9 Additional Behaviours 
  Incontinence 
Incontinence is relatively common in the middle and later stages of 
Frontotemporal Dementia. Incontinence often occurs within 18 months of 
diagnosis. In contrast, incontinence generally occurs in the later stages of 
Alzheimer’s Disease (Nicolai & Lazzarino, 1992; Neary & Snowden et al. 1998; 
McKhann & Albert et al. 2002) 
    
  Pleasant Disposition and More Affectionate 
Patients with Alzheimer’s Disease often maintain premorbid personality 
characteristics until the late stages of the illness. If Alzheimer’s  Disease patients 
had previously had a pleasant disposition, they generally maintain these 
characteristics (Snowden & Neary et al. 1996; Harciarek & Jodzio 2005).  No 
evidence was found in the literature of either Frontotemporal Dementia or 
Alzheimer’s Disease patients becoming more affectionate during the course of 
their illnesses.    100 
5.2 HUMOUR IN FRONTOTEMPORAL DEMENTIA AND 
ALZHEIMER’S DISEASE. 
 “Humour is a defining human attribute” 
 Shammi & Stuss, 1999 
 
Humour plays an important part in all human interactions, helps build social 
groups, and assists in the communication of complex ideas and feelings 
(Brownell & Gardner, 1988).   The role of the frontal lobes in processing 
humour has been well documented (e.g. Gardner & Ling et al. 1975; Lezak, 
1995; Shammi & Stuss, 1999). The frontal lobes play a pivotal role in the 
integration of information from several different regions in the brain essential 
for the understanding of humour (Shammi & Stuss, 1999).   
 
5.2.1 Neurological Underpinnings of Humour 
 Recent research has indicated that both right and left frontal lobes are involved 
in the understanding of humour (Moran & Wig et al. 2004; Shammi & Stuss, 
1999).  Moran and colleagues have also described the importance of the 
interaction between the frontal and temporal lobes, and the neural connections to 
the insular cortex and amygdala in the understanding of humour (Moran & Wig 
et al. 2004).     101 
5.2.2 Cognitive Functions Involved in Humour 
Humour is a higher cognitive function, and the understanding of humour uses a 
variety of cognitive processes:  the ability to hold information in memory whilst 
it is being manipulated; the ability to change mental sets rapidly, and the ability 
to think abstractly (Shammi & Stuss, 1999).   
 
5.2.3 Humour in Frontotemporal Dementia and Alzheimer’s Disease 
Any frontal lobe damage has been consistently found to cause deterioration in 
the ability to understand humour (Lezak, 1995).  Humour in Alzheimer’s 
Disease is generally well-preserved until late in the course of the illness 
(Buckwalter & Gerdner et al. 1995). Buckwater and colleagues (1995) found 
that patients with Alzheimer’s Disease generally maintained their sense of 
humour, and they suggested that humour could be used as a therapeutic strategy 
for people with Alzheimer’s Disease.  
 
In marked contrast to the relatively well-preserved sense of humour in 
Alzheimer’s Disease, Frontotemporal Dementia Patients rapidly lose their 
ability to understand humour. The loss of a sophisticated sense of humour is 
often replaced by the development of   “Witzelsucht” – childish and 
inappropriate humour - and “slapstick humour”. The development of the 
childish “Witzelsucht” in Frontotemporal Dementia is accompanied by a 
profound loss of ability to understand complex adult humour (Vardi & 
Finkelstein et al. 1994; Shammi & Stuss, 1999).   102 
5.3 SUMMARY OF PSYCHIATRIC AND BEHAVIOURAL CHANGES 
 
Table 27: Summary of psychiatric and behavioural changes 
 
  Frontotemporal Dementia  Alzheimer’s Disease 
Eating and 
drinking 
Hyperorality, excessive and indiscriminant eating, gluttony, preference for 
sweet food, carbohydrate craving, and weight gain (Bathgate & Snowden et 
al. 2001; Miller & Cummings et al. 1995; Ikeda & Brown et al. 2002).   
 
 
Unchanged (Bathgate & Snowden et al. 2001; Miller 
& Cummings et al. 1995) 
Motivation  Rapid loss of motivation and energy.  Apathy, indifference, aspontaneity and 
inertia.  Deterioration in occupational performance is common early in the 
course of the illness (Elfgren & Passant et al. 1993; Pasquier & Delacourte, 
1998; van Reekumk, Stuss, & Ostrander, 2003: Diehl-Schmid & Pohl et al. 
2006). 
Slow loss of motivation throughout the course of the 
illness (Snowden & Neary et al.  1996; van Reekumk, 
Stuss, & Ostrander, 2003).  
Other 
behaviours 
Motor and verbal perseverations and markedly reduced verbal fluency.  
Utilization behaviours, disabling compulsions, stereotypical and ritualistic 
behaviours such as collecting coupons or papers, spending many hours in the 
bathroom, or repetitive pacing (Gregory & Hodges, 1993; Bathgate & 
Snowden et al. 2001; Miller & Cummings et al. 1995; Shigenobu & Ikeda et 
al. 2002). 
 
Personal 
hygiene 
Personal neglect, loss of interest in appearance. Incontinence as disease 
progresses may be a product of the patient’s apathy (Nicolai & Lazzarino, 
1991). 
 
Often preserved until late in course of illness (Mace 
& Rabins, 1991). 
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Table 27 Continued: Summary of psychiatric and behavioural changes 
 
 
 
Personality  Profound personality change in early stages. Disinhibited, loss of social 
awareness, impaired social skills, rudeness, emotional blunting, fatuous 
jocularity, disregard for others, breakdown of social communication (Brun & 
Englund et al. 1994; Kertesz, Davidson & Fox, 1997; Walsh & Darby, 1999).  
 
Mild personality changes in early stages.  Relatively 
preserved social graces.  Manners and courtesy 
remain long-preserved (Snowden & Neary et al. 
1996).  Ability to present a facade of normality, 
hiding underlying deficits (Miller & Cummings et al. 
1995; Rubin & Morris et al. 1987; Tanabe, Ikeda & 
Komori, 1999).    
Planning   Retardation, mental rigidity, lack of initiative, judgment, and foresight. 
Personal responsibilities and self-care are generally neglected (Walsh & 
Darby, 1999). 
 
More likely to become anxious, perplexed, and 
agitated in novel situations  (Snowden & Neary et al.  
1996).  
Psychological/ 
psychiatric 
symptoms 
Depression, anxiety, excess sentimentality, early “psychotic” symptoms, 
hallucinations, disabling compulsions, repetitive pacing (Elfgren & Passant 
et al. 1993; Miller & Cummings, 1995; Spinnler & Della Salla, 1988).  
Late onset psychosis, hallucinations, delusions. 
Depression (Cummings & McPherson, 2001; 
Gormley & Rizwan, 1998; Snow & Arnold, 1996).  
Insight  Unaware of disability. Patients indicate little or no distress or anxiety when 
unable to complete tasks. Loss of ability to dissociate from immediate 
environment (Snowden & Neary et al. 1996; Gustafson & Brun, 1999; 
Mendez & Shapira, 2005; Rankin & Baldwin et al. 2005).  
Variable. Often preserved until late in course of 
illness (Pasquier & Delacourte, 1998; Rankin & 
Baldwin et al. 2005) 
Sleep  Increased sleeping (Harper & Stopa et al. 2001).   Increased nocturnal activity (Harper & Stopa  et al. 
2001) 
Smoking and 
drinking 
Increased smoking and alcohol consumption (Gustafson, 1987).  Unchanged (Gustafson, 1987).  
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Table 27 Continued: Summary of psychiatric and behavioural changes 
 
Spatial skills, 
visual and 
auditory 
perception, 
motor skills, 
memory  
Relatively preserved, can accurately copy simple designs early in the course 
of the illness  (Gustafson & Brun, 1999; Johanson & Hagberg, 1989; 
Snowden & Neary et al. 1996).   
Impaired copying ability at first assessment 
(Johanson & Hagberg, 1989). 
Speech  Economy of speech, reduction in speech output, late mutism.  PEMA 
Syndrome:  Palilalia (repeating the same word over and over again), 
Echolalia (the involuntary copying of another’s speech), Mutism, and 
Amimia (an aphasic symptom involving the loss of the power to use gestures 
and other pantomimic means of expression of thought) (Guiraud, 1936; Brun 
& Gustafson, 1999; Snowden, Neary & Mann 1996).   
 
This syndrome is extremely rare in Alzheimer’s 
Disease (Brun & Gustafson, 1999).   
Spelling and 
handwriting.  
Spelling errors, slowing of speed of handwriting (Gustafson & Brun, 1999).  Distinctive tempo-parietal dysgraphia characteristic 
of Alzheimer’s Disease (Gustafson & Brun, 1999). 
Thinking   Concreteness of thinking is common.  Patients with FTD tend to take objects 
at their face value, and lose the ability to dissociate themselves from their 
immediate environment.  Planning and goal direct behaviours therefore 
become increasingly rare (Gustafson & Brun, 1999). 
 
Slow decline, concrete thinking late in course of 
illness (Cummings & McPherson, 2001).   
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5.4 TWO MODELS FOR UNDERSTANDING BEHAVIOURAL AND 
PSYCHIATRIC CHANGES IN FRONTOTEMPORAL DEMENTIA 
The frontal and anterior temporal regions of the brain play a major role in the 
modulation of behaviour (Miller & Diehl et al. 2003).  In Frontotemporal 
Dementia, the deterioration is often asymmetric, affecting differing regions of 
the right or left frontal and temporal lobes (Miller & Ikonte et al. 1997).  The 
location of the deterioration is commonly related to the pattern of behavioural 
disturbances accompanying Frontotemporal Dementia (Snowden & Neary et al. 
1996; Chow & Cummings, 1999).   Any deterioration of the frontal and 
temporal areas of the brain invariably leads to some disruption in the conscious 
control of behaviour.  The degree of disruption of normal pre-morbid behaviour 
is directly related to the level of neurodegeneration in the frontal and temporal 
lobes (Miller & Chang et al. 1993).  
 
Two groups of researchers, Snowden & Neary et al. (1996), and Tanabe & Ikeda 
et al. (1999) have proposed comprehensive and clinically useful frameworks for 
understanding the behavioural syndromes accompanying Frontotemporal 
Dementia:  
 
 
 
 
 
   106 
5.4.1 Snowden Neary, and Mann’s Model of Behavioural Syndromes 
Associated with Frontotemporal Dementia 
Snowden, Neary and Mann (1996) described three major behavioural syndromes 
observed in Frontotemporal Dementia patients. Table 28 (below)  
summarises the three behavioural syndromes and indicates the area of the brain 
commonly affected for each syndrome.  
 
Table 28: Frontotemporal behavioural syndromes 
Behavioural Syndrome  Associated area of brain 
1.  A profile of overactivity, 
inattention, and disinhibition 
orbitofrontal region 
2.  Retardation, apathy and 
withdrawal  
Dorsolateral region 
3.  Stereotypic and ritualized 
behaviours  
Associated with any 
frontotemporal  lobar 
degeneration 
 
 
Overactivity, Inattention and Disinhibition  
Overactivity, inattention and disinhibition are often most marked when patients 
are in the presence of others.  Patients who display overactive, inattentive, and 
disinhibited behaviours usually lack motivation and do not instigate activities if 
left alone.  Restlessness, pacing, and apparently directionless wandering are 
commonly associated with Frontotemporal Dementia (Snowden & Neary et al. 
1996).  
 
The first symptoms of Frontotemporal Dementia often include rudeness and lack 
of conformity to social conventions (Gregory & Hodges, 1996).  Frontotemporal 
Dementia patients break social conventions without apparent awareness that   107 
they are breaking the conventions (Gustafson & Brun, 1999).  Examples of such 
behaviour include ignoring visitors, addressing people rudely,  
making tactless comments, or bumping into strangers without attempting to 
avoid colliding with them (Snowden & Neary et al. 1996).   When dining out, 
patients may eat off others diners’ plates, or drink from the wine bottle without 
apparent awareness that their behaviour is unusual. Shoplifting is not 
uncommon, but is always unplanned, and may be an example of  environmental 
dependency syndrome ((Lhermitte, 1986; Miller & Darby, 1997).  Patients may 
wander naked in front of strangers with no apparent awareness that they are 
breaking social rules.  Overfriendliness and over-familiarity are common (Miller 
& Darby et al. 1995).  
 
Although patients with Frontotemporal Dementia often engage in disinhibited 
and inappropriate behaviours, major incidents of law breaking are rare 
(Mychack & Kramer et al. 2001).    There is no evidence of wilful attempts to 
flout social rules.  The probable cause of the behaviours is a profound lack of 
awareness of social rules and constraints (Snowden & Neary et al. 1996).   
Degeneration of the frontotemporal region is associated with high levels of 
socially undesirable behaviours (Mychack & Kramer et al. 2001).  
 
Retardation, Apathy and Withdrawal   
Loss of motivation, apathy and energy are common early in the course of the 
illness (Pasquier & Delacourte, 1998; Diehl-Schmid, J., C. Pohl et al. 2006).   
These features have often been mistaken for menopause, depression and chronic    108 
fatigue syndrome (Pasquier & Delacourte, 1998). 
 
Personal hygiene is commonly neglected.  Some patients show an aversion to 
water.   Patients generally lose interest in their appearance, and sometimes dress 
in unusual combinations of clothing.  Incontinence increases as the disease 
progresses, and may be a product of the patient’s apathy rather than loss of 
control of their bodily functions (Nicolai & Lazzarino, 1991). Loss of libido 
(hyposexuality) is common in the early stages of the illness (Miller & Darby et 
al. 1995).  However, a minority of patients exhibit a preoccupation with sex 
(Pasquier & Delacourte, 1998).    
 
Stereotypical and Ritualised Behaviours  
Patients become increasingly inflexible, and may adopt a fixed daily routine 
(Bathgate & Snowden et al. 2001; Shigenobu & Ikeda et al. 2002).  Performing 
daily activities “by the clock” is common.  If patients walk, they often follow an 
identical route every day (Mendez & Selwood et al. 1993).   Patients regularly 
repeat the same sentence, phrase, puns, or ditty. This behaviour can mask the 
degree of impairment to others who do not see the patients regularly (Miller & 
Ikonte et al. 1997).  Many patients develop disabling compulsions, such as 
collecting coupons or papers, spending many hours in the bathroom, or 
repetitive pacing (Miller & Ikonte et al. 1995).   109 
5.4.2 MacLean’s Triune Theory 
Tanabe & Ikeda et al. (1999, see below) have provided a complex framework 
for understanding the behavioural changes accompanying Frontotemporal lobe 
degeneration.  Tanabe and colleagues (1999) use Dr Paul MacLean’s (1973, 
1990) triune, or “three brains in one” neurological theory to provide a 
conceptual model for understanding typical behavioural changes accompanying 
the onset of Frontotemporal Dementia.   The significant behavioural and 
personality changes associated with atrophy in the frontal and anterior temporal 
lobes are interpreted by studying the interaction between the basal ganglia, the 
limbic system, and the neocortex.  MacLean’s (1973, 1990) theory divides the  
brain into three interconnected hierarchical parts: the brain stem, the limbic 
system, and the neocortex.   The parts are described in evolutionary terms, 
starting with the reptilian brain (brain stem), old mammalian (limbic system), 
and new mammalian (neocortex).     There are no clear lines of separation 
between the three areas, with some brain-structures involved such as the 
thalamus being seen as part of both the reptilian brain and the old mammalian 
brain.  
 
Reptilian Brain (Brain stem, basal ganglia, thalamus, globus 
pallidus,    putamen) 
The behaviours associated with the reptilian brain are the basic drives and 
instincts, needs and avoidances. These behaviours are primarily ritualistic and 
stereotyped.  Behaviours controlled by the reptilian brain include mating rituals,    110 
territoriality, rote behaviours, greeting rituals, the internal environment of the 
body, and various types of display. Tanabe (2000) noted that the structures of 
the reptilian brain have important connections to the orbitofrontal lobes and the 
anterior and medial temporal lobes.   The basal ganglia are composed of the 
caudate, putamen, globus pallidus, and amygdala.  The amygdala is the nucleus 
of the anterior temporal lobe, and is also part of the limbic system (Pinel & 
Edwards, 1998).  
 
Old Mammalian Brain (limbic system, thalamus, hippocampus, 
amygdala) 
The behaviours associated with the old mammalian brain are instinctive 
behaviours, emotions, and memory.   Emotions are generated via the amygdala.   
The limbic system plays an important role in social bonding patterns, 
appropriate expressiveness, controls attention, and filters incoming and outgoing 
information.  The limbic system is richly interconnected with the frontotemporal 
lobes.   
 
New Mammalian Brain (neocortex, frontal, temporal, parietal, & 
occipital lobes) 
The new mammalian brain, or neocortex, is the most recent evolutionary brain 
structure. The neocortex is the seat of the intellect and all thinking skills.  The 
neocortex gives planning and adaptive functioning ability, and allows functional 
interactions with the external world.  The neocortex allows for the 
understanding of metaphors, and models of understanding the world.  
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5.4.3 Tanabe, Ikeda, and Komori’s Evolutionary and Developmental Model 
The classification system of Tannabe and colleagues (Tannabe et al. 1999) 
builds on McLean’s (1973, 1990) triune brain theory, and has many similarities 
to the model proposed by Snowden and colleagues (1996, see above) to help 
understand behavioural syndromes accompanying Frontotemporal Dementia.  
Behaviour changes are interpreted through an understanding of interactions 
between the basal ganglia, the limbic system, and the neocortex (the anterior and 
posterior association cortex).  
 
Behaviours associated with Frontotemporal Dementia are classified as:  
 
1.  Stimulus bound behaviour   
2.  Going My Way Behaviour 
3.  Stereotypical Behaviour 
 
Stimulus bound behaviour (also referred to as utilization 
behaviour and hypermetamorphosis) 
Common stimulus-bound behaviours are:  imitation behaviours (Shimomura & 
Mori, 1998), environmental dependency syndrome (Lhermitte, 1986), and 
utilization behaviours.  Lhermitte (1986) described environmental dependency 
syndrome as a condition where a person is unable to control impulses to interact 
with the outside world. Utilisation behaviour is the tendency to pick up and 
manipulate any object in the environment.  Stimulus bound behaviour is 
associated with damage to the dorsal frontal area of the brain causing an 
imbalance between the frontal and parietal lobes.  Tanabe and associates (1999)   112 
propose that degeneration or damage to the dorsal frontal area of the brain 
commonly results in the freeing up of parietal lobe activity.   This pattern of 
damage leads to Frontotemporal Dementia patients’ attention being absorbed by 
any environmental stimuli, without the moderating input from the 
frontotemporal regions of the brain.   
 
It is common for Frontotemporal Dementia patients to inappropriately pick up, 
explore, and manipulate, random objects in their immediate environment.  This 
tendency has been labelled “utilization behaviour” (Gustafson & Brun, 1999).   
This pattern of being “controlled” by the immediate sensory environment is 
extremely uncommon in patients diagnosed with Alzheimer’s Disease 
(Snowden & Neary et al. 1996). 
 
Going My Way Behaviour  
”Going My Way” behaviour includes various forms of instinctive acts that are 
not mediated by rational thought, disinhibited and antisocial behaviours, 
impulsivity, and over familiarity (Tanabe, 1999).   This behaviour stands in 
contrast to normal behaviour in Alzheimer’s Disease, where patients are more 
likely to engage in “saving appearance” or covering up behaviour.  Going my 
way behaviour is associated with damage to or degeneration of the orbitofrontal 
area of the brain.   Damage to the orbitofrontal area commonly results in a loss 
of higher cortical control of the limbic system.   
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Stereotypic Behaviour 
Examples of stereotypical behaviour are repetitive rubbing, stereotypical 
laughing, walking the same route every day, and adherence to a strict timetable.  
Stereotypical behaviour is associated with damage or degeneration to the frontal 
lobes leading to increased basal ganglia activity.  The dorsal area of the basal 
ganglia controls simple stereotypies, such as knee rubbing. The ventral area of  
the basal ganglia controls more complex stereotypies, such as daily activities 
and complex rituals (Snowden & Neary et al.  2002).   
 
5.5 LOSS OF “SELF” IN FRONTOTEMPORAL DEMENTIA AND 
ALZHEIMER’S DISEASE 
 
The concept of “self” is inherently difficult to quantify.     Nevertheless, the 
changes in “self” accompanying Frontotemporal Dementia are striking to carers, 
friends, and family members (Miller & Seeley et al. 2001).  In marked contrast, 
relatives and friends commonly report relatively preserved characteristics of 
“self” in Alzheimer’s Disease. Relatives and friends of Frontotemporal 
Dementia patients report what they perceive as fundamental personality 
changes, with these changes often occurring rapidly early in the course of the 
illness (Miller & Seeley et al. 2001).   Miller and colleagues (2001) have 
described the characteristic “loss of self” accompanying Frontotemporal 
Dementia.  They define self as: 
  
“The total, essential, or particular being of a person involving the 
essential qualities distinguishing one person from another”.  (p 818)   114 
 
The research by Miller and colleagues (2001) indicates that the frontal and 
anterior temporal lobes, especially the non-dominant hemisphere are responsible 
for what we perceive as a person’s ‘self”.  Significant damage to the frontal and 
anterior temporal lobes results in the loss of a person’s sense of self and 
previously learned self-concepts.   
 
Lough & Gregory et al. (2001) have also studied changes to self typically 
accompanying Frontotemporal Dementia.   They propose that Frontotemporal 
Dementia patients lose core social reasoning abilities, and in particular the 
ability to internally represent the thoughts and feelings of others.   Lough and 
colleagues (2000) argue that this fundamental incapacity to internally represent 
the thoughts and feelings of others accompanying Frontotemporal Dementia 
patients invariably results in this group  being viewed as fundamentally different 
to their previous self by others.   
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5.6 ASSESSMENT OF BEHAVIOUR 
Clinical assessment of behavioural change is an essential component in the 
diagnosis of Frontotemporal Dementia, and assists in the differential diagnosis 
of Frontotemporal Dementia from Alzheimer’s Disease (Miller & Cummings, 
1991; Kertesz, Davidson, & Fox, 1997; Lebert & Pasquier et al. 1998).  A few 
studies (Miller & Darby et al. 1997: Bozeat & Gregory et al. 2000; Shigenobu & 
Ikeda et al. 2002; Ikeda & Brown et al. 2002) found that analysis of behavioural 
variables without neuropsychological assessment was able to accurately 
differentially diagnose Frontotemporal Dementia from Alzheimer’s disease.   
 
5.6.1 Frontotemporal Dementia Behavioural Assessment Instruments 
Kertesz & Davison et al. (1997) operationalised the behavioural criteria for 
Frontotemporal Dementia utilising the core features of the Lund/Manchester 
Frontotemporal Dementia consensus statement criteria (Brun & Englund et al.  
1994; Kertesz & Nadkami et al. 2000), and their own clinical experience with  
twelve Frontotemporal Dementia patients.   They constructed a 24 item 
inventory, the Frontal Behavioural Inventory (FBI).  The FBI was designed to 
assist with the diagnosis of Frontotemporal Dementia, and to differentiate 
Frontotemporal Dementia from other forms of dementia and neurological 
conditions.  In addition, the inventory was designed to provide information to 
increase understanding of the natural history of Frontotemporal Dementia.  The 
items on the inventory were selected to represent two major behavioural styles, 
negative behaviours, and disinhibited behaviours.  The items were designed to 
measure a patient’s loss of social awareness, disinhibition, mental rigidity,   116 
inflexibility, hyperorality, and perseverative behaviour, and distractibility, loss 
of insight, speech reduction, and impaired self-care.    
 
 
 
5.6.2 Additional Important Behaviours for the Diagnosis of Frontotemporal 
Dementia.  
Miller and colleagues (1997) reported that behavioural assessment alone could 
be used to accurately differentially diagnose Frontotemporal Dementia patients 
from Alzheimer’s Disease patients. They found that five behaviours accurately 
discriminated all thirty Alzheimer’s Disease patients from the thirty 
Frontotemporal Dementia patients in the study.     
The five behaviours found to discriminate between the two groups were: 
1.  Stereotypical and ritualistic behaviours in  Frontotemporal Dementia. 
2.  Loss of personal awareness in Frontotemporal Dementia. 
3.  Hyperorality in Frontotemporal Dementia. 
4.  Progressive reduction in speech output in  Frontotemporal Dementia. 
5.  Impaired spatial orientation in Alzheimer’s Disease.  
 
Stereotypical and ritualistic behaviours or preserved spatial orientation were not 
included in the Frontotemporal Behavioural Inventory (see above).  
Stereotypical and ritualistic behaviours have commonly been associated with 
frontal lobar atrophy, and were found to be among the five most important 
behaviours to discriminate Frontotemporal Dementia from Alzheimer’s Disease 
(Miller & Darby et al. 1997; Shigneobu & Ikeda et al. 2002).     117 
 
5.6.3 Standardised Interview 
Lebert and colleagues (1998) produced a format for a standardised interview, 
the Frontotemporal Behaviour Scale, designed to monitor changes associated 
with frontal lobe dysfunction, and to differentially diagnose Frontotemporal 
Dementia patients from Alzheimer’s Disease and Vascular Dementia patients.   
The Frontotemporal Behavioural Scale added several behaviours not included in 
the Frontotemporal Behaviour Inventory (Kertez, Davidson, & Fox, 1997).   The 
additions were depressive symptomatology, perseveration, and ritualistic 
behaviours.  
  
5.7 METHOD 
5.7.1 Classification of Behaviours in Current Study 
The criteria employed by Kertesz & Davidson et al. (1997) and Lebert et al. 
(1998) were used in the present study to classify the behaviours of the 
Alzheimer’s Disease and Frontotemporal Dementia patients.  Additional 
behaviours were recorded in their own categories (Table 29). The additional 
behaviours not measured by the above inventories were recorded to ensure that 
possible important behavioural changes associated with Frontotemporal 
Dementia were not overlooked.   
 
In the current study, the files of patients were read thoroughly by the author, and 
each behaviour (see Table 29 below) recorded in the files by professionals 
(neurologists, clinical psychologists, speech pathologists, social workers, and 
psychiatrists), were recorded verbatim.  All staff had extensive experience   118 
working with Frontotemporal Dementia and Alzheimer’s Disease patients, and 
were familiar with the behavioural profiles associated with these conditions.   
As part of the normal patient services, comprehensive case notes were recorded 
for each patient.  The author recorded behaviours at two time intervals:  
 
Time 1 Behaviour Recording Protocol 
Consisted of behaviours recorded in patient files by the hospital neurologist, 
clinical psychologists, speech pathologists, or social workers that occurred in a 
six-month interval prior to first assessments, or during the first assessments.  
 
Time 2 Behaviour Recording Protocol 
Consisted of behaviours recorded in patient files by the hospital neurologist, 
clinical psychologists, speech pathologists, or social workers that occurred in a 
six-month interval between two years and nine months and three years and three 
months after the initial assessments.  This time interval was chosen as the 
neurologist routinely reviewed patients at six-month intervals.   
 
Patients were reviewed more frequently if additional clinical services were 
required, or if there were rapid changes or deterioration in the patient’s 
condition. Patients were also routinely reviewed when carers required additional 
assistance with patient care.  
 
All behaviours indicating a change in the patient’s behaviour, including positive 
changes and stable personality traits, were recorded.   This was done to provide   119 
a comprehensive profile of the common and uncommon behaviours associated 
with Frontotemporal Dementia and Alzheimer’s Disease.   
 
The above method of obtaining behavioural change data was employed to 
ensure that families were not burdened with test-material and interviews in 
addition to the routine hospital procedures and the often overwhelming demands 
of caring for a relative or partner with early-onset dementia.   It is important to 
note that  the behaviours recorded in the files do not necessarily represent all 
behaviours observed.  The behaviours may have been misidentified or 
misrepresented by the team member who recorded the behaviours in the file 
notes.     120 
5.7.2 Criteria for extracting behaviours from patients’ files  
The following criteria were adapted by the author from Kertesz & Davidson et al. (1997) and Lebert et al (1998).  
Table 29: Criteria used to extract behaviours from files and for calculating inter-rater reliability 
 
Development of Childish 
humour 
The patient has markedly changed, with the development of childlike humour.  
Clinical Depression.  Patients with depression were given a diagnosis of clinical depression by a 
psychiatrist, and treated with antidepressants and/or Cognitive Behaviour Therapy. 
Confabulation  The patient has started fabricating stories in response to questions.  
Echolalia  The patient immediately  and involuntarily repeats words or phrases spoken by 
others 
Increased emotional 
indifference.    
The patient has increasingly shown emotional flatness, and has lost emotional 
responsiveness, especially for family members. 
Hallucinations  The patient has described hallucinations they have experienced. There is 
documented evidence of hallucinations.   
Hiding food or clothes  The patient has recently begun hiding food or clothing.   
Hyperorality.    The patient’s eating habits have dramatically changed. The patient has started 
eating and drinking more, eating excessively, or putting non-food objects in their 
mouth. 
Hypersexuality  The patient’s levels of sexual activity have become abnormally high.  
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Table 29 continued: Criteria used to extract behaviours from files and for calculating inter-rater reliability  
Impaired Judgment  The patient has lost their ability to plan and organise activities, and is unable to 
complete tasks without prompting and assistance 
Impaired object 
recognition 
Patient has lost ability to recognise some common objects such as cooking utensils, 
and common household items.  
Increased impulsivity.    The patient has become more impulsive, and acts or speaks without apparent regard 
for the consequences. 
Increased inattention and 
distraction  
The patient has increasingly failed to pay attention to their environment, has 
become easily distracted, and loses track of conversations or instructions. In the 
extreme, the patient does not follow conversations or instructions at all. 
Incontinence.    The patient has begun experiencing urinary and/or fecal incontinence.  
Increased anxiety/panic 
attacks.  
The patient has become increasingly anxious about a range of issues, such as their 
food, money, and times of meals. The patient has started experiencing panic 
attacks.  
Increased Concrete 
Communication 
The patient increasingly understands only the concrete meaning of what is being 
said.  The patient’s expressive language has become increasingly concrete.  
Increased incidents of 
aggression.   
The patient has become more aggressive, with documented incidents of verbal 
and/or physical abuse directed towards primary caregivers. 
Increased Inflexibility.    The patient has become increasingly stubborn and rigid in their behaviour to the 
degree that their stubbornness and rigidity has caused significant difficulties for 
primary caregivers.  
Increasingly disinhibited  The patient has begun displaying disinhibited behaviours in more than one 
situation. 
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Table 29 continued: Criteria used to extract behaviours from files and for calculating inter-rater reliability  
Increasingly getting lost  The patient has lost their sense of direction, and has started getting lost in 
previously familiar environments. 
Increasing errors of  speech   The patient has increasingly made grammatical errors of speech and/or begun 
slurring 
Increasingly sparse speech  Sparse grammatically correct speech.  
Increased Jealousy  The patient has increasingly become jealous, and has displayed uncharacteristic 
jealousy. 
Loss of Humour  The patient has lost their characteristic sense of humour. 
Loss of Insight *  The patient has marked deterioration in insight in speech and actions.  
Loss of motivation.     The patient has lost interest in friends and former daily activities.  The patient does 
not instigate actions without prompting.  The patient has a tendency to sleep unless 
stimulated. The patient has become increasingly indifferent to others.  
More Affectionate  The patient has become more affectionate.  
Paranoia  The patient has developed significant paranoid ideation and behaviour.  
Perseverative Speech  The patient has started uncontrollably repeating particular responses such as  words, 
phrases or gestures despite the absence or cessation of stimuli.  
Pleasant Disposition  The patient displays a pleasant disposition towards primary carers.  
Problems Dressing  The patient has developed problems dressing.    123 
 
Table 29 continued: Criteria used to extract behaviours from files and for calculating inter-rater reliability  
Increased restless and 
pacing.   
The patient has become more restless or hyperactive.  The patient paces apparently 
without direction 
Ritualistic behaviours.       Ritualistic behaviours include repeating socially inappropriate routines such as 
collecting a set number of objects and placing them in a specific spot without 
apparent reason.  
Stealing  Patient has begun taking the property of others without permission. 
Unable to recognise own 
reflection  
The patient has lost the ability to recognise their own reflection.  
Utilisation behaviour.    The patient has begun automatically feeling, examining, picking up and 
manipulating objects in the environment.   
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5.7.3 Inter-Rater Reliability Coefficients — Calculating Inter-Rater 
Reliability  
Inter-reliability was calculated on 11 randomly selected behaviours using 
Cohen’s kappa.  This statistic measures the agreement between the evaluations 
of two raters when both are rating the same categorical variables. A value of 1 
indicates perfect agreement. A value of 0 indicates that agreement is no better 
than chance (Coakes & Lyndall, 1999).  The author and a postgraduate 
psychology student rated the behaviours independently using the criteria in 
Table 29.   Behaviours were rated as either “Yes” (the behaviour occurred) or 
“No” (the behaviour did not occur).  The data was entered in SPSS Version 
7.5.1 for each variable and the reliability coefficients were calculated using the 
“Crosstabs” Kappa function.  
 
Table 30: Inter-rater reliability coefficients (valid cases = 62) 
Variable name  Kappa 
Coefficient 
Value 
Apathy time 1  .777 
Apathy time 2  .839 
Clinically depressed time 1  .943 
Clinically depressed time 2  .924 
Concreteness time 1  .850 
Concreteness time 2  .832 
Errors of speech and/or slurring time 1  .621 
Errors of speech and/or slurring time 2  .545 
Indifference Time 1  .750 
Indifference time 2  .719 
Inflexibility time 1  .757 
Inflexibility time 2  .803 
Loss of insight time 1  .751 
Loss of insight time 2  .868 
Loss of sense of humour time 1  .924 
Loss of sense of humour time 2  .897 
More affectionate time 1  1.000 
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Table 30 continued: Inter-rater reliability coefficients (valid cases = 62) 
 
Variable name  Kappa Coefficient 
Value 
More affectionate time 2  1.000 
Poor judgment time 1  .737 
Poor judgment time 2  .834 
Restlessness pacing time 1  .955 
Restlessness pacing time 2  .931 
 
 
Cohen’s kappa values were interpreted using the following table, Table 31 
(Altman, 1991).  
 
Table 31:  Cohen’s kappa interpretation table 
 
Value of K  Strength of agreement 
< 0.20  Poor 
0.21 — 0.40  Fair 
0.41 — 0.60  Moderate 
0.61 — 0.80  Good 
0.81 — 1.00  Very good 
 
All Cohen’s kappa coefficient values (Table 30) fell in either the “good” or 
“very good” range (Table 31), with the exception of “Errors of Speech and 
Slurring – Time 2” which produced a result in the “Moderate” range.  The 
Cohen’s kappa results indicate acceptable levels of inter-rater reliability for the 
variables used in the study.  
 
5.8 BEHAVIOURAL RESULTS 
The results are presented below in tables.  It is important to note that the 
behaviours reported below are the behaviour recorded by team members in file 
notes and, as noted above, do not necessarily represent all behaviours observed.    126 
The results under “Initial Assessment” are for the full groups of Alzheimer’s 
Disease and Frontotemporal Dementia patients.  The results under “Additional 
cases at 3-year follow-up” involve the subset of Alzheimer’s Disease and 
Frontotemporal Dementia patients who were without the specified features at 
the initial assessment: 
 
5.8.1 Loss of Motivation/Apathy & Clinical Depression 
Table 32: Percentage and Chi Square significance of difference between 
Frontotemporal Dementia & Alzheimer’s Disease patients reported in file notes 
with loss of motivation and apathy at initial assessment and additional cases at 3-
year follow-up 
 
BEHAVIOURAL 
SYNDROMES  Cases at Initial 
Assessment 
Additional Cases at  
3-Year Follow-up 
  FTD   AD  
chi 
square  FTD   AD  
chi 
square 
Loss of Motivation/ 
Apathy 
12/37 
(32.4%) 
5/25  
(20%)  1.2 
14/25 
(56%) 
3/20 
(15%)  7.9 * 
* = p < .05 
 
Loss of Motivation/ Apathy (Table 32) 
Both Frontotemporal Dementia and Alzheimer’s Disease subjects exhibited 
high, clinically significant rates of loss of motivation at their initial assessments.  
After an interval of three years there was a marked deterioration in the 
Frontotemporal Dementia patient group with significantly less deterioration in 
the Alzheimer’s Disease group.  At the second assessment a total of 70.2% of 
Frontotemporal Dementia patients were recorded with the behaviours compared 
with only 32% of Alzheimer’s Disease patients.  None of the Frontotemporal    127 
Dementia or Alzheimer’s Disease patients were noted to have any improvement 
in motivation or decrease in apathy over the 3-year time interval. 
 
This result is consistent with previous research findings that have shown 
consistently rapid deterioration of motivational abilities in Frontotemporal  
Dementia patients (Diehl-Schmid & Pohl et al. 2006).  In contrast, Alzheimer’s 
Disease patients have been found to undergo a less insidious, gradual loss of 
motivation (Elfgren & Passant et al. 1993; Pasquier & Delacourte, 1998; 
Snowden & Neary et al.  1996). 
 
5.8.2 Behavioural Changes Associated with Loss of Executive Functions 
Table 33: Percentage and Chi Square significance of difference between 
Frontotemporal Dementia & Alzheimer’s Disease patients reported in file notes 
with behavioural changes associated with loss of executive functions  
BEHAVIOURAL 
SYNDROMES 
Cases at Initial 
Assessment 
Additional Cases at  
3-Year Follow-up 
  FTD   AD  
chi 
square  FTD   AD  
chi 
square 
Increased Concrete 
Communication 
12/37 
(32.4%)  0/25 
10.1 
** 
6/25 
(24 %) 
2/25 
(8 %)  2.4 
Increased 
Inflexibility 
16/37 
(43.2%) 
1/25 
(4%) 
11.6 
** 
1/21 
(4.8 %) 
2/24 
(8.3 %)  5.3  
Loss of Insight 
21/37 
(56.8%)  0/25 
21.5 
*** 
13/16 
(81 %) 
4/25 
(16 %) 
17.1 
*** 
Emotional 
Indifference 
1/37 
(2.7%)  0/25  0.91 
10/36 
(27.7 %) 
3/25 
(12 %)  4.7 * 
* = p < .05;  ** = p < .005; *** = p < .0005   128 
Increased Concrete Communication (Table 33) 
A significantly large number of the Frontotemporal Dementia group had become 
increasingly unable to understand complex speech, and were able to understand 
only the concrete meaning of conversations. Their expressive communication 
had become similarly concrete.  In marked contrast, no Alzheimer’s Disease 
patients were recorded with this impairment at the initial assessment.  After an 
interval of three years 18 of the 37 Frontotemporal Dementia patients (49%)  
were recorded with concrete patterns of thinking.  In contrast, only 8% of 
Alzheimer’s Disease patients were reported with increased concreteness of 
thinking.  
 
These findings are consistent with previous research that has indicated that 
Frontotemporal Dementia patients rapidly begin to take objects at face-value. In 
marked contrast concrete thinking in the Alzheimer’s Disease patients has been 
found to slowly increase late in the course of the illness (Gustafson & Brun, 
1999; Cummings & McPherson, 2001).   
 
Increased Inflexibility (table 33) 
At the initial assessments a large number of the Frontotemporal Dementia group 
had become increasingly stubborn and rigid in their behaviours, and this 
deterioration in behaviour had led to significant problems for the patient’s 
primary caregivers. In contrast, only one Alzheimer’s Disease patient had    129 
developed this pattern of behaviour.  After an interval of three years nearly half 
the Frontotemporal Dementia patients had become increasingly inflexible, 
compared with only twelve percent of Alzheimer’s Disease patients. 
 
This result is consistent with previous research findings that show rapid 
deterioration in Frontotemporal Dementia patients’ ability to think and behave 
flexibly.  In contrast, Alzheimer’s Disease patients have been found to lose 
flexible thinking skills relatively slowly (Gustafson & Brun, 1999; Cummings & 
McPherson, 2001). 
 
Loss of Insight (table 33) 
Over half of the Frontotemporal Dementia patients were reported to have 
significant loss of insight in their speech and actions at their initial assessment. 
No Alzheimer’s Disease patients were recorded with this deficit. After an 
interval of three years, all but 8% of the Frontotemporal Dementia patients were 
reported to have lost insight. In comparison, only 16% of Alzheimer’s Disease 
patients had lost insight at the final assessment, as documented in the case notes.  
 
The results are consistent with previous research which has found rapid early 
loss of insight in Frontotemporal Dementia patients, with typically relatively 
slow loss of insight over many years in Alzheimer’s Disease patients.   
Frontotemporal Dementia patients have been found to rapidly lose awareness of 
their deficits, and generally appear unaware that they are failing at tasks or    130 
breaking social rules.  In contrast, Alzheimer’s Disease patients have been found 
to generally retain awareness of their deficits, and are able to follow social rules 
until late in the course of their illness (Rubin & Morris et al. 1987; Snowden & 
Neary et al. 1996; Gustafson & Brun, 1999; Bozeat & Gregory et al. 2000; 
Mendez & Shapira, 2005; Rankin & Baldwin et al. 2005).    
 
Emotional Indifference (table 33) 
Only one Frontotemporal Dementia patient displayed emotional indifference at 
the initial assessment, with no Alzheimer’s Disease patients recorded with this 
deficit.  After an interval of three years nearly 30% of the Frontotemporal  
Dementia had become emotionally “flat” and had lost emotional responsiveness 
when dealing with family members.  In contrast, a total of 12% of the 
Alzheimer’s Disease group had become emotionally indifferent by the end of 
the second time-interval.  
 
This finding is consistent with previous research that has found emotional 
indifference more common amongst patients with Frontotemporal Dementia 
early in the course of the illness, whereas Alzheimer’s Disease patients 
deteriorate later and more slowly (Elfgren & Passant et al. 1993; Pasquier & 
Lebert et al. 1998; Snowden & Neary et al.  1996).   131 
 
Implications for providing care 
The rapid loss of insight associated with Frontotemporal Dementia, and the 
relatively well-preserved insight associated with Alzheimer’s Disease has major 
implications for caregivers.  Alzheimer’s Disease patients generally appear 
keenly aware of any loss of ability, and of task failure.  Alzheimer’s Disease 
patients generally attempt to maintain social relationships and conceal any 
deficits (Bozeat & Gregory et al. 2000).    
 
In marked contrast, Frontotemporal Dementia patients are often unaware that 
they are failing at tasks, have any deficits, or are breaking social rules (Bozeat & 
Morris et al. 2000; Gustafson & Brun, 1999).   This pattern of markedly 
different levels of insight between the groups indicates that individualized care-
plans can assist with the maintenance of dignity amongst dementia patients by  
providing services and activities that do not needlessly expose their deficits. The 
relatively preserved visuo-spatial skills amongst the Frontotemporal Dementia 
group, combined with their profound loss of insight and social skills, indicates 
they may benefit from structured physical  activities such as outdoor activities 
and simple board games (e.g. Tanabe & Ikeda et al.1999).    132 
5.8.3 Speech and Language Changes 
Table 34: Percentage and Chi Square significance of difference between 
Frontotemporal Dementia & Alzheimer’s Disease patients reported in file notes 
with behavioural changes associated with deterioration of speech and language 
ability at initial assessment and after three years  
 
BEHAVIOURAL 
SYNDROMES 
Cases at Initial 
Assessment 
Additional Cases at  
3-Year Follow-up 
  FTD  AD  
chi 
squa
re  FTD   AD  
chi 
square 
Echolalia 
1/37 
(2.7%)  0/25  0.7 
2/36 
(5.5 %)  0/25  1.5 
Errors of 
speech/slurring 
7/37  
(18.9%) 
1/25 
(4%)  2.9 
4/30 
(13.3 %) 
7/24 
(29.2 %)  2.1 
Increasingly 
sparse speech 
15/37 
(40.5%)  0/25 
13.4 
** 
11/22 
(50 %) 
1/25 
(4 %)  13.1 ** 
Perseverative 
Speech  
10/37 
(27%)  0/25  8.1 * 
12/27 
(44.4 %)  0/25  14.5 ** 
 * = p < .01; ** = p < .001 
 
Echolalia (table 34) 
At the initial assessment one of the Frontotemporal Dementia group 
demonstrated echolalia (the immediate and involuntary repetition of words or 
phrases spoken by others).  Two more Frontotemporal Dementia subjects  
developed this impairment over the following three years. None of the 
Alzheimer’s Disease group developed Echolalia during the course of the study.  
This result is consistent with previous research (Gustafson, 1987; Bathgate & 
Snowden et al. 2001).  
Errors of speech and slurring (table 34) 
At the initial assessment approximately 19% of the Frontotemporal Dementia 
group and 4% of the Alzheimer’s Disease group had increasing grammatical   133 
errors of speech and/or slurring.  After an interval of three years nearly 30% of 
both Alzheimer’s Disease and Frontotemporal Dementia groups exhibited this 
speech deficit. There is no previous research that has examined the comparative 
increase in errors of speech in Frontotemporal Dementia and Alzheimer’s 
Disease over time.  
 
Increasingly sparse speech (table 34) 
At the initial assessment approximately 40% of the Frontotemporal Dementia 
group exhibited increasingly sparse, grammatically correct speech. None of the 
Alzheimer’s Disease group exhibited sparse speech.  After an interval of three 
years speech had become sparse, but had retained its grammatical correctness in 
nearly 70% of the Frontotemporal Dementia group. Only one of the Alzheimer’s 
Disease group had developed this verbal deficit.  This finding is consistent with 
previous research which has found that Frontotemporal Dementia is very 
commonly associated with sparse, correct speech early in the course of the 
illness, with this trend continuing often to the point of mutism as the disease  
progresses. In contrast, speech in Alzheimer’s Disease patients rarely becomes 
sparse until the late stages of the illness (Galton & Patterson, 2000; Bathgate & 
Snowden et al. 2001; Flaherty, 2005).  
Perseverative Speech (table 34) 
At the initial assessment nearly 30% of the Frontotemporal Dementia group 
were reported to have started uncontrollably repeating particular responses such 
as words, phrases or gestures, despite the absence or cessation of external 
stimuli.  After an interval of three years nearly 60% of Frontotemporal Dementia 
patients had developed this speech deficit.  In contrast, no Alzheimer’s Disease   134 
patient developed perseverative speech at either the initial assessment, or after 
an interval of three years.  This pattern of marked increase in perseverative 
speech amongst Frontotemporal Dementia patients, but little or no perseverative 
speech in Alzheimer’s Disease until the late stages of the illness, is consistent 
with previous research (Kertesz & Davidson et al. 1997; Smeding & de Koning, 
2000).    135 
5.8.4 Visuo-spatial Skill Changes 
Table 35: Percentage and Chi Square significance of difference between 
Frontotemporal Dementia & Alzheimer’s Disease patients reported in file notes 
with behavioural changes associated with deteriorating visual recognition and 
visuo-spatial abilities at initial assessment and after an interval of three years    
BEHAVIOURAL 
SYNDROMES 
Cases at Initial 
Assessment 
Additional Cases at  
3-Year Follow-up 
  FTD  AD  
chi 
square  FTD   AD  
chi 
square 
Increasingly getting 
Lost  0  5(20%)  8.1 **  0  2(8%)  4.3 
Impaired object 
recognition  0  0    0  4(16%)  6.3 * 
Unable to recognise 
own reflection  0  0    0  1(4%)  1.5 
* = p < .01; ** = p < .001 
Increasingly getting lost (table 35) 
At the initial assessment, and after an interval of three years, none of the 
Frontotemporal Dementia group was reported to have started getting lost in 
previously familiar environments.  In comparison, 20% of the Alzheimer’s 
Disease group were reported to have started getting lost. After an interval of 
three years a total of nearly 30% of the Alzheimer’s Disease group were getting 
lost.  This finding is consistent with previous research that has found 
Frontotemporal Dementia patients rarely become lost. In marked contrast, 
Alzheimer’s Disease patients experience increasing difficulties finding their way 
(Barber, Snowden, & Craufurd, 1995; Pasquier & Richard et al. 2004).  This 
finding has important implications for  caregivers of Alzheimer’s Disease 
patients, as the inability to negotiate successfully through previously familiar 
environments requires high levels of supervision to ensure patient safety.  136 
          Impaired object recognition (table 35) 
None of the Frontotemporal Dementia patients were found to have impaired 
recognition of common objects at either the initial or 3-year follow-up 
assessment. No Alzheimer’s Disease patients had this deficit at the initial 
assessment, but after an interval of three years 16% of the Alzheimer’s Disease 
group had impaired object recognition.  Previous research has shown that 
Alzheimer’s Disease patients develop object recognition deficits more rapidly  
than Frontotemporal Dementia patients (Brun & Passant, 1996; Kramer & Jurik 
et al. 2003).   The Frontotemporal Dementia patients that were studied for 
longer than three years (see case studies p. 173) developed impaired object 
recognition for some common objects.  The results show a pattern of differential 
deterioration of object recognition skills, with Frontotemporal Dementia patients 
having relatively preserved abilities in this area.   
 
Unable to recognise own reflection (mirror sign)  (table 35) 
At the initial assessment none of either the Frontotemporal Dementia or 
Alzheimer’s Disease group were reported to have lost the ability to recognise 
their own reflection.  After an interval of three years one of the Alzheimer’s 
Disease patients had developed this deficit.  The development of the “mirror 
sign” in Alzheimer’s Disease is rare, and its onset signals a poor prognosis for 
the patient (Breen & Caine et al. 2001).   137 
         Summary 
Table 35 shows that over a three year period there was no deterioration in visual 
recognition and visuo-spatial abilities in the Frontotemporal Dementia group.  In 
marked contrast, significant numbers of Alzheimer’s Disease patients exhibited 
marked impairment in these areas.  This result indicates preserved visuo-spatial 
abilities in the Frontotemporal Dementia group, and marked visuo-spatial 
processing deterioration in the Alzheimer’s Disease group. These findings are 
consistent with previous research (Johansen & Hagberg, 1989; Miller &  
Cummings et al. 1991; Elfgren & Ryding et al. 1996; Lindau & Almkivist et al.  
2000; Rascovsky & Salmon et al. 2002).  The results, showing differential 
deterioration in each group, are consistent with the loci of neurological 
deterioration associated with Frontotemporal Dementia and Alzheimer’s 
Disease (see Chapter 3).    138 
5.8.5 Inattention and Judgment 
Table 36: Percentage and Chi Square significance of difference between 
Frontotemporal Dementia & Alzheimer’s Disease patients reported in file notes 
with behavioural changes associated with inattention at initial assessment and 
after three years 
 
BEHAVIOURAL 
SYNDROMES 
Cases at Initial 
Assessment 
Additional Cases at  
3-Year Follow-up 
  FTD   AD  
chi 
square  FTD   AD  
chi 
square 
Inattention/Distraction 
18/37 
(48.6%)  0/25 
17.1 
*** 
6/19 
(31.6 %) 
4/25 
(16 %)  0.6  
Impaired Judgment 
16/37 
(43.2%)  0/25 
14.6 
*** 
10/21 
(47.6 %) 
1/25 
(4 %) 
11.9 
** 
** = p < .001; *** = p < .0001 
 
Inattention/Distraction (table 36) 
At the initial assessment nearly half the Frontotemporal Dementia group were 
experiencing difficulties paying attention to their environment, losing track of 
conversations, were easily distracted, and not following instructions.  None of 
the Alzheimer’s Disease group were reported to have this cluster of problems.  
After an interval of three years nearly sixty-five percent of the Frontotemporal 
Dementia group had deficits of attention.  In contrast, sixteen percent of the 
Alzheimer’s Disease group had developed impairment in this area.   This  
finding, showing a marked increase of inattention and distraction in the 
Frontotemporal Dementia patients, and relatively slow development of 
attentional difficulties in the Alzheimer’s Disease group, is consistent with 
previous research (Snowden & Neary et al. 1996; Binetti & Locascio, 2000; 
Geschwind & Robidoux, 2001).     139 
 
Impaired Judgment (table 36) 
At the initial assessment almost half of the Frontotemporal Dementia group 
had lost their ability to plan and organise activities, and required assistance and 
prompting to complete tasks. None of the Alzheimer’s Disease group were 
reported with this deficit.  After an interval of three years almost 70% of the 
Frontotemporal Dementia group had impaired judgment.  During this time 
only one of the Alzheimer’s Disease group were reported to have developed 
deficits in their judgment.   This result is consistent with previous research that 
has shown marked deterioration of judgment in Frontotemporal Dementia, and 
relatively preserved judgment in the early years of Alzheimer’s Disease  
(Gustafson, 1993).  Other researchers have found that judgment in certain 
areas reliant on calculation ability may be more impaired in Alzheimer’s 
Disease than in Frontotemporal Dementia (Mendez & Doss et al. 1998).   
 
The combination of attention and judgment deficits at the initial assessment 
and increasing deficits over a period of three years in the Frontotemporal 
Dementia group compared with the Alzheimer’s Disease group has major 
implications for management strategies for each group.   These implications 
will be fully explored below in Chapter 7. 
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5.8.6 Disinhibition  
Table 37: Percentage and Chi Square significance of difference between 
Frontotemporal Dementia & Alzheimer’s Disease patients reported in file notes 
with behavioural changes associated with Disinhibition at initial assessment and 
after three years  
 
BEHAVIOURAL 
SYNDROMES 
Cases at Initial 
Assessment 
Additional Cases at  
3-Year Follow-up 
  FTD   AD  
chi 
square  FTD   AD  
chi 
square 
Aggression 
12/37 
(32.4%) 
3/25 
(12%)  3.4  0/25 
4/22 
(18.1 %)  7.2 * 
Disinhibition 
10/37 
(27%)  0/25  8.1 ** 
9/27 
(33.3 %)  0/25  8.1 ** 
Impulsivity 
12/37 
(32.4%)  0/25  10.1 ** 
13/25 
(52 %) 
3/25 
(12 %)  4.2 * 
Stealing 
3/37 
(8.1%)  0/25  2.1 
3/34 
(8.8 %) 
3/25 
(12%)  0.2 
* = p < .05; ** = p < .01 
 
Aggression (table 37) 
At the initial assessment there were clinically significant numbers of both 
Frontotemporal Dementia and Alzheimer’s Disease patients directing verbal 
and/or physical abuse toward their primary caregivers.  There was no statistical 
difference between the two groups.  Rates of aggression were significantly 
higher amongst Alzheimer’s Disease patients after three years. Previous research 
has shown that aggression is commonly associated with both Frontotemporal 
Dementia and Alzheimer’s Disease, with higher rates of aggression associated 
with Frontotemporal Dementia (Miller & Darby et al. 1997; Hirono & Mega et 
al. 2000).  The current study indicates that aggression is common in both 
Frontotemporal Dementia and Alzheimer’s Disease in the initial stages of the    141 
illness.  This finding has important implications for the clinical management of 
early-onset dementia, as resources may be required at the age of onset to 
effectively manage incidents of aggression.   
 
Disinhibition (table 37) 
At the initial assessment over one quarter of the Frontotemporal Dementia group 
were exhibiting disinhibited behaviours. After an interval of three years 
approximately 50% of the Frontotemporal Dementia group was exhibiting 
disinhibited behaviours.  In marked contrast, none of the Alzheimer’s Disease 
group were reported with disinhibited behaviours at either time interval. This 
finding is consistent with previous research that has shown patients with 
Frontotemporal Dementia often engage in disinhibited and inappropriate  
behaviours, whereas disinhibition is rarely associated with Alzheimer’s Disease 
(Brun & Englund et al. 1994; Kertesz & Davidson et al. 1997; Walsh & Darby, 
1999; Snowden & Bathgate et al. 2001).  
 
Impulsivity (table 37) 
At the initial assessment approximately one third of the Frontotemporal 
Dementia group were demonstrating impulsive behaviours. After an interval of 
three years over two-thirds of the Frontotemporal Dementia group had 
developed impulsive behaviours. In contrast, at the initial assessment no 
Alzheimer’s Disease patient was reported with impulsive behaviours, and after 
an interval of three years only 12% of the Alzheimer’s Disease group had 
developed impulsive behaviours. Rapid increases in impulsive behaviours    142 
amongst the Frontotemporal Dementia patients, and relatively slow increases in 
impulsivity as the disease progresses in Alzheimer’s Disease patients, are 
consistent with the findings of  previous research (Kertesz & Davidson et al. 
1997; Chow, 2000; Kertez & Nadkarni, 2000; Passant & Ostojic, 2004).   
 
Stealing (table 37) 
At the initial assessment approximately 8% of the Frontotemporal Dementia 
group had started stealing. No Alzheimer’s Disease patients were reported to 
have started stealing.  After an interval of three years a total of 16% of the 
Frontotemporal Dementia group were reported to have started stealing. 12% of 
the Alzheimer’s Disease group were reported to have started stealing in the three  
year period after the first assessment. Previous research has shown that stealing 
is commonly associated with Alzheimer’s Disease and Frontotemporal 
Dementia (Harwood & Ownby, 1998; Mendez & Chow et al. 2000).  
 
Although the numbers are relatively small, stealing can pose a challenge to 
carers, and can bring patients suffering from dementia into contact with the 
police.  Management strategies that provide unobtrusive monitoring and 
direction of behaviour may assist with this problem.    143 
5.8.7 Humour 
Table 38: Percentage and Chi Square significance of difference between 
Frontotemporal Dementia & Alzheimer’s Disease patients reported in file notes 
with changes in humour at initial assessment and after three years  
BEHAVIOURAL 
SYNDROMES 
Cases at Initial 
Assessment 
Additional Cases at  
3-Year Follow-up 
  FTD  AD  
chi 
square  FTD   AD  
chi 
square 
Loss of Humour 
8/37 
(21.6%)  0/25  6.2 * 
5/29 
(17.2 %)  0/25  4.8 * 
Development of 
Childish humour 
1/37 
(2.7%)  0/25  0.7 
7/36 
(19.4 %)  0/25  5.3 * 
* = p < .05 
  
        Loss of Humour (table 38) 
Approximately twenty-two percent of Frontotemporal Dementia patients had 
lost their characteristic sense of humour at the time of the initial assessment. 
After an interval of three years a total of approximately thirty-five percent of  
Frontotemporal Dementia patients had lost their sense of humour. In marked 
contrast, no Alzheimer’s Disease patients were reported to have lost their sense 
of humour at either time interval.  
 
Development of Childish Humour (table 38) 
At the initial assessment one of the Frontotemporal Dementia group had 
developed childish humour. After an interval of three years approximately 
twenty-three percent of the Frontotemporal Dementia group had developed 
childish humour. None of the Alzheimer’s Disease group developed childish 
humour at either time interval.    144 
 
    Summary 
The results support previous findings which have consistently shown rapid loss 
of the ability to understand humour in Frontotemporal Dementia subjects and 
relatively preserved humour ability in Alzheimer’s Disease patients (Lezak, 
1995; Moran et al. 2004; Shammi & Stuss 1999).   The current study is also 
consistent with previous research that has found the loss of ability to understand 
humour in Frontotemporal Dementia is often replaced by childish humour 
(Shammi & Stuss 1999).  
 
The results provide support for previous research findings that indicate that 
humour ability relies on the healthy functioning of the frontotemporal lobes, and 
undamaged connections between these areas and subcortical regions of the brain 
(Shammi & Stuss, 1999; Moran et al. 2004).   
          Implications for Management 
The rapid loss of humour in Frontotemporal Dementia patients, and the 
preserved sense of humour in Alzheimer’s Disease patients, has significant 
implications for the differential clinical management of these groups.   For 
Alzheimer’s Disease patients, their relatively preserved humour allows them to 
understand many human interactions, and humour can be used as a therapeutic 
tool (e.g. Buckwalter & Gerdner et al. 1995).   Preserved humour allows 
Alzheimer’s Disease patients to understand the subtleties of conversation, and 
benefit from therapies such as “reminiscence therapy” (e.g. Moss & Polignano    145 
et al. 2002). In contrast, the profound loss of humour accompanying 
Frontotemporal Dementia indicates that this group is unlikely to respond 
positively to verbally-based therapies.   
 
5.8.8 Overactivity 
Table 39: Percentage and Chi Square significance of difference between 
Frontotemporal Dementia & Alzheimer’s Disease patients reported in file notes 
with behavioural changes associated with overactivity at initial assessment and 
after three years 
BEHAVIOURAL 
SYNDROMES 
Cases at Initial 
Assessment 
Additional Cases at  
3-Year Follow-up 
  FTD  AD 
chi 
square  FTD   AD   chi square 
Hyperorality 
7/37 
(18.9%)  0/25  5.3 * 
10/30 
(33.3 %)  0/25  8.1 ** 
Hypersexuality 
1/37 
(2.7%)  0/25  0.7 
1/36 
(2.8)  0/25  0.7 
Restlessness/ 
Pacing 
14/37 
(37.8%)  0/25 
12.2 
*** 
6/23 
(26.1 %) 
4/25 
(16 %)  0.7 
* = p < .05; ** = p < .01; *** = p < .001 
              Hyperorality (table 39) 
Nearly 20% of the Frontotemporal Dementia group’s eating habits had 
dramatically changed at the initial assessment. The patients had started eating 
and drinking more, eating excessively, and putting non-food objects in their 
mouths.  After an interval of three years nearly half of the Frontotemporal 
Dementia group had developed these hyperoral behaviours.   In contrast, none of 
the Alzheimer’s Disease group were reported with this pattern of deficits at 
either the initial assessment, or after an interval of three years.   This finding is    146 
consistent with previous research that has shown that hyperorality often 
accompanies the onset of Frontotemporal Dementia, and hyperoral behaviours 
rapidly increase as the disease progresses.   
 
Previous studies reported 100% of Frontotemporal Dementia cases and 58.1% 
of Alzheimer’s Disease cases showed at least one abnormal eating behaviour in 
various disease stages (Ikeda & Brown et al. 2002).  Hyperoral behaviours are 
associated with human Kluver-Bucy syndrome (Lily, Benson & Frakel, 1983; 
Aggleton & Mishkin, 1990; Clarke & Brown, 1990; Heutink & Stevens et al. 
1997; Spillantini & Murrell et al. 1998). Hyperoral behaviours are discussed 
further in Chapter 7, and illustrated with case studies. 
  
Hypersexuality (table 39) 
One Frontotemporal Dementia patient was reported to have abnormally high 
levels of sexual activity at the initial assessment, accompanied by disinhibited 
and inappropriate sexual acts. This patient continued to be sexually disinhibited  
during the 3-year assessment period.  None of the Alzheimer’s Disease patients 
were reported with unusually high levels of sexual activity at either assessment.  
One Frontotemporal Dementia patient became increasingly sexually active and 
inappropriate over the following 3 years.   
 
Restlessness/Pacing (table 39) 
At the initial time assessment nearly 40% of the Frontotemporal Dementia group  
had  become more restless or hyperactive, and had started  
”pacing” – walking without apparent direction. After an interval of three years   147 
over half of Frontotemporal Dementia group were reported to have developed 
“Restlessness/Pacing behaviours.  In contrast, no Alzheimer’s Disease patients  
were reported with this deficit at the initial assessment.  After an interval of 
three years 16% of Alzheimer’s Disease patients had developed 
“Restlessness/Pacing behaviours.  
 
For purposes of clinical management it is important to note that although there 
were significantly greater numbers of Frontotemporal Dementia patients with 
this cluster of deficits than Alzheimer’s Disease patients, the Frontotemporal 
Dementia patients were not getting lost as a result of this restlessness and 
pacing.   Allowing Frontotemporal Dementia patients access to areas where they 
can safely walk may be a useful means of providing healthy, socially appropriate 
activities, and may also assist in the control of weight gain.  This is discussed 
further in Chapter 7.    148 
 
 
 
5.8.9 Other Behaviours Associated with Frontal Lobe Deficits 
Table 40: Percentage and Chi Square significance of difference between 
Frontotemporal Dementia & Alzheimer’s Disease patients reported in file notes 
with stereotypical and ritualised behaviours at initial assessment and after an 
interval of three years 
BEHAVIOURAL 
SYNDROMES  Cases at Initial 
Assessment 
Additional Cases at  
3-Year Follow-up 
 
FTD  AD  
chi 
square  FTD   AD   chi square 
Hiding Food or 
Clothes  0/37  0/25   
2/37 
(5.4 %)  0/25  1.4 
Ritualistic 
Behaviours 
4/37 
(10.8%)  0/25  2.9  
5/33 
(15.2 %)  0/25  3.7  
Utilisation 
Behaviours 
11/37 
(29.7%)  0/25  9.1 ** 
3/26 
(11.5 %)  0/25  3.1 
** = p < .01 
 
Hiding Food or Clothes (table 40) 
No Frontotemporal Dementia or Alzheimer’s Disease patients hid food or 
clothing at the initial assessment.  During the following three years two of the 
Frontotemporal Dementia patients developed this behaviour.   None of the 
Alzheimer’s Disease patients developed this behaviour at either time interval. 
Hiding food and clothing is a form of hoarding behaviour, and has been 
frequently noted in Frontotemporal Dementia patients (Lynch & Marder et al. 
1994; Neary & Snowden, 1996).  
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Ritualistic Behaviours (table 40) 
At the initial assessment approximately 11% of the Frontotemporal Dementia 
group had developed ritualistic behaviours including socially inappropriate 
routines such as collecting a set numbers of objects and placing them in a 
specific spot without apparent reason. After an interval of three years nearly 
quarter of the Frontotemporal Dementia group had developed ritualistic 
behaviours. None of the Alzheimer’s Disease group were reported to have 
developed these behaviours at either time interval.  This finding is consistent 
with previous research that has reported ritualistic behaviours are common at the 
onset of Frontotemporal Dementia, and that these behaviours increase as the 
disease progresses. The research also indicates that ritualistic behaviours are 
extremely rare in Alzheimer’s Disease (Neary & Snowden, 1996; Nyatsanza & 
Shetty et al. 2003; Pasquier & Delacourte, 1998; Bathgate & Snowden et al. 
2001; Miller & Cummings et al. 1995).  
 
The clinically significant (25%) of ritualistic behaviours that developed in the 
Frontotemporal Dementia group over 3 years, and the absence of these 
behaviours in Alzheimer’s Disease, suggests that management strategies for the 
two groups of patients need to be significantly different, with some researchers 
proposing that behavioural changes associated with Frontotemporal Dementia 
can be utilised to assist with patient care (Tanabe, Ikeda, & Komori, 1999).  
This is discussed further in Chapter 8.  
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Utilisation Behaviours (table 40) 
At the initial assessment nearly 30% of the Frontotemporal Dementia group had 
developed “utilisation behaviours”.  These behaviours involved the patients 
automatically feeling, examining, picking up and manipulating objects in the 
environment.   After an interval of three years nearly 40% of the Frontotemporal  
Dementia group had developed utilisation behaviours. No Alzheimer’s Disease 
patient developed these behaviours at either time interval. This finding is 
consistent with previous research which has found utilisation behaviours are 
common in Frontotemporal Dementia, and rarely occur in Alzheimer’s Disease 
(Ikeda & Tanabe, 2000; Nyastanza & Shetty et al. 2003). 
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5.9 PSYCHIATRIC SYMPTOMS 
5.9.1 Confabulation, Anxiety/Panic Attacks, Hallucinations, & Paranoia 
Table 41: Percentage and Chi Square significance of difference between 
Frontotemporal Dementia & Alzheimer’s Disease patients reported in file notes 
with psychiatric symptoms at initial assessment and after an interval of three 
years 
 
PSYCHIATRIC 
SYMPTOMS 
Cases at Initial 
Assessment 
Additional Cases at  
3-Year Follow-up 
  FTD   AD  
chi 
square  FTD   AD   chi square 
Anxiety/Panic 
Attacks 
5/37 
(13.5%)  1/25(4%)  1.5 
2/32 
(6.3 %) 
1/24 
(4.2 %)  0.1 
Confabulation  0/37 
1/25 
(4%)  1.5  0/37 
1/24 
(4.2 %)  1.6 
Clinical 
Depression 
7/37  
(18.9%) 
4/25 
(16%)  0.09 
3/30     
(10%) 
2/21 
(9.5%)  0.1 
Hallucinations 
4/37 
(10.8%)  1/25(4%)  0.9  0/33 
2/24 
(8.3 %)  2.8 
Paranoia 
7/37 
(18.9%)  0/25  5.3 *  0/30 
5/25 
 (20 %)  11.5 ** 
* = p < .05; ** = p < .01  152 
Anxiety/Panic Attacks (table 41) 
Anxiety and panic attacks occurred in approximately 13% of the Frontotemporal 
Dementia patients, and one Alzheimer’s Disease patient at the initial 
assessment.  A total of approximately 19% of Frontotemporal Dementia patients 
and 8% of Alzheimer’s Disease patients had experienced anxiety/panic attacks 
after an interval of three years.  The results are inconsistent with previous 
research which has indicated little or no anxiety and panic associated with 
Frontotemporal Dementia, with higher rates of anxiety and panic associated with 
Alzheimer’s Disease (Snowden & Neary et al. 1996; Gustafson & Brun, 1999; 
Pasquier, 1999; Cummings & McPherson, 2001; Mendez & Shapira, 2005).    
 
The previous studies did not examine the natural histories of patients with 
Frontotemporal Dementia.  As the incidents of anxiety/panic were generally of 
short duration, and did not continue for the course of the illness, it is possible 
that such incidents were not detected in previous studies. Also, as noted above, 
all research in this area has used relatively small sample sizes. Therefore the 
results of the current study need to be treated with caution.   
 
Confabulation (table 41) 
None of the Frontotemporal Dementia patients exhibited confabulation at either 
the initial assessment, or after an interval of three years. One Alzheimer’s 
Disease patient exhibited confabulation at time one, with a total of two 
Alzheimer’s Disease patients exhibiting this behaviour after three years.   This    153 
finding is consistent with previous research that has found confabulation rarely 
occurs in Frontotemporal Dementia, and is more commonly associated with 
Alzheimer’s Disease (Merriman & Aronson, 1988; Pasquier, 1999). 
 
Clinical Depression (table 41) 
A significant and similar number of both Frontotemporal Dementia and 
Alzheimer’s Disease patients were diagnosed with depression at their initial 
assessments. Rates of increase of depression were low for both groups over 
three years.  Similar rates of depression between Frontotemporal Dementia and 
Alzheimer’s Disease groups have been found by other researchers (Cummings 
& McPherson, 2001; Elfgren & Passant et al. 1993; Gormley, & Rizwan, 1998; 
Miller & Cummings et al. 1995; Snow & Arnold, 1996).   
 
    Hallucinations (table 41) 
 
Approximately 11% of Frontotemporal Dementia patients had experienced 
hallucinations at the time of the initial assessment. All of these patients had 
hallucinations for less than three months duration.   The pattern of hallucinations 
was different in both groups, with more Frontotemporal Dementia patients with 
hallucinations at the initial assessment, and more Alzheimer’s Disease patients 
than Frontotemporal Dementia patients with hallucinations after a three year 
interval.  Although the result was not statistically significant, the result has 
important implications for clinical management due to the behavioural 
disturbances commonly associated with hallucinations.  In the two Alzheimer’s    154 
Disease patients, hallucinations continued as the patients deteriorated.  Previous 
research has found that hallucinations in Frontotemporal Dementia are 
associated with motor neuron disease (FTD/MND, see Chapter 6) (Dickson & 
Horoupian et al. 1986; Lopez & Gonzalez et al. 1996; Nitrini & Rosemberg, 
1998). Three of the four Frontotemporal patients with hallucinations were 
diagnosed with FTD/MND.  The current research supports previous findings 
that indicate that hallucinations are an indicator of rapid deterioration, as all 
Frontotemporal and Alzheimer’s patients with hallucinations deteriorated 
rapidly, and exhibited severe behavioural disturbances.    
 
A case study presented below (7.2.3 p. 193) details the rapid deterioration of a 
man who experienced disturbing hallucinations early in the course of his illness.  
This man developed a severe behavioural disturbance, and died approximately 
seven years after first showing signs of dementia.  
 
Paranoia (table 41) 
Paranoia was common in the Frontotemporal Dementia group at the initial 
assessment, whereas no Alzheimer’s Disease patient exhibited paranoia.  In 
contrast, no additional Frontotemporal Dementia patients developed paranoia 
over three years whereas 20% of Alzheimer’s Disease patients developed 
paranoia by the final assessment. This research is consistent with previous 
findings that have indicated paranoia often occurs early in the course of    155 
Frontotemporal Dementia, and develops more slowly in Alzheimer’s Disease 
(Merriman & Aronson, 1988; Harwood & Ownby, 1998; Snowden & Neary, 
1999).   
 
5.10 OTHER BEHAVIOURS: INCONTINENCE, MORE 
AFFECTIONATE & PLEASANT DISPOSITION 
Table 42: Percentage and Chi Square significance of difference between 
Frontotemporal Dementia & Alzheimer’s Disease patients reported in file notes 
with other behaviours  
 
Cases at Initial 
Assessment 
Additional Cases at  
3-Year Follow-up 
  FTD  AD  
chi 
square  FTD  AD   chi square 
Incontinence 
2/37 
(5.4%)  0/25  1.4 
12/35 
(34.3 %) 
3/25 
(12 %)  3.4 
More 
affectionate 
1/37 
 (2.7%)  0/25   
2/36 
(5.5 %)  0/25  1.4 
Pleasant 
disposition 
3/37 
(8.1%) 
7/25 
(28%)  4.4 *  0/34  0/18   
* = p < .05 
        5.10.1: Incontinence, More Affectionate, & Pleasant Disposition. 
Incontinence (table 42) 
A small number of Frontotemporal Dementia patient were incontinent at the 
initial assessment, with no incontinent Alzheimer’s Disease patients.  At the 
final assessment a total of 37.8% of Frontotemporal Dementia patients were 
incontinent, with 12% of Alzheimer’s Disease patients becoming incontinent 
over a period of three years.    This finding is consistent with previous research    156 
that has shown incontinence commonly occurs within 18 months of diagnosis in 
Frontotemporal Dementia, and develops more slowly in Alzheimer’s Disease 
(Nicolai & Lazzarino, 1992; Neary & Snowden et al. 1998; McKhann & Albert 
et al. 2002).  The rates of incontinence in this study suggest that incontinence 
management is an important component of early-onset dementia care.  
 
More affectionate (table 42) 
No Alzheimer’s Disease patient was reported to have become more affectionate 
at the initial assessment, but one Frontotemporal Dementia patient was reported 
to have become more affectionate. A total of three Frontotemporal Dementia 
patients were reported to have become more affectionate at the final assessment. 
All three Frontotemporal Dementia patients who became more affectionate were 
given the additional diagnosis of Frontotemporal Dementia/Primary Progressive 
Aphasia (FTD/PPA) after the initial assessment. FTD/PPA is a form of 
Frontotemporal Dementia with severe language deterioration, and less severe 
behavioural disturbances (Kertez & Martinz-Lage, 2000).   
Pleasant disposition (table 42) 
The three Frontotemporal Dementia patients reported to have a pleasant 
disposition at the initial assessment were the same patients who were given a 
diagnosis of FTD/PPA by the final assessment. A large number of Alzheimer’s 
Disease patients were reported to have a pleasant disposition at the initial 
assessment, and this disposition appeared to be stable over the 3-year 
assessment period.    157 
CHAPTER 6 
FRONTOTEMPORAL DEMENTIA AND 
CONNECTED CONDITIONS 
 
6.1 CONDITIONS ASSOCIATED WTIH THE ONSET OF 
FRONTOTEMPORAL DEMENTIA 
Frontotemporal Dementia is commonly diagnosed in conjunction with a range 
of neurological conditions such as Human Klüver-Bucy Syndrome; Corticobasal 
Degeneration Syndrome/ Parkinsonism, and Motor Neurone Disease  (Foster & 
Wilhelmsen  et al. 1997; Gustafson, Brun & Passant, 1992; Lebert & Pasquier et 
al. 1998; Mathuranath & Xuereb et al. 1999; Davies & Hodges et al. 2005).  
  
 
6.1.2 Human Kluver-Bucy Syndrome 
 
“Dementia is always hard on the spouse but Frontotemporal 
Dementia is particularly trying because of the symptoms, which may 
be extremely difficult to cope with. The fact that Frontotemporal 
Dementia also affects younger people who may have dependant 
children makes the disease so much more devastating”.  
      Passant & Elfgren et al. 2005, p. 17   158 
Human Klüver-Bucy Syndrome is an extremely rare medical 
condition. The majority of human Klüver-Bucy Syndrome cases 
involve patients who have suffered severe damage to the bilateral 
anterior temporal lobes, and specifically the amygdala (Anson & 
Kulman, 1993; Conlon, 1988; Hayman & Rexer et al. 1998; 
Cummings & Duchen, 1981; Filley & Cullum, 1993; Nahm, 1997).   
Human Klüver-Bucy Syndrome is associated with profound 
behavioural changes. These changes are detailed below in Table 43.  
All recorded cases of Human Klüver-Bucy Syndrome have been 
associated with a combination of aphasia, amnesia, or dementia (Lilly 
& Cummings et al. 1983; Janita, 1985).  
 
There are no universally accepted diagnostic criteria for human Klüver-Bucy 
Syndrome, and published diagnostic criteria vary widely (Hayman & Rexer et 
al. 1998). Human Klüver-Bucy syndrome is, in most cases, associated with 
progressive or chronic neurological disorders.   It is probable that human 
Klüver-Bucy Syndrome is a result of combined frontal and temporal deficits.   
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  Table 43: Behaviours associated with Human Klüver-Bucy syndrome 
 
Behaviour  Description 
Extreme sexual 
behaviour 
 Including public and excessive masturbation, and the inappropriate touching of others.  Inappropriate sexual remarks 
and gestures
 are frequent (Lily & Benson et al. 1983; Boller & Kim et al. 1984; Hayman & Rexer et al. 1998; Jha & 
Patel, 2004). Changes in sexual preferences and paedophilia have also been reported (Mendez & Chow et al.  2000).  
Environmental 
dependency 
syndrome 
Utilization behaviour or stimulus-bound behaviour (Hashimoto & Yoshida et al. 1995). This cluster of behaviours 
bears striking similarities to the “hypermetamorphosis” described in rhesus monkeys by Klüver and Bucy (1939).  
Klüver and Bucy defined hypermetamorphosis as “the irresistible tendency of the monkeys to pick up and manipulate 
objects in their environment”.     This tendency is often an early sign of Frontotemporal Dementia, and has been linked 
to neuronal loss in the frontal and fronto-thalamic regions of the brain (Hashimoto &Yoshida et al. 1995).  
Hyperorality   The exploration of the environment with the mouth, and an urge to put all kinds of inedible objects into the mouth 
(Clarke & Brown, 1990; Lily & Benson et al. 1983). Lesions in both the inferior temporal cortex and the superior
 
temporal polysensory area mimic the deficits observed after
 amygdala ablation, implying that these two regions supply 
the
 amygdala with information that identifies objects as being edible
 or inedible (Aggleton & Mishkin, 1990).  
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Table 43 continued: Behaviours Associated With Human Klüver-Bucy syndrome 
 
Behaviour  Description 
Appetite  An almost uncontrollable appetite for food and drink.  This often manifests itself with the eating of food off other 
people’s plates, and stealing food (Mendez & Foti, 1997). 
Memory loss   (Hayman & Rexer et al. 1998; Lily & Benson et al. 1983).   
Blunted affect  Emotional unresponsiveness, indifference, apathy, and even pet-like compliance. This cluster of behaviours may be 
due to damage to the amygdala. Such damage invariably results in loss of ability to make emotionally meaningful 
discriminations between stimuli (Boller & Kim et al. 1984).  
Visual agnosia  Visual agnosia associated with human Klüver Bucy Syndrome is characterized by the inability to distinguish friends, 
relatives and strangers (Hayman & Rexer et al. 1998; Goscinki & Kwiatowski et al. 1997).  Disorders of facial
 
recognition in humans have been seen following bilateral amygdalotomy (Jacobson, 1986). It has been shown 
repeatedly in animal studies that bilateral
 lesions in the amygdala by themselves will produce the visual
 agnosia 
component of Klüver —Bucy Syndrome (Zola-Morgan &  Squire et al. 1989).   161 
Table 43 continued: Behaviours Associated With Human Klüver-Bucy syndrome 
 
Hyperactivity 
and 
distractibility 
Lesions in the Frontotemporal system can disrupt access
 to learned emotional associations and responses, including 
inhibitory
 social restraints (Shoenbaum & Chiba et al. 2000).   Shoenbaum and associates (2000, 2001) have described 
the critical importance of the interconnections between orbitofrontal cortex and baso-lateral amygdala for encoding and 
using information about the motivational significance of stimuli.  Damage to this system results in lack of access to 
learned responses. The result of damage to orbitofrontal cortex/basolateral amygdala system is commonly hyperactive 
non-specific undirected exploration of the environment. 
  
Loss of fear  LeDoux
 (1992) has demonstrated the role of the amygdala in fear conditioning and in learning
 about the emotional 
significance of social interactions.   Damage to the amygdala results in loss of fear and inability to learn through fear    
conditioning.    162 
 
6.1.3 Corticobasal Degeneration Syndrome/ Parkinsonism   
Corticobasal Degeneration (CBD) and Frontotemporal Dementia (FTD) have 
historically been viewed as two distinct neurodegenerative processes (Kertez, 
2000).  Recent research has seriously challenged this view, and established clear 
connections between the two conditions (Kertez & Martinez-Lange et al. 2000; 
Mathuranath & Xuereb et al. 2000). 
 
Corticobasal Degeneration refers to a neurodegenerative process affecting the 
fronto-parietal regions of the cortex and the basal ganglia (Mathuranath & 
Xuereb et al. 2000).  Corticobasal Degeneration (CBD) has similarities to Pick’s 
disease due to the focal cortical atrophy and the ballooned neurons 
characteristically associated with Pick’s Disease. Corticobasal Degeneration 
Syndrome (CBDS) is characterized by extrapyramidal signs, including slowness, 
clumsiness and stiffness, starting on one side of the body, predominantly in the 
arms or legs.  Other features of the illness include dysphasia (difficulty with 
speech generation), dysarthria (difficulty with articulation), difficulty controlling 
the muscles of the face and mouth, swallowing difficulties, and loss of balance. 
Patients have often been first diagnosed in movement disorder clinics.  
Corticobasal Degeneration Syndrome is associated with Motor Neurone 
Disease/Frontotemporal Dementia and Frontotemporal Dementia (Kertez & 
Martinez-Lange et al. 2000).   The rigidity, poor motor control, loss of balance, 
and slow movements associated with Corticobasal Degeneration Syndrome are a 
form of Parkinsonism (Chow & Miller et al. 1999).     163 
Studies of the natural history of Frontotemporal Dementia indicate that in some 
cases Corticobasal Degeneration Syndrome develops as the disease progresses 
(Mathuranath & Xuereb et al. 2000; Wenning & Litvan et al. 1998).    
 
6.1.4 Tau Mutations: A Link Between Frontotemporal Dementia and 
Corticobasal Degeneration Syndrome 
TAU is an important protein that assists with neuronal communication, and 
supports neuronal survival (Hong & Zhakareva et al. 1998).  Tau protein 
mutations have been found in Frontotemporal Dementia and Corticobasal 
degeneration (Poorkaj & Grossman et al. 2001).   Identical Tau protein 
mutations in one family have been found in family members with both 
Frontotemporal Dementia and Corticobasal degeneration (Bugiani & Murrell et 
al. 1999).   Bugiani and colleagues (1999) suggest that the finding of identical 
Tau protein mutations in both Corticobasal degeneration and Frontotemporal 
Dementia indicates that Tau mutations can, in some families, result in either 
Frontotemporal Dementia or Corticobasal degeneration, and that there is an 
underlying connection between the two conditions.  
 
6.1.5 Frontotemporal Dementia and Motor Neurone Disease (FTD & MND) 
Frontotemporal Dementia (FTD) and Motor Neurone Disease (MND) often co-
exist, and the inter-related disease processes represent a pathological continuum 
(Mitsuyama, 1984; Bak & Hodges, 1999; Brun & Passant, 1996; Neary & 
Snowden et al. 1990; Neary & Snowden, 1996; Nitrini & Rosemberg, 1998;    164 
Talbot & Goulding et al. 1995).   When Frontotemporal Dementia occurs in 
conjunction with motor disturbance, the term FTD/MND is now commonly 
accepted (Barson & Kinsella et al. 2000).   Amyotrophic Lateral Sclerosis and 
Motor Neurone Disease (ALS/MND) is a widely used term describing motor 
neuron degeneration.  For the purposes of this research the term “MND” is used 
to describe “ALS/MND” and all motor neurone diseases.  
 
Patients often present with Frontotemporal Dementia symptomatology, 
including significant behavioural and cognitive changes, before they develop 
Motor Neurone Disease (Bak & Hodges, 1999).   Barson and colleagues (Barson 
& Kinsella et al. 2000) studied 69 patients diagnosed with Motor Neurone 
Disease. They found that when dementia was also diagnosed in the patients, the 
dementia could be accurately classified as Frontotemporal Dementia.  
 
In conjunction with the characteristic changes in the frontal and temporal lobes 
associated with Frontotemporal Dementia, Frontotemporal Dementia/Motor 
Neurone Disease patients also exhibit a cluster of additional neurological 
changes.  These changes commonly include bulbar atrophy, status spongiosus 
(widespread neuronal death and collapse of the cerebral cortical 
cytoarchitecture), gliosis (i.e., the production of a dense fibrous network 
consisting of a proliferation of astrocytes resulting from neurodegeneration), 
hypoglossal cell loss and atrophy of the anterior temporal horns of the spinal 
cord (Brun & Englund et al. 1994; Neary & Snowden et al. 1990; Neary,    165 
Snowden, & Mann, 2000).  The link between Motor Neurone Disease and 
Frontotemporal Dementia has been further established through SPECT studies 
(Talbot & Snowden et al. 1995).  Talbot and colleagues (1995) found that the 
SPECT findings of FTD/MND patients and Frontotemporal Dementia patients 
showed a similar pattern of cerebral involvement.  
 
The prognosis for patients diagnosed with FTD/MND is very poor, with rapid 
deterioration and death generally occurring within five years of diagnosis.  
FTD/MND is commonly accompanied by severe behavioural and psychiatric 
symptoms (Barson et al. 2000; Nitrini & Rosemberg, 1998). Hallucinations and 
other psychotic symptoms are not common in Frontotemporal Dementia (Lopez 
& Gonzalez et al. 1996).   However, in FTD/MND psychotic symptoms and 
hallucinations are common, and often occur early in the course of the illness 
(Dickson & Horoupian et al. 1986; Nitrini & Rosemberg, 1998).  Nitrini & 
Rosemberg (1998) have hypothesised that when psychotic symptoms occur in 
conjunction with FTD/MND the temporal lobes are affected early in the course 
of the illness.    
 
6.1.6 Increased Artistic Ability and Frontotemporal Dementia 
Miller and colleagues (Miller & Ponton et al. 1996; Miller & Cummings et al. 
1998) described a series of Frontotemporal Dementia patients who exhibited 
heightened artistic ability at the onset of their Frontotemporal Dementia.   Miller 
and Cummings et al. (1998) presented case studies of 5 Frontotemporal    166 
Dementia patients.  The patients were selected from a group of 69 patients 
diagnosed with Frontotemporal Dementia because of their heightened interest in 
art.   The patients all became interested in art in the early stages of their illness.    
The patients began painting obsessively and attending art classes after 
previously showing no artistic inclination.   SPECT studies revealed that the 
patients had significant anterior temporal lobe atrophy and relatively spared 
dorsolateral frontal cortex.    The patients all demonstrated profound personality 
change, with impaired speech and social skills.   Miller and colleagues (1998)  
hypothesised that the anterior temporal lobe atrophy may have facilitated the 
patient’s artistic skills.   No published follow-up studies have as yet replicated 
the above findings linking increased artistic creativity to Frontotemporal 
Dementia.   
   
    Observations from the Current Study 
In the current research there was no reported increase in artistic creativity in any 
of the Frontotemporal Dementia or Alzheimer’s Disease patients.  Two of the 
Frontotemporal Dementia patients worked in creative fields (graphic design and 
architecture).   Both experienced marked deterioration in their ability to draw 
before diagnosis, and one began producing child-like drawings.   
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6.2 CASE STUDIES – GLORIA, MICHAEL, STEVEN, JULIE 
 Four case studies are presented below.  The first case study is an Alzheimer’s 
Disease patient (See “Gloria”, section 6.2.1 below). This patient exhibited the 
most extreme behaviours by far of any of the Alzheimer’s Disease group, and 
was in no way typical of the Alzheimer’s group.  This patients profile was 
presented to illustrate the complex care requirements of some early-onset 
Alzheimer’s Disease patients.  The next case studies, a patient with 
Frontotemporal Dementia  (See Michael, section 6.2.2 below) and a patient with 
Frontotemporal Dementia with Motor Neurone Disease (FTD/MND, see 
“Steven”, section 6.2.3 below) are presented to illustrate the behaviours 
associated with these conditions. Both these patients displayed extremely 
difficult behaviours.   Frontotemporal Dementia patients displayed behaviours  
of varying intensity. A profile of a Frontotemporal Disease patient with 
parkinsonism with some of the least severe behavioural problems (see “Julie” 
6.2.4 below) is also presented to illustrate the range of behaviours associated 
with this condition.  
 
6.2.1 Alzheimer’s Disease Case Study 1: “Gloria” – Mirror Sign 
 Age:  58  
Gloria was initially referred to a neurologist by her doctor who had become 
increasingly concerned about her rapid decline in functioning in all areas of her 
life.  She was seen by the team neurologist with her husband.  Her husband 
stated that he had become increasingly concerned that she had been developing a 
medical or psychiatric disorder for approximately ten years.  Gloria was unable 
to give a coherent life history.     168 
 
Her husband stated that her memory and general functioning had deteriorated 
steadily over the past 10 years, and she now needed help with many activities of 
daily living. For example, she required assistance to cook simple meals, to 
organise her clothing, and to dress.  He stated that she increasingly fabricated 
stories, and provided numerous examples.  Approximately four years previously 
he stated that she had become progressively more “unreasonable and 
disorientated”.  She had acted erratically, and made some disastrous business 
decisions.   She unexpectedly and uncharacteristically left her children with her 
husband and went travelling for twelve months.  When Gloria returned from her 
travels, her husband reported that she had deteriorated further.   
He stated that, due to her steady deterioration in functioning, he had taken over 
all domestic duties gradually over the past 10 years.  For the previous four years 
he had completed all domestic duties.  He reported that Gloria was still able to 
perform some tasks if he supervised her closely, such as washing clothes.  He 
stated that over the past 12 months she had completely lost her sense of 
direction, and frequently got lost, even in familiar environments such as her 
local shopping centre. She often became distressed if she had to leave her home.  
She reported frequent headaches.   
 
Gloria still attempted to iron, but had difficulties working out how to place the 
clothing on the ironing board.  Her husband stated that he had to help her dress 
as she had problems doing up zips and belts, and was unable to tell if she had 
put her clothes on incorrectly.  Gloria was clearly distressed during the 
interview, and was frequently tearful.  She was sensitive to her failures when   169 
asked to perform tasks.  For example, Gloria was unable to successfully write a 
simple sentence, and cried, stating “My writing is terrible now, it used to be 
good”, and “I used to be clever once, I can’t believe I have ended up like this”.  
She appeared anxious and agitated throughout the assessment.  
 
Age: 58 years 6 months.   
Gloria was seen by her neurologist accompanied by her husband.  They were 
told that she had “probable Alzheimer’s Disease”:  
 
EEG: Abnormal, showing a slowing of the background rhythms and is 
compatible with an encephalopathy of any cause. 
 
MRI:  Parietal and occipital lobes show extensive enlargement of the cortical 
sulci.  Frontal lobes relatively spared, but these show some degree of atrophy.   
 
SPECT: Appearance supports the diagnosis of Alzheimer’s Disease.   
 
Gloria’s husband reported that there had been acceleration in her rate of 
deterioration over the past six months. She had become increasingly confused 
and unable to cope.   She had forgotten how to do all household tasks, and 
required assistance with all activities of daily living, including toileting.  Her 
speech was normal, but her memory was impaired. She was unable to recall 
what she had done a few hours previously, and did not know where she was.  
She was distressed, agitated, and tearful throughout the assessment.   
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Age: 58 years 8 months 
Gloria was assessed by a speech pathologist at home.  The speech pathologist 
reported adequate reading skills for single words, but difficulties with 
comprehension of more complex written and spoken material.  
Age: 59 Years 2 Months 
Gloria was seen for neurological review.  Her husband reported that she no 
longer recognised herself in the mirror (mirror sign, concrete thinking, see above 
p.130), and talked to her reflection, believing it was someone else.   She had lost 
the ability to put on even a dressing gown without assistance, and frequently  
attempted to put clothes on the wrong way.  For example, she would try to put a 
t-shirt on upside down.  Her inability to perform such simple actions caused her 
great distress. Her memory continued to deteriorate, and she was constantly 
confused, distressed, and anxious.  
 
Age: 59 Years 5 Months.   
Gloria’s husband reported that she had continued to believe her reflection was 
someone else, and argued with him if he tried to explain that the reflection was 
her image. She had recently started having arguments with her reflection, and 
had hit out and spat at the mirror.   She had lost the ability to recognise her 
friends and family, and occasionally didn’t recognise her husband.   Gloria had 
become increasingly disoriented, and often became lost in her own house.  She 
was often frustrated, and had become verbally and physically aggressive.  
Friends and family members rarely visited due to her deteriorated condition.  
Her husband described his wife as “extremely difficult to care for”.   At times   171 
she would throw household objects at him without apparent reason. At other 
times she would “switch back to her old pleasant self” for short periods of time.  
Age: 59 Years 8 months.   
Gloria’s husband telephoned Gloria’s social worker to inform her that he was no 
longer able to cope with his wife’s behaviour, and she had been placed in a 
nursing home.   
Age: 60 Years. 
Gloria died in her sleep in the nursing home.    172 
Gloria’s Timelines:   Each bar indicates the length of time (years) each event 
occurred.   
Timeline 1: Behaviours 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  48    57    58    59    60     
  AGE → 
 
 
Timeline 2: Speech 
 
 
 
 
 
 
 
 
 
 
  48    57    58    59    60   
  AGE → 
 
Timeline 3: Diagnoses.  
 
 
 
 
 
 
 
  48    57    58    59    60   
  AGE →
Progressive memory deterioration.  
Rapid deterioration of self-care, cooking. 
Impaired decision making.   
Incontinent. 
Constantly confused 
Normal speech 
Confabulation 
Simple speech, difficulty 
with complex material.  
Depression 
Alzheimer’s Disease 
Verbally and 
physically 
aggressive   173 
Timeline 4: Syndromes 
 
 
 
 
 
 
 
  48    57    58    59    60   
  AGE → 
 
 
 
Timeline 5: Imaging results 
 
 
 
 
 
 
 
 
 
 
 
  48    57    58    59    60 
  AGE → 
 
 
Timeline 6: Affective conditions 
 
 
 
 
 
 
  48    57    58    59    60   
  AGE → 
 
Mirror Sign – 
believes her 
reflection is 
someone else 
EEG abnormal. MRI  
Parietal and occipital 
damage.  Frontal 
lobes spared. SPECT 
indicates AD.   
Increasing anxiety and depression. → 
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Timeline 7: Memory & preserved skills.  
 
 
 
 
 
 
 
 
 
 
 
 
  48    57    58    59    60   
  AGE → 
 
 
 
 
Timeline 8: Hospital & Residential Services 
 
 
 
 
 
 
 
  48    57    58    59    60   
  AGE → 
 
Preserved single-
word reading skills. 
Forgotten how to do common 
household tasks. Impaired new 
learning. 
Placed in 
nursing home 
due to high 
care needs 
Getting lost in own 
house   175 
6.2.2 Frontotemporal Dementia Case Study 2: “Michael” 
Age: 47 
Michael first presented to his doctor with a list of problems at age 47.   The 
doctor’s report indicated he was well groomed.  Michael reported increasing 
difficulties following conversations, and often forgot what he wanted to say.   
He was a self-employed small businessman, and reported problems running his 
business.  The doctor stated that he appeared to have “lost all conversational 
skills”, and noted that Michael exhibited “mild levels of anxiety and 
depression”.    His depression and anxiety were treated for twelve months with 
an SSRI antidepressant, with no improvement noted in his depression.   He had 
recently divorced, but denied being concerned about this.   
 
He was subsequently referred by his doctor to a psychiatrist.     The psychiatrist 
reported that Michael was unable to give an accurate history.  He scored 28/30 
on the Mini Mental State Exam.   The psychiatric exam indicated mild 
depression with no psychotic features.   Michael stated that he was doing his job 
well, but stated that his family were “concerned about me”.  He believed his 
work output was a little slower, but he did not think he was making errors of 
judgement.   The psychiatrist noted paucity of thought and language, with 
accompanying memory and concentration difficulties.    The psychiatrist queried 
early onset dementia, and referred him for neurological and neuropsychological 
investigations.  A CT scan performed at this time was reported to be within 
normal limits.     176 
Age: 51 years 2 months 
He was seen for neuropsychological assessment at age 51.  He was accompanied 
by his sister, who provided answers when Michael was unable to do so. At the 
neuropsychological assessment he reported that he was “only able to do one 
thing at a time”, and had difficulty concentrating, following television plots, and 
stated “I forget everything”.   Michael’s sister reported that she had noticed 
subtle changes perhaps two years previously, with a gradual loss of motivation, 
and rapid deterioration in his expressive language.   Michael’s tennis partners 
had contacted his sister to express their concern about his increasingly 
disinhibited behaviour.   
 
Michael denied any worsening of his symptoms, but did not elaborate.  He had 
recently “retired” from work due to inability to cope.  He denied being 
concerned about this.  His sister also noted that he now experienced difficulty 
recognizing friends, and no longer read after being a big reader.   She noted that 
Michael had become increasingly self-absorbed, appeared unable to make 
decisions, and would try to argue a point, but would immediately forget why he 
was arguing.   She stated that he had become increasingly indifferent to his 
obvious difficulties.    
 
His verbal fluency was noted to be “severely defective” throughout the 
assessment.  However, he appeared to enjoy the assessment tasks, and followed 
task instructions eagerly.  He persevered on tasks even if he was experiencing 
difficulty completing a task.    177 
Age: 51 years 8 months.  
He was seen for neuropsychological review six months later.  He was again 
accompanied by his sister.  At that time his condition had deteriorated markedly.   
He was very slow completing tasks, and rapidly forgot information.  He required 
constant prompting to complete most tasks. His spontaneous verbal recall was 
impaired.  However, with prompting, he was able to recall some significant 
points from the stories read to him.    He exhibited severe word retrieval 
difficulties throughout the assessment.      Unlike the previous assessment, he 
was passive and disinterested, and showed no spontaneous actions.   His 
visuospatial skills, although falling well below normal limits on standardised 
tasks, remained relatively intact in comparison to his verbal skills.    
 
Age: 51 years 10 months 
He was seen for neurological assessment two months later, accompanied by his 
sister.  She stated that her brother was rapidly deteriorating, and had become 
increasingly childlike. He had lost all motivation, and was now totally reliant on 
friends and family members.    He “shadowed” his sister and her husband 
around, and appeared happy to do this.    
 
He stated cheerfully “my brain is awful”. His sister had met with other family 
members due to her concern about her brother, and had compiled a list of 
changes family and friends had noted in her brother’s behaviour over the past 
two years:    178 
 
•  Frequently crying for no apparent reason.  
•  Loss of interest in all activities after being previously highly motivated, and 
actively involved in social and sporting groups.  
•  Was now “a different person”.   
•  He was formerly polite and had a sharp sense of humour.  He was now usually 
rude and humourless.  Complete loss of interest in friends.  
•  If friends visit, he usually leaves the room without explanation, without 
apparent awareness that this behaviour is unusual.  
•  If questioned about his behaviour he usually stated, “I don’t like people”.   
•  He was now “self-centred”, after being “a kind and sensitive man”. 
•   Michael had started eating compulsively, eating any food in front of him, and 
eating off others’ plates. This was a drastic change in his eating behaviour, as 
he had previously shown “impeccable manners”.     
•   Inability to keep still, with increasing pacing and wandering.  He had never 
become lost.  
•   Slow to respond to any stimulus.   
•   Rapid deterioration over the previous year.  
 
The neurological examination revealed slowness of mental activity, speech and 
motor function.   179 
Age: 52 years 1 month.   
A family meeting was held with a clinical psychologist and social worker.  The 
family had requested the meeting due to a rapid deterioration in Michael’s 
condition.  They reported difficulties managing his behaviours.  Michael had 
developed a range of obsessive and ritualistic behaviours. He constantly swept 
certain parts of the house, and sorted out rubbish, stating that he knew the right 
way to do it.  He collected specific objects from the house and placed them in a 
designated spot in the garden.  He appeared happy doing this, and if he gave any 
explanation at all said, “This is my job”.   
 
When not engaged in the above activities, he constantly shadowed people he 
was familiar with.  He avoided or was rude to old friends.   He made sexually 
inappropriate remarks and advances.  His sexually disinhibited behaviour had 
resulted in family members being concerned about him being around his 
grandchildren.   His speech output was dramatically reduced.   Michael 
constantly interrupted family members, but appeared confused when he 
attempted to communicate.   
 
Age: 52 years 4 months.  
Michael was assessed at home by the author.  His brother was present at the 
meeting.  His brother reported that Michael had continued to deteriorate.  He 
tired easily.  If friends came over, he made an effort to play card games with 
them.  He no longer understood the rules of the card games, but enjoyed playing    180 
according to what appeared to be his own idiosyncratic rules.  His appetite had 
continued to increase. If Michael was not constantly monitored he would 
constantly drink very strong coffee, any alcohol he could find, or soft drinks.   
 
Michael increasingly disliked leaving home, and didn’t like to be alone.  This 
placed an enormous strain on his family, as he constantly “shadowed” the 
person looking after him.  If asked if he wanted to do anything, such as going for 
a walk, or to town, he always stated that he was “sorting things out”.   By this he 
meant he was moving certain objects from the house that appeared to have 
significance to him and placing them in the garden in designated spots, or he 
swept patches of the floor.   He also obsessively polished certain cupboards and 
appeared to get great satisfaction from washing the dishes.  His brother stated 
that he did a good job of washing the dishes. Michael stated that he didn’t like 
going out because people “talk too much”.  
 
Throughout his illness Michael had continued to show an interest in his dress, 
and always ensured that he was shaved and well dressed.   Apart from his 
interest in his appearance, he had lost all concern about his public presentation.  
He urinated in public places, and showed no concern or shame.  He had become 
stubborn, and demanded immediate attention. If he wasn’t given attention, he 
became loud and verbally aggressive.  
 
He enjoyed helping in the kitchen, and made simple meals for himself and 
others, such as cereals and coffee, or toast.  Michael constantly paced, and liked    181 
to constantly move objects from one place to another, without apparent reason.  
His comprehension was extremely limited, and he did not appear aware of 
others.   
 
Age: 52 years 6 months 
Michael was seen by his neurologist with his sister and brother.   Michael was 
given a diagnosis of Frontotemporal Dementia, in line with the test results:  
 
CT: clear symmetrical cortical atrophy of the frontal lobes. 
 
SPECT: Predominant bilateral frontal lobe perfusion abnormality, and most  
marked posteriorly in keeping with frontal lobe degeneration. 
  
EEG: showed non-specific slowing of the cerebral rhythms in the frontal and 
temporal regions bilaterally  
 
Michael appeared to be very well physically. He spoke briefly when addressed, 
but initiated no conversation.  With extensive prompting, he stated that he had 
lost interest in any activities other than drawing, and this does not bother him.  
His brother and sister reported further deterioration. He was constantly 
shadowing those he knew well, and became extremely anxious when he was not 
in their company. Michael showed total loss of interest in all activities except 
his ritualistic behaviours. He continued to performed tasks such as helping in the 
kitchen if requested.  He showed no distress or unhappiness, and appeared    182 
unaware and/or unconcerned about his lack of interest.  
 
His sister and brother reported that Michael was becoming increasingly irritable 
and verbally aggressive.   He had lost the ability to correctly verbally identify 
common objects.  He was unable to label a ruler, a chair, and a door.  His sister 
stated that he had recently forgotten how to dress properly, and would place his 
singlet over his shirt.  He had begun regular respite care, which he apparently 
enjoyed.  She described him as “worse than a three year old”, and stated that his 
friends had commented that he had become childlike.  
 
Age: 53 Years 1 month.  
Michael was visited at home by a clinical psychologist and social worker.  His 
sister and son were present.   He wandered around during the visit, and ate 
constantly.   His son reported that his father enjoyed going out now, and 
particularly liked going for drives and walks.  Michael’s sister stated that he 
used to enjoy drawing, but had stopped drawing after his drawings had become 
increasingly childlike.   He was often irritable, and verbally aggressive.  His 
appetite had increased “enormously”, and the family had to hide food and drinks 
from him.  He continued to “shadow” family members, and appeared scared 
when left alone, even for short periods of time.  He answered questions 
appropriately with either “yes” or “no”, but did not use sentences.  He continued 
to move objects from the house and place them in seemingly designated 
positions in the garden. He also repeatedly polished the same object,    183 
sometimes 10 times in a row.  He appeared to enjoy these activities, and became 
verbally aggressive if interrupted.  
 
Age: 53 Years 4 months 
Michael was visited at home by a clinical psychologist and social worker.  He 
was seen with his son and sister.  They reported that he was “driving them 
crazy”, shadowing them around, and requiring constant prompting to complete 
even the simplest of tasks.   His speech had deteriorated further, and his 
sentences were apparently meaningless.  For example “is my car in billiards 
room”.   He also often asked apparently meaningless questions.  The family 
were also experiencing difficulties with what they described as “interruptive 
behaviours” that he used to gain attention, such as becoming enraged and 
verbally aggressive.   
 
There had been some incidents of physical aggression, and his sister stated that 
she had been scared on several occasions.  He had started hurling objects at 
family members and carers when angry. He still enjoyed going for drives with 
family members, but refused to get out of the car.   
He still enjoyed playing games with playing cards, although the “games” had no 
discernable logic to anyone else.  At the time of the visit Michael was well 
groomed, and “a picture of health”.   His sister stated that he still enjoyed being 
well dressed, but required some assistance to organise his clothing.    184 
 
Age: 53 years 6 months 
Michael was placed in nursing home due to severe behavioural problems.  The 
nursing home reported difficulties managing his behaviours.  He refused to 
allow staff to wash him, and washed ritualistically with a small amount of water  
and soap.   He wandered constantly, and had lost the ability to recognise all but 
his closest family members.  He refused to believe that his friends were really 
his friends, but called them “people from overseas”.   
 
He urinated in his room, and around the nursing home, and did not care if he 
was in the sight of others.  The nursing home also reported that he had damaged 
computers and kitchen appliances attempting to “fix them”.  He continued to 
enjoy card games and outings.  He enjoyed visits from family members, and 
happily played card games with them.    185 
Michael’s Timelines: Each bar indicates the length of time (years) each event 
occurred.   
Timeline 1: Behaviours 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  48         49               50          51       52     53          54 
  AGE → 
 
   
Timeline 2: Speech 
 
 
 
 
 
 
  48         49               50          51       52     53          54 
  AGE → 
Difficulty recognising friends 
Increasingly disinhibited, loss of 
insight 
Pacing,  “Shadowing” family 
members, never gets lost 
Crying 
Loss of all conversational skills – increasingly concrete one-word 
speech 
Sexually inappropriate behaviours 
 
Ritualistic behaviours 
Enjoyed helping in kitchen, 
washing dishes 
Urinating in public 
Loud and verbally 
aggressive if doesn’t get 
his own way 
Enjoys drives, 
walks 
Increased 
aggression, 
hurling objects   186 
Timeline 3: Eating & Swallowing.  
 
 
 
               
 
 
 
 
 
 
 
  48         49               50          51       52     53          54 
  AGE → 
 
Timeline 4: Changing diagnoses.  
 
 
 
 
 
 
 
  48         49               50          51       52     53          54 
 
  AGE → 
 
 
Timeline 5: Syndromes 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
  48         49               50          51       52     53          54 
 
  AGE → 
Drinking very strong coffee, alcohol, craving 
sweets 
Depression  Frontotemporal Dementia 
Delusional 
Misidentification 
Syndrome, calling 
friends “people 
from overseas” 
Eating and drinking compulsively, 
stealing food, preference for sweet 
foods.  
Kluver-Bucy Syndrome   187 
Timeline 6: Imaging results 
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Timeline 7: Affective conditions 
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AGE → 
 
 
Timeline 8: MMSE, memory & preserved skills.  
 
 
 
 
 
 
 
 
 
 
 
 
  48         49               50          51       52     53          54 
  AGE → 
Depression  
Visuo-spatial skills relatively intact, rapid deterioration of verbal 
skills 
Well groomed, enjoys 
dressing 
MMSE = 28/30 
Enjoys card-games 
CT within 
normal limits 
CT: clear cortical atrophy 
of the frontal lobes. 
SPECT:  bilateral  frontal 
lobe  perfusion,  frontal 
lobe degeneration. 
 EEG:  slowing  of  frontal 
and temporal regions  
 Well groomed, requires some 
assistance to organise clothes when 
dressing   188 
Timeline 9: Hospital & Residential Services 
 
 
 
 
 
 
 
 
 
 
 
 
 
  48         49               50          51       52     53          54 
  AGE → 
 
 
 
 
 
 
 
Respite care 
Placed in 
nursing 
home 
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6.2.3 Frontotemporal Dementia Case Study 3 “Steven” 
Age: 48 
Steven, a 48 year old tradesman, first presented for assessment at hospital after 
being arrested for a very minor shoplifting offence.  The police had been unable 
to successfully interview him, and contacted his wife.  Shortly after this incident 
his family contacted his doctor who admitted him to hospital. After being 
admitted to hospital he showed no interest as to why he had been hospitalised, 
ate and drank excessively, and did not socialize.  Staff reported that he did not 
appear depressed in hospital and there was no evidence of psychotic symptoms.  
He slept through the days, becoming active only at night.  
 
Steven’s wife gave a history of progressive memory deterioration over 3 years, 
with increased emotionality, and increasingly disinhibited socially inappropriate 
behaviours.  Family members reported no history of depression or psychiatric 
illness.  On the contrary, family and friends indicated he had previously been a 
well-balanced, active member of the community, with excellent social skills.   
His wife reported increasing memory lapses and incidents where he would 
forget social and work engagements.   
 
Two years before presenting at the hospital she reported a marked increase in 
her husband’s level of anxiety, and incidents when he would cry for no obvious 
reason.  He was seen by a psychiatrist at this time.  Steven was diagnosed with 
depression and prescribed antidepressants.  There was no noticeable change in 
his mood or memory associated with the medication.  He was subsequently   190 
referred to a neurologist who suggested his problems were of psychiatric or 
psychological origin.  
 
His family and friends noticed increasing incidents of rudeness and lack of 
motivation. He stopped playing sport, and stopped reading.  He had been a 
heavy smoker, but had virtually stopped smoking.  He had become increasingly 
impulsive, spontaneously flying interstate, and walked aimlessly for long 
distances.  He did not get lost at any time.  He scratched his genitals in 
company, and appeared to enjoy burping and farting in public.  
Six months before initially presenting at the hospital, family members and 
friends reported a marked deterioration in Steven’s overall level of functioning.  
He had increasingly gone for long walks without explanation, and paced 
aimlessly around the house.  His sleep pattern had become erratic, and he 
sometimes went into town in the middle of the night.   Incidents of unusual 
behaviour increased, with friends reporting that he had visited them and had not 
talked to them.   He reported increased headaches at this time.   
 
Over the six months before presenting at hospital, Steven’s eating habits had 
completely changed.  Previously he had been conscious of his diet, and ate 
healthy foods.  He now compulsively ate any food he could find, and 
particularly sought out sweet foods.  He had rapidly gained weight.  Friends 
reported that he had “become childlike”.  His memory had continued to 
deteriorate, and he now was rarely able to remember friends’ names.  He often 
said he missed his mother, and became scared when left alone.  His wife stated 
that he was always anxious unless he was by her side.    191 
 
Shortly before his admission to hospital his wife took him to see his psychiatrist.  
He reported to the psychiatrist that he had “seen things”, including seeing a 
headless man with a long neck and holes for eyes and nose and mouth.   He did 
not realise that this was illogical. He had told his wife that his friends were 
“doubles” of people he knew (this is a classic Delusional Misidentification 
Syndrome, as first described by Pick, 1903). The psychiatrist reported a strong  
compulsive element in his behaviours accompanied by memory deficits. 
 
While in hospital he was given a comprehensive neurological work-up:  
 
MMSE = 28/30 
 
CT of cranium:  - Slight prominence of the anterior and temporal horns of the 
lateral ventricles bilaterally and also the 3
rd ventricle.  
Conclusion: Possible early atrophy.  
 
EEG:  Grossly abnormal with poorly organised activity.  Diffuse slowing 
dominated by theta waves.  Short dysrhythmic bursts with sharply contoured 
potentials in the frontal and temporal regions.  
Short dysrhythmic bursts are commonly found in patients with delusional 
misidentification syndromes (Chistodoulou & Malliara-Loulakaki, 1981). 
 
Previous CT and EEG scans completed twelve months previously were reported 
to have been normal.    192 
 
He was given a neuropsychological assessment shortly after admission to 
hospital. He was superficially cheerful and compliant throughout the 
assessment.  He showed no curiosity as to why he was being assessed, and    193 
asked no questions.  He denied any problems, and said he was “good”.   There 
was little spontaneous speech.  He needed continual breaks during the 
assessment.   
 
He denied any symptoms of depression.  He picked up a range of non-test 
materials during the assessment, including the psychologist’s diary. He looked 
through without permission, and appeared unaware that his behaviour was 
unusual. At times he stood up and walked around the office touching and 
examining various objects. 
 
He was seen for neuropsychological review three months later.  He was again 
cooperative, superficially cheerful, with a bland facial expression.  He was 
restless and fidgeted throughout the assessment.  He denied any problems, and 
was unaware of test failure.   He compulsively picked up test materials and 
wandered around the room, examining objects.  The clinical psychologist 
thought a psychiatric diagnosis was the most likely cause of his behaviour.  
 
Further imaging studies were conducted three months after his admission to 
hospital:  
 
MRI: - frontotemporal atrophy, pronounced symmetrical temporal lobe and 
inferior frontal lobe atrophy, and anterior basal ganglia atrophy.    194 
CT: - Mild frontal lobe atrophy, and pronounced relatively symmetrical 
temporal and inferior basal ganglia atrophy.  The degree of atrophy was found to 
be unusually severe for his age.  
 
SPECT:  - unequivocal frontal lobe hypoperfusion. He was extremely agitated 
before the study, which showed symmetrical hypoperfusion in both frontal lobes 
plus mesial portion of right temporal lobe.  
Conclusion: Results typical of frontotemporal dementia.  
 
MMSE = 25  
  
Electron microscopy:  
•  The axons showed wrinkling, - an axonopathy. 
•  Mitochondrial paracrystaline inclusions.  
•  Chronic denervation with reinnervation 
•  Chronic neuropathy 
 
After the neurological work-up he was given the diagnosis of Frontotemporal 
Dementia by the hospital neurologist.  
 
Three months after his admission to hospital, staff reported increasing 
swallowing problems, and coughing during fluid intake.  His self-care had    195 
deteriorated markedly.  He now dribbled when drinking, and appeared unaware 
when he had spilled food or drink on himself, and made no attempt to clean 
himself up. 
 
Steven was seen for neuropsychological review 12 months after his initial 
hospitalisation.  He was slightly agitated during assessment, and showed no  
insight.  He did not speak unless prompted, and then only gave occasional one 
or two word answers.   He was perseverative and impulsive during the 
assessment. He drew the same design three times, and continually attempted to 
read the psychologist’s notes, despite being asked not to.  
 
Age: 48 years 7 months 
Approximately five months after admission to hospital he had begun exposing 
himself.  This behaviour was noted to be associated with increasingly 
disinhibited groping of staff.  He was medicated with Depo Provera, 
Thioridazine, and Clonazepam.  No improvement was noted in his behaviour.   
 
Age: 49 years 6 months 
Steven was seen by his neurologist 16 months after first being hospitalised.    
He was unable to describe his problems, answered questions with short phrases 
such as “being here”, “the other day”, “not particularly interested”.   Steven told 
the neurologist that he fed animals when asked what he did. When prompted    196 
repeatedly he replied “particularly birds”.   He was unable to give any details of 
his history.   He was unable to give his own name. 
 
Nursing staff had reported that Steven was often found crying, but was unable to 
give reasons for his sadness, except to say, “need to be held”.  He often cried 
when listening to music.  He increasingly liked to hold on to, and cuddle people.  
He also cuddled a range of objects, including pillows and blankets.  He 
sometimes “howled” for up to ten minutes, and was unable to tell staff why he  
was upset, or even if he was upset.  
 
His gait had become unsteady, and he had developed a range of unusual 
movements, and performed rapid alternating movements with his legs.  He had 
become doubly incontinent and required assistance with all activities of daily 
living.  His days were spent watching television, and he often turned the volume 
up excessively.   
 
Steven’s weight had continued to increase, and he had become clinically obese.   
Hospital staff reported that he “guzzled food and drink” without chewing.  He 
attempted to eat large pieces of food without chewing them, including whole 
biscuits.  He had started eating off his plate without using his hands.  His eating 
and drinking had recently been assessed by a speech pathologist, and he was 
placed on a soft diet due to incidents of choking.    His eating was noted to 
improve if he was given constant prompts to chew his food, but regressed to his    197 
“gulping” food down and coughing as soon as the prompts ceased.  He was 
diagnosed with Frontotemporal Dementia with Motor Neurone Disease 
(FTD/MND). 
Age: 49 years 8 months 
Approximately 18 months after his hospital admission his medication was 
changed by a psychiatrist: 
 
Anti depressant — Sertraline 50 mg per day 
Anti psychotic — thioridazine 500 mg per day 
 
No improvement was noted in his behaviour.  
 
Staff reported that he had continued to deteriorate.  He urinated anywhere, 
sometimes on the floor.  His rate of urination increased.   He began to exhibit 
increasingly sexually inappropriate behaviours, including exposing himself to 
staff and visitors, and touching female staff on their breasts and buttocks.   He 
also showed sexual interest in visitors’ pets.  
 
He appeared briefly pleased if family or friends visited, but would go back to 
watching television after a few minutes.  He frequently wandered, randomly 
turning on and off of any switches he could find.   The hospital attempted to 
place him in a nursing home.  This failed due to inappropriate behaviour, 
including public masturbation and “bear hugging” women.     198 
Age: 49 years 10 months 
Approximately 20 months after admission to hospital he developed diabetes 
mellitus.    He now rarely cried, and spent most of his time watching children’s 
television, which he watched for hours at a time, and appeared to enjoy.   He 
actively avoided washing or showering.  He began to make numerous loud 
animal-like noises, and frequently touched objects that he appeared to find 
visually appealing.  Staff stated that he had settled well, and despite his unusual 
behaviours, appeared to enjoy the hospital routine, and had become easier to 
manage.  
 
Age: 50 years 
Two years after his admission to hospital he was placed in a nursing home.  He 
continued to grope female staff if he had the opportunity, and often masturbated 
in public.   He continued to enjoy watching children’s television programs.  
 
Age: 50 years 3 months 
Twenty-seven months after his admission to hospital he continued to deteriorate.  
He continued to crave sweets, and ate and drank compulsively.  He had started 
stealing food from other residents’ rooms, and from their plates in the dining 
room.  His favourite things to steal were sweets and biscuits.  He cried 
frequently, and repeated numbers out loud.    
 
His movement disorder worsened, and he now exhibited marked tremor, and    199 
was “wobbly” on his legs.   He was able to answer concrete questions that 
required only one-word answers accurately. For example, if he was asked what 
he had eaten for breakfast he was able to respond “toast” or “cereal”.  He had 
lost the ability to brush his teeth, and required extensive prompting for all daily 
activities.  Staff in the nursing home found his behaviour increasingly difficult 
to manage, and complained that they were not sufficiently resourced to manage 
someone with his complex behavioural and medical problems. The staff stated 
that he required one-to-one male 24 hour supervision, but they were unable to 
supply this.  He paced around the nursing home constantly and other residents 
complained about his behaviour.  He constantly attempted to fondle female staff 
and pinch their bottoms.   
 
Steven remained oriented to his immediate environment, and despite his 
constant pacing and wandering, did not get lost.   His daily activities consisted 
of pacing around or watching children’s programs on television.  He enjoyed 
colouring in children’s colouring books, and would spend long periods of time 
colouring in.  He enjoyed praise for his work.  He was still able to play 
dominoes, and enjoyed counting the small sums of money he was given.  He 
regularly looked through the daily paper, and especially enjoyed looking at the 
car and travel sections.  He was able to communicate through writing better than 
through speech, which had continued to deteriorate.  He enjoyed being well 
groomed, and appeared pleased when others commented on his appearance.  If 
given one-to-one attention, he was compliant, and was capable of remaining on 
task for up to two hours if being assessed by an occupational therapist or speech   200 
pathologist.   His limited speech consisted of perseverative, syntactically correct, 
one or two word utterances.  
 
Age: 50 years 6 months 
Two and a half years after his initial hospitalisation his condition continued to 
worsen.  He wrote long letters, composed of the same line repeated over and 
over.  He was reviewed by his neurologist who noted a further reduction in 
speech output.  He continued to grope females, and had begun smearing his 
excreta on walls.   He enjoyed farting and blowing bubbles throughout the 
assessment.   
 
Despite his deterioration, he continued to enjoy family visits, and board games.   
He enjoyed going for drives with family members, and exhibited no behavioural 
problems at these times.   
 
Age: 50 years 10 months 
He was assessed by the neurologist and the author.  He was difficult to assess. 
He responded to questions by looking briefly at the neurologist, and making 
brief grunts.  He showed no sign of distress, and repeatedly wandered out of the 
room.  On one occasion he took himself to the toilet and returned without 
assistance. He ate biscuits continually, played with his genitals, and smelled his 
fingers.  He did not use any discernible words throughout the assessment.  
 
Staff at the nursing home reported that they were increasingly alarmed by his 
behaviours, and felt that he was a risk to himself and others. He was placed on a   201 
combination of Clonazepam, Thioridazine, and Cyproterone.    Staff reported 
that the medication did not change his behaviour.   Shortly after the introduction 
of the above medication he became more aggressive, and began pushing 
residents and staff.    There were insufficient staff to implement behavioural 
interventions, and no staff with psychiatric nursing experience. 
 
Staff at the nursing home reported that Steven was spending much of his time 
sleeping with brief periods of hyperactivity.  During his hyperactive periods he 
grabbed the breasts of staff and patients, and howled. He was medicated with 
Olanzapine.  He died in his sleep 3 weeks later.    202 
Steven’s Timelines: Each bar indicates the length of time (years) each event occurred.   
 
Timeline 1: Behaviours 
 
 
 
 
 
 
 
 
 
 
  48         49        50           51 
  AGE → 
 
   
 
Timeline 2: Speech 
 
 
 
 
 
 
 
 
 
 
 
  48         49        50           51 
  AGE → 
 
 
 
 
 
 
 
 
 
 
 
 
 
Increasingly childlike & disinhibited. Pacing.  Sleep disturbance 
Aggressive.  
Unable to work 
Doubly incontinent 
Increasingly impoverished speech. 
One-word answers, no spontaneous speech, 
increasingly perseverative answers. 
Howling.   203 
 
Timeline 3: Eating & Swallowing.  
 
 
 
 
 
 
 
 
 
  48         49        50           51 
  AGE → 
 
Timeline 4: Changing diagnoses.  
 
 
 
 
 
 
 
 
  48         49        50           51 
  AGE → 
 
 
Timeline 5: Syndromes 
 
 
 
 
 
 
 
 
 
 
  48         49        50           51 
  AGE → 
 
 
 
 
 
 
Compulsive eating. Stealing food. Rapid weight gain.  
Obese, eats without hands, drinks compulsively 
Depression 
Conversion 
Disorder 
Frontotemporal Dementia/ Motor 
Neurone Disease 
Stimulus-bound behaviour 
Misidentification syndrome 
Kluver-Bucy Syndrome 
Increasing incidents of choking   204 
Timeline 6: Imaging results 
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Timeline 7: Affective conditions 
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Timeline 8: IQ, memory & preserved skills.  
 
 
 
 
 
 
 
 
 
 
 
  48         49        50           51 
  AGE → 
Treated for depression, emotional 
Anxiety 
No depression, superficial 
Cheerful. Bland.  
Increasingly forgetful, unable to remember own name after 36 months 
Maintains ability to play simple board games ie, dominoes. 
IQ 90, MMSE 
28/30 
IQ 75 
Hallucinations 
CT – early atrophy 
EEG abnormal 
SPECT – 
Frontotemporal 
hypoperfusion 
MRI –Frontotemporal 
and basal ganglia 
atrophy – FTD/MND   205 
Timeline 9: Hospital & Residential Services 
 
 
 
 
 
 
 
 
 
  48         49        50           51 
  AGE → 
 
Hospitalised, 
settled 
quickly 
Readmitted 
to hospital 
Staff unable to 
manage behaviours 
Placed in nursing home   206 
6.2.4 Frontotemporal Dementia Case Study: “Julie” age 46  
 
Age: 46 Years 5 months 
“Julie” 
Julie was initially referred to the hospital neurologist by her doctor who 
suspected dementia.   She was initially seen with her husband who stated that 
her speech was “very poor”.   Julie was cheerful during the interview, and 
denied any problems.   Her husband stated that her memory had deteriorated 
rapidly over the past 18 months.   She had become “stressed” at work, and had 
to stop working.  She now required assistance to perform simple tasks, such as 
shopping, something she had previously loved doing alone.  Her husband also 
noted some behavioural changes, such as walking around in the daytime in her 
underwear, something she previously would never do.    He stated that his wife 
was generally happy, and had not noticed any major behavioural problems.  
 
The results of the neurological investigations revealed a range of deficits:  
 
CT: - shows some atrophy, no acute lesion.   
 
SPECT:  – symmetrical reduced perfusion to the frontal and temporal lobes 
 
EEG: – Abnormal, slowing of the central rhythms as a result of structural 
abnormality or encephalopathy.   
 
MRI: - Cortical atrophy present, particularly was affecting the frontal lobes.    207 
 
Diagnosis: Frontotemporal Dementia/Parkinsonism 
 
Age: 46 years 6 months.  
Julie was seen for neurological assessment accompanied by her husband.  He 
stated that her memory had continued to deteriorate, and that she had forgotten 
well-known prayers.  She had difficulty naming objects, and recalling names of 
friends.  He noted that her “personality had completely changed”.   Julie had 
previously been outgoing and sociable, “a very confident person”.  She was now 
withdrawn and uncertain, and completely dependent on her family.  She was 
often tearful and anxious, and had frequent panic attacks, especially if taken out 
of her home.   She frequently repeated herself during the assessment.  Her 
speech was impoverished.  Julie described herself as “very unhappy”.  
The neuropsychological assessment was conducted over two days due to Julie’s 
slowness.  She was easily distractible, had difficulties understanding the test 
instructions, and exhibited impaired memory. For example, she could not recall 
any details of the previous day.   She was constantly distracted by objects in the 
room, and commented frequently on objects outside the window.   
 
Age: 46 years 7 months 
Julie was assessed by a speech pathologist.  She was able to independently 
generate and employ a range of highly effective strategies to assist word 
retrieval and memory. However, she performed poorly on many tests sensitive to 
mild dementia.  Julie reported that she had been prescribed an SSRI   208 
antidepressant, and was now sleeping better, and was feeling less “panicky”.   
She showed some insight into the fact that her memory was failing.   
 
Age: 46 years 8 months.   
Julie was seen for neurological review.  She complained of discomfort and 
aching in the top of her head, neck, chest, and limbs, and stated that sometimes 
she felt that her “head is going to blow up”.    
 
Age: 46 Years 11 months 
Julie was seen for neurological review.  Her illness had progressed. Speech 
production was further reduced.  She had developed significant tremors, more 
marked in the right upper limbs. She exhibited a resting tremor in her right hand.  
She complained of burning feet.   She also exhibited jerks in her arms and legs.   
 
These were described by the neurologist as “extra pyramidal features associated 
with Frontotemporal Dementia”.  Her husband reported that Julie complained of 
“bad smells”, olfactory sensations of manure, sometimes overpowering.  The 
neurologist suspected the smells were the result of olfactory seizures. Her 
husband stated that the “smells” occurred at the same time as her panic attacks.  
She often complained of feeling “cold and shaky”.   Olfactory seizures are 
associated with progressive atrophy of the hippocampus and medial temporal 
lobe (Fried & Spencer et al. 1995; Pikkarainen & Pitkanen, 2001).   
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Age: 47 years 4 months 
Julie was seen for her routine neurological review.  The neurologist noted that 
she was more relaxed than at previous consultations.  Her episodic memory, 
linguistic expression, and linguistic comprehension were all impaired.  Her 
visuospatial construction skills remained within normal limits.  Julie’s 
Parkinsonism had become more profound, with her tremor now more 
exaggerated.  She now experienced difficulty dressing.   She complained of 
worsening depression and agoraphobia. Her husband reported increased 
episodes of crying.  He also stated that she now had difficulty reading and 
writing, and was tearful at night, often waking from “bad dreams”.  She had lost 
her sex drive.   
 
Julie had continued to experience panic attacks preceded by olfactory 
hallucinations.   Her husband stated that the onset of these incidents were  
sudden, and their cessation swift.  He reported these episodes occurred 
approximately twice per week.  
 
Age: 47 years 11 months 
Julie was visited at home by the author.   She was fearful, and had only spoken 
when prompted.  Her husband stated that she was scared when left alone.  She 
had been attending respite care, and appeared to enjoy this.  Her husband stated 
that Julie’s memory had continued to deteriorate.  She could no longer read or 
write, forgot people’s names, and was unable to follow conversations.  
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Age: 48 years 6 months 
Julie was seen by a speech pathologist.  Julie spoke in slow, halting utterances, 
with frequent semantic errors.  She was able to accurately copy a geometric 
design. All other assessment tasks were impaired. She was experiencing 
increasing swallowing difficulties, and was placed on a soft diet.  
 
Age: 48 years 8 months. 
Julie was assessed as requiring “high level hostel care”, and placed in permanent 
care.   
 
Age: 49 years 
Staff at the nursing home reported that Julie was deteriorating rapidly, and had 
developed generalized tonic clonic seizures. 
 
Age: 49 years 2 months.  
Julie died in the nursing hostel.  Staff reported seizures continued until her 
death.     211 
Julie’s Timelines: Each bar indicates the length of time (years) each event 
occurred.   
Timeline 1: Behaviours 
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Timeline 2: Speech 
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Timeline 3: Eating & Swallowing.  
 
 
 
 
 
 
 
  46          47            48          49             
  AGE → 
Cheerful 
Low level disinhibition 
Less anxious, 
happier 
Crying for long periods 
Increasing swallowing difficulties 
Placed on soft diet 
Steady deterioration in expressive language 
Naming difficulties 
Unable to follow 
conversations 
Problems dressing 
Loss of sex drive 
Increasing tremors, extra pyramidal 
features 
Panic attacks accompanying olfactory 
seizures   212 
Timeline 4: Diagnosis.  
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Timeline 5: Imaging results 
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  AGE → 
 
Diagnosis: Frontotemporal Dementia/Parkinsonism 
Dementia 
Frontotemporal Dementia with Parkinsonism 
CT- atrophy, no acute lesion.   
SPECT - perfusion of frontal and temporal 
lobes  
EEG – structural abnormality or 
encephalopathy.   
MRI - Cortical atrophy present, 
particularly of the frontal lobes.    213 
Timeline 6: Affective conditions 
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Timeline 8: Memory & preserved skills.  
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Timeline 9: Hospital & Residential Services 
 
 
 
 
 
 
 
 
 
  46          47            48          49             
  AGE → 
Agoraphobia 
Continual deterioration of memory 
Relatively preserved visuo-spatial skills 
Respite care 
Permanent nursing 
home care 
Depression, short term benefits from SSRI’S   214 
CHAPTER 7 
CONCLUSIONS AND IMPLICATIONS OF 
THE STUDY FOR THE CARE OF PATIENTS 
WITH EARLY-ONSET DEMENTIA 
 
“It is our responsibility to treat patients and teach others to care for 
patients in the least restrictive environment possible, while maintaining a 
choice of options, promoting optimal functioning, and fostering 
independence in the patient” 
            Richards, 1990 
 
 
7.1 CONCLUSIONS 
7.1.1 Study Objectives 
 
•  This evaluation of Frontotemporal Dementia found that this relatively 
new diagnostic category is valid and useful, and can be reliably 
differentiated from Alzheimer’s Disease.  
•  Behavioural, neurological, and neuropsychological assessment were 
found to be important in the early and accurate diagnosis of early-onset 
dementia.    215 
 
•  This study provides practical information to care-providers regarding the 
needs of people who receive a diagnosis of early-onset dementia.  
 
7.1.2 Hypotheses 
1.  This study found that the clinical criteria developed by Neary & Snowden 
et al. (1998)  differentially diagnosed early-onset Frontotemporal 
Dementia patients from early-onset Alzheimer’s Disease patients.  
 
2.  The analysis of this group of patients provides information that can assist 
in the formulation of care and treatment plans for patients with differing 
forms of early-onset dementia.  
 
3.  This study found that the Frontotemporal Dementia patient group had 
significantly increased behavioural disturbances throughout the course of 
the illness in comparison with Alzheimer’s Disease patient group. 
Evaluation of behavioural profiles assisted with the differential diagnosis 
of Frontotemporal Dementia patients from Alzheimer’s Disease patients, 
supporting previous research (Levy & Miller et al. 1996; Duara & Barker 
et al.  1999; Pasquier 1999; Tanabe & Ikeda et al. 1999; Cummings & 
McPherson, 2001; Kertesz & Davidson et al. 2003; Mourik & Rosso et 
al. 2004; Engelborghs & Maertens et al. 2005; Thompson & Stopford et 
al. 2005).      216 
4.  This study found that Frontotemporal Dementia and Alzheimer’s Disease 
patients showed significant differences on visuospatial 
neuropsychological tests.  The Frontotemporal Dementia patients had 
relatively preserved visuo-spatial abilities compared to Alzheimer’s  
Disease patients, supporting previous research (Elfgren & Passant et al. 
1993; Stuss, 1993; Gregory & Orrell et al. 1997; Duara & Barker et al.  
1999; Pasquier, 1999; Ikeda & Tanabe, 2000; Storey & Slavin et al. 
2002; Kramer & Jurik et al. 2003; Harciarek Jodzio, 2005).  
 
5.  This study found that the course of the illnesses differed significantly 
between the early-onset Frontotemporal Dementia and Alzheimer’s 
Disease groups. Frontotemporal Dementia patients experienced rapid 
progression of disease symptoms, with all but one of the Alzheimer’s 
Disease patients showing a more gradual deterioration.   These findings 
are consistent with previous research (Barber, Snowden & Caufurd, 1995; 
Pasquier & Richard et al. 2004; Kertesz & McMonagle et al. 2005; 
Roberson & Hesse et al. 2005; Pasquier & Lebert et al. 2005).    217 
7.2 CARE OF PATIENTS WITH EARLY ONSET DEMENTIA 
This research has shown that over a 3-year time period Frontotemporal 
Dementia patients’ care needs are more complex and difficult to manage than 
that of all but a few Alzheimer’s Disease patients.  Care programs need to be 
capable of adapting to the patients’ (and families’) rapidly changing 
requirements.   
 
This study found that families, health service providers, and residential care 
facilities were commonly overwhelmed by the ever-changing needs of some 
early-onset Alzheimer’s Disease patients, and nearly all the Frontotemporal  
Dementia patients.   The rapid onset of complex behavioural problems, often 
combined with marked physical decline, posed significant challenges to all those 
involved in the care of this often overlooked group of dementia sufferers.  These 
findings support previous research which has highlighted the difficulty in caring 
for patients with early-onset dementia (Harvey, 1998; Tanabe, Ikeda, & Komori, 
1999; Tune & Bowie, 2000; Mourik & Rossi et al. 2004; Passant & Elfgren et 
al. 2005; Chapman & Williams et al. 2006; Yokota & Fujisawa et al. 2006).  
 
A major obstacle to the provision of quality services for this group has been that 
generic dementia services have been designed to cater for patients fitting the 
traditional profile of Alzheimer’s Disease.  These services work with the 
underlying assumption that there will be adequate time to tailor services, and 
that there will be suitable accommodation options.  Generic services also 
assume    218 
that patients fall into the broad framework of Alzheimer’s Disease (Harvey, 
1998). Common assumptions are that patients have relatively preserved social 
skills, impaired memory, impaired visuospatial functioning, and decline slowly.  
The results of this study support previous research (e.g. Neary, Snowden, & 
Mann, 2005; Passant & Elfgren et al. 2005) which has found that 
Frontotemporal Dementia patients do not fall into this framework. 
Frontotemporal Dementia patients have relatively preserved visuo-spatial skills, 
decline rapidly, exhibit extremely challenging behaviours, and undergo a rapid 
change of personality (Chapman & Williams et al. 2006; Roberson & Hesse et 
al. 2006).  
 
This research indicates that for most Frontotemporal Dementia patients and 
some early-onset Alzheimer’s Disease patients the generic model of dementia 
care does not adequately meet the needs of patients and their families.  
 
7.3 SUGGESTIONS FOR THE IMPROVEMENT OF SERVICES FOR 
EARLY ONSET DEMENTIA  
7.3.1 Rapid Service Response 
Due to the rapid onset of Frontotemporal Dementia, and the high level care and 
respite requirements early in the course of the illness, special funding should be 
allocated to patients immediately a diagnosis of Frontotemporal Dementia is 
given.  Most current dementia services are funded for the over 65 age group. 
This mode of funding has resulted in early-onset dementia patients being 
inappropriately hospitalised in psychiatric units and nursing homes.    219 
The current services, although providing much needed relief for families, are 
often seen as degrading by families and the patients.  This research indicates that 
Frontotemporal Dementia patients often require 24-hour supervision early in the 
course of their illness.  If this supervision was implemented with specialist back-
up, many of the behavioural problems outlined above may be minimised, and 
the quality of life for patients and their families greatly increased (see below for 
details).  
 
7.3.2 Nursing Homes and Hospitals 
Staff in nursing homes are often untrained in the management of severe 
behavioural problems such as those exhibited by many of the Frontotemporal 
Dementia patients in this study. This lack of training inevitably leads to 
behavioural disturbances that could be avoided if an adequately resourced 
management plan was in place.  Several recent studies have shown that 
modification of the nursing home or hospital environment can significantly 
improve the quality of life for patients with Frontotemporal Dementia (e.g. 
Robinson, 2001; Testad & Aasland et al. 2005; Yokota & Fujisawa et al. 2006).  
 
7.3.3 Palliative Care 
This study produced results consistent with previous research which has shown 
that patients diagnosed with Frontotemporal Dementia frequently die 2-3 years 
after diagnosis (Pasquier & Richard et al. 2004; Roberson & Hesse, 2005).   
These findings have important implications for the care of this population.    220 
Frontotemporal Dementia patients deteriorate rapidly, experiencing severe 
behavioural changes accompanied by increasing medical problems such as gait 
disturbance and swallowing difficulties. In the context of crisis responses to 
challenging behaviours, palliative care issues can easily be overlooked.   
 
Providing palliative care for this group of patients requires significant skills and 
resources.  The provision of quality palliative care services may assist families 
through their grief processes, and allow patients to feel secure during their last 
days.   All the Frontotemporal Dementia patients in this study remained aware of  
their immediate environment, and continued to recognise and respond positively 
to family members.  This preserved orientation to environment holds open the 
opportunity to provide a pleasant environment that patients can enjoy, and a 
peaceful space for family members to spend their last hours with their loved 
ones.   
 
Although behavioural problems can persist to the end of the illness, the episodes 
of problematic behaviours described in this study were generally of short 
duration, and patients continued to enjoy activities such as playing cards and 
drives with relatives.  If the focus of care is solely on behavioural and medical 
management, rich opportunities for enhancing not only the early stages but also 
the last stages of life can be lost.   
 
There is currently no published research on the provision of palliative care to    221 
Frontotemporal Dementia patients.  This is an important area for future research, 
not only in assisting the dying, but also for their families. Due to the strong 
hereditary component of the condition it is important that family members see 
that their loved ones are cared for in the best possible way. Families caring for 
relatives who have a long family history of Frontotemporal Dementia know that 
they may develop the illness. Seeing that relatives are well cared for may reduce 
their anxiety about their own future.  
 
7.3.4 Behavioural Care  
This study found high levels of ritualistic and environmentally dependent 
behaviours in the Frontotemporal Dementia patients, and a complete absence of  
these behaviours in the Alzheimer’s Disease patients. This finding suggests that 
behavioural care strategies for the two groups of patients may need to be 
significantly different.  Recent research has shown that individualised 
behavioural care programs can successfully improve the quality of life for 
dementia patients who display challenging behaviours (e.g. Moniz-Cook & 
Woods et al. 2001). 
 
    Using Preserved Skills 
Utilising the preserved skills of Alzheimer’s Disease patients has successfully 
been used to enhance their quality of life. For example, patients are encouraged 
to recall pleasant memories from their past (e.g. Rentz, 1995; Cotelli & Calabria  
et al.2006; Yokoto & Fujisawa et al. 2006).  A similar strengths-based approach    222 
shows promise with Frontotemporal Dementia patients.  Several researchers 
(Ikeda & Tanabe et al. 1995; Tanabe & Ikeda et al. 1999;  Robinson, 2001) have 
successfully used the preserved skills associated with Frontotemporal Dementia 
to enhance the quality of patient care.  
 
Recommendations 
Assess all Frontotemporal Dementia patients’ histories to find out non-verbal 
procedures that the patients carried out before developing their illnesses. This 
information can provide a rich source of information for structuring care plans. 
Utilising activities that the patients are familiar with may assist with creating 
least-restrictive environments and reduce behavioural problems.  
 
7.3.5 Promising New Therapies 
Routinizing Therapy 
One new therapy that has shown promise for use with Frontotemporal Dementia 
patients has been developed by Tanabe, Ikeda and colleagues (Ikeda & Tanabe 
et al. 1995; Tanabe & Ikeda et al. 1999).  These researchers have outlined a form 
of behavioural care which they have labelled “routinizing therapy”.  Routinizing 
therapy uses patients’ environmental dependency syndrome and stereotypical 
behaviours (see table 43 above) to improve their quality of life, and to reduce 
the burden on caregivers.   They present 5 case studies where patients with 
previously unmanageable behaviours were encouraged to perform visuospatial 
tasks they had performed frequently before they became affected by    223 
Frontotemporal Dementia.  The tasks used included knitting, board games, and 
assisting nurses to measure blood pressure.  All these tasks were procedures that 
the patients had performed routinely before they developed Frontotemporal 
Dementia.  For example, the patient who assisted the nurses measuring blood 
pressure had been a doctor.   Although this patient had been difficult to manage, 
once assigned a task that he was familiar with, his behavioural problems rapidly 
decreased.  
 
In the current study many of the Frontotemporal Dementia patients exhibited 
similarly preserved procedural memory, and enjoyed outings, board games, 
television and sometimes performing ritualistic behaviours throughout the 
course of their illness (see Chapter 6 above).  
 
Harnessing environmental dependency and preserved visuo-spatial 
skills. 
If adequate resources are available to implement behavioural management 
programs Frontotemporal Dementia patients can be engaged in a range of 
activities such as going for drives, playing card and board games, walking, 
playing pool, and gardening. Focusing on such positive activities can provide 
patients with opportunities to engage in behaviours that are enjoyable, and divert 
them away from engaging in socially inappropriate behaviours.     224 
Recommendations  
Given these findings, future applied research could explore the efficacy of 
utilising visuospatial tasks to enhance the quality of life for Frontotemporal 
Dementia patients.   
 
7.3.6 Flexible Care Plans 
A major issue in the behavioural management of early-onset Frontotemporal 
Dementia patients and some early-onset Alzheimer’s Disease patients is the 
rapid deterioration in their functioning.  If behavioural care programs are to have 
any chance of success they need to be constantly updated to meet the changing 
needs of the patients.  For example, in the early stages of the illness a walking 
partner may be suitable. As the patient deteriorates, drives or walks in a 
wheelchair may be appropriate.   
 
7.3.7 Ethical Issues – Creating “Least Restrictive Environments”     
Early-onset dementia patients, regardless of their diagnosis, deserve to be cared 
for in the least restrictive environment possible.  That is, in an environment that 
is as close to home-like as possible, and maximizes independence and 
functioning.  
 
Providing “appropriate” services to young Frontotemporal Dementia patients is 
an ethically difficult task. Many Frontotemporal Dementia patients in this study 
became childlike, and enjoyed activities such as playing with dolls, colouring-in    225 
children’s books, and watching children’s television programs.  To ensure that 
dementia-care programs enhance patients’ quality of life, and are acceptable to 
families, it is essential that a clear framework of service delivery is developed 
(e.g. Kalis & van Delden et al. 2004). 
 
Early-onset dementia patients are one of the most vulnerable groups in our 
society, and have specific requirements.  Providing safety and meeting the basic 
needs of FTD patients in as normal a setting as possible is a special challenge.  
There are no easy answers to providing appropriate care.  Care-plans should 
always attempt to meet the sometimes competing needs of the individual (for 
example, if an adult patient wants to play with dolls) and the ideals of the “least 
restrictive environment”.  
 
7.3.8 Pharmacological Interventions 
Recent research has indicated that pharmaceutical treatments can assist with the 
management of the behavioural disorders accompanying Frontotemporal 
Dementia (Lebert & Stekke et al. 2004; Morretti & Torre et al. 2004; Ishikawa 
& Shimomura et al. 2006).  medications for treating dementia are designed to 
treat abnormalities in the cholinergic and serotonigenic systems (Snowden & 
Neary et al.  2002; Chow, 2005).     226 
    Cholinergic Medications 
There is limited evidence that cholinergic medications have any clinical effect 
with Frontotemporal Dementia patients as there is no clear evidence that this 
group has any disruption of the cholinergic system (Snowden & Neary et al.  
2002; Chow, 2005).   One study using a cholinergic medication, Rivastigmine, 
indicated that the medication significantly reduced the frequency and intensity 
of behavioural disturbances, and subsequently reduced caregiver distress 
(Moretti & Torre et al. 2004).   
 
    Selective Serotonin Reuptake Inhibitors 
There is some limited evidence indicating that selective serotonin reuptake 
inhibitors (SSRI’s) may reduce ritualistic behaviours, disinhibition, and 
compulsive eating in a minority of Frontotemporal Dementia patients (Swartz & 
Miller et al. 1997). The SSRI Trazodone, in a randomized placebo-controlled 
study of 26 Frontotemporal Dementia patients, was shown to significantly 
decrease patients’ irritability, agitation, depression, and eating abnormalities 
(Lebert & Stekke et al. 2004).   The SSRI fluvoxamine malate was found to 
significantly reduce stereotyped behaviours in 16 Frontotemporal Dementia 
patients over a 16 week period (Ikeda & Shigenobu, 2004). Paroxetine has been 
found ineffective in reducing behavioural problems in 10 Frontotemporal 
Dementia patients (Deakin & Rahman et al. 2004).  The caregivers of 8  
Frontotemporal Dementia patients treated with Paroxetine reported a decrease in  
their levels of stress (Moretti & Torre et al. 2003).   227 
    Neuroleptics 
Neuroleptic medications may not be suitable for use with Frontotemporal 
Dementia patients. A study of 24 Frontotemporal Dementia patients medicated 
with neuroleptics found significant extrapyramidal side effects in 33% of the 
patients.  The study recommended that if neuroleptics are used with 
Frontotemporal Dementia patients, caution should be used as this group appears 
to be particularly susceptible to the adverse side-effects associated with this 
class of drugs (Pijnenburg & Sampson et al. 2003). 
 
Other Agents 
Several medications have shown promise for controlling behavioural 
disturbances associated with Frontotemporal Dementia. valproic acid has been 
found useful in some patients for agitation, anxiety, and repetitive/ritualistic 
behaviours.  Donepezil has not been shown to have any clinical efficacy (Chow 
& Mendez, 2002).  
 
Recommendations 
There is evidence that pharmacological interventions may assist with managing 
some of the symptoms associated with Frontotemporal Dementia. Symptoms 
that have shown response to medications include aggression, stereotypical 
behaviours, disinhibition, impulsivity, and abnormal eating behaviours.  Further 
research is required to determine the long-term effects of medications, and to 
evaluate the impact of the medications on the quality of life of both patients and 
their carers.     228 
7.3.9 Neuropsychological and Behavioural Assessment 
The results of the current study indicate that neuropsychological assessment of 
patients with Frontotemporal Dementia provides useful information that can be 
used in clinical management (see Chapter 4 for details). Much of the useful 
information obtained was from the observation of the patients’ behaviours 
during the extended time intervals spent with the patients.  It is possible that the 
use of a behavioural rating scale during assessment could assist in quantifying 
behaviours.  Rating scales that have been shown to have clinical utility are the  
Stereotypy Rating Inventory (SRI, Shigenobu & Ikeda et al. 2002), the  
Frontotemporal Behavioral Scale (Lebert & Pasquier et al. 1998), the Frontal 
Behavioural Inventory (Kertesz & Davidson et al. 1997), and the 
Neuropsychiatry Inventory (NPI, Srikanth, Nagaraja, & Ratnavalli, 2005).  
These scales have the advantage of being brief, and are effective in differentially 
diagnosing Frontotemporal Dementia from other conditions such as vascular 
dementia and Alzheimer’s Disease.  
 
Drawbacks of Using Neuropsychological Tests  
Verbal Tests of Limited Use 
This study has shown that the vast majority of the neuropsychological tests were 
sensitive to neurological dysfunction. However, only one verbal test (the 
immediate recall condition of the Wechsler Memory Scale Logical Memory test) 
was found to differentiate between the two groups.  Non-verbal tests were found    229 
to be useful in discriminating between the groups (WAIS-111 Block Design and 
Picture completion subtests;  Purdue Pegboard Test; Tactile Finger Recognition 
Test; Rey-Osterrieth Complex Figure Test; Freehand Clock Drawing test;  
Written component of the Symbol Digit Modalities Test; Wechsler Memory 
Scale Visual Recall Test).  The results are consistent with previous research that 
has shown that the majority of neuropsychological tests are not useful in the 
differential diagnosis of Frontotemporal Dementia from other conditions (e.g. 
Siri & Benaglio et al. 2002). 
 
Time and Cost 
Neuropsychological assessment is costly and time-consuming.  Testing places 
patients in situations where their deficits are exposed.  If not managed tactfully, 
the assessment can be disturbing for the patient (Lezak, 1995).  
 
Recommendations 
To minimise patient distress assessments should be kept to a minimum. 
Neuropsychological assessment should only be conducted if there is a clear 
clinical purpose (i.e. to assist with differential diagnosis from other neurological 
conditions).    
 
The Mini Mental State Exam (MMSE, see Chapter 4) and a behavioural 
inventory such as the Neuropsychiatry Inventory (NPI, see section 7.2.7) can be    230 
used in conjunction with brief neuropsychological instruments such as the 
Tactile Finger Recognition Test and the Freehand Clock Drawing test.  If results 
of this brief battery were found to be abnormal patients should be given a 
comprehensive neurological imaging work-up.    
 
7.3.10 Limitations of the current study 
Within this study neuropsychological tests were administered in a non-
standardised way (see Chapter 4).  The tests were used to assist with the clinical 
management of the patients rather than primarily for research purposes.  
Therefore, the neuropsychological test results reported above need to be treated 
with caution.    
 
Neurological imaging investigations (CT, MRI, EEG, SPECT) occurred at 
different times during the course of patients’ illnesses. As neurological imaging 
assessments were not conducted at the same point in their illness for each 
patient, direct comparison between the different imaging modalities was not 
possible. A standardised approach to neurological imaging studies may assist in 
the exploration of early-onset dementia patients.  
 
Some of the “difficult behaviours” reported in this study may have been the 
result of the failure of care and support services to adequately respond to the 
rapidly changing needs of early-onset dementia patients.    231 
7.3.11 Directions for future research 
Future research in the area of early-onset dementia care is required to develop 
services that have the capacity to combine high-quality medical care with 
behavioural care.  This study has highlighted the individualised and ever-
changing needs of many early-onset dementia patients.  The provision of  
palliative care to this group has not been researched.  Future research could 
assist in the development of palliative care services for this population. Specific 
issues that could be examined by future research are the provision of age-
appropriate services, and developing individualised care-plans that focus on 
patients’ strengths, rather than on their deficits.      232 
APPENDICIES 
 
APENDIX 1: CONSENT FORM 
MURDOCH UNIVERSITY LETTERHEAD 
CONSENT FORM FOR CARER 
I am a Doctor of Psychology student at Murdoch University.  I am investigating if people 
diagnosed with Alzheimer’s Disease perform differently to people diagnosed with 
Frontotemporal Dementia on commonly used neuropsychological tests.  I am also investigating 
the sorts of behavioural and memory difficulties people with Frontotemporal Dementia and 
Alzheimer’s Disease experience.  
The purpose of this study is to look for factors that may help with the diagnosis of 
frontotemporal dementia and Alzheimer’s disease.  New treatments are becoming available, so 
correct diagnosis may help people diagnosed with either Frontotemporal Dementia or 
Alzheimer’s Disease get the best treatment available.  
You can help in this study by consenting to the information obtained during the assessment from 
the person for whom you are the authorised representative being used for this proposed research.  
You can decide to withdraw your consent at any time.  All information given during the 
assessment is confidential and no names or other information that might identify the person for 
whom you are the authorised representative will be used in any publication arising from the 
research.  
If you are willing for the person for whom you are the authorised representative to participate in 
this study, could you please complete the details below?  If you have any questions about this 
project please feel free to contact either myself, John Rudge, on 9347 6464 or my supervisor, Dr 
Peter Drummond on 9360 2415 
My supervisor and I are happy to discuss with you any concerns you may have on how this study 
has been conducted, or alternatively you can contact Murdoch University’s Human Research 
Ethics Committee on 9360 6677.  
***********************************************************    233 
I have read the information above.  Any questions I have asked have been answered to my 
satisfaction.  I agree for the person for whom I am the authorised representative to take part in 
this activity.  However, I know that I may change my mind and stop the participation at any time 
without prejudice to the future medical treatment of the person I am signing on behalf of.  
I understand that all information provided is treated as confidential and will not be released by 
the investigator unless required to do so by law.  
I agree that research data gathered for this study may be published provided the name of the 
person for whom I am the authorised representative or other information which might identify 
the person for whom I am the authorised representative is not used.  
Authorised Representative: 
Date: 
Investigator: 
Date: 
Investigator’s Name:    234 
APPENDIX 2: FRONTOTEMPORAL DEMENTIA (FTD) – 
ALTERNATIVE LABELS 
 
• DISINHIBITION-DEMENTIA-PARKINSONISM-AMYOTROPHY COMPLEX 
(DDPAC) 
 
• FRONTAL VARIANT OF FRONTOEMPORAL DEMENTIA (fv-FTD) 
 
• FRONTOTEMPORAL DEMENTIA WITH MOTOR NEURONE DISEASE 
(FTD/MND) 
 
• FRONTOTEMPORAL DEMENTIA WITH PARKINSONISM 
 
• FRONTOTEMPORAL DEMENTIA-AMYOTROPHIC LATERAL SCLEROSIS 
(FTD-ALS) 
 
• FRONTOTEMPORAL LOBAR DEGENERATION (FTLD) 
 
• FRONTOTEMPORAL LOBE DEMENTIA (FLDEM) 
 
• FRONTOTEMPORAL LOBE DEMENTIA ASSOCIATED WITH MUTATIONS 
ON THE TAU GENE (FTDP17) 
• MULTIPLE SYSTEM TAUOPATHY WITH PRESENILE DEMENTIA (MSTD) 
 
• PICK COMPLEX 
 
• PRIMARY PROGRESSIVE APHASIA (PPA) 
 
• SEMANTIC DEMENTIA (SD) 
 
• TEMPORAL VARIANT OF FRONTOTEMPORAL DEMETIA (tv-FTD) 
 
• WILHELMSEN-LYNCH DISEASE (WLD)   235 
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